Garrett L. Walsh, M.D.

Peer-Reviewed Articles

1. Cascone T, Leung CH, Weissferdt A, Pataer A, Carter BW, Godoy MCB, Feldman H, William WN, Xi Y, Basu S, Sun JJ, Yadav SS, Rojas Alvarez FR, Lee Y, Mishra AK, Chen L, Pradhan M, Guo H, Sinjab A, Zhou N, Negrao MV, Le X, Gay CM, Tsao AS, Byers LA, Altan M, Glisson BS, Fossella FV, Elamin YY, Blumenschein G, Zhang J, Skoulidis F, Wu J, Mehran RJ, Rice DC, Walsh GL, Hofstetter WL, Rajaram R, Antonoff MB, Fujimoto J, Solis LM, Parra ER, Haymaker C, Wistuba II, Swisher SG, Vaporciyan AA, Lin HY, Wang J, Gibbons DL, Jack Lee J, Ajami NJ, Wargo JA, Allison JP, Sharma P, Kadara H, Heymach JV, Sepesi B. Neoadjuvant chemotherapy plus nivolumab with or without ipilimumab in operable non-small cell lung cancer: the phase 2 platform NEOSTAR trial. Nat Med 29(3):593-604, 2023. e-Pub 2023. PMID: 36928818.
2. Feldman HA, Zhou N, Deboever N, Hofstetter W, Mehran R, Rajaram R, Rice D, Roth JA, Sepesi B, Swisher S, Vaporciyan A, Walsh G, Godoy M, Strange C, Antonoff MB. Intraoperative challenges after induction therapy for non-small cell lung cancer: Effect of nodal disease on technical complexity. JTCVS Open 12:372-384, 2022. e-Pub 2022. PMID: 36590745.
3. Bhutani MS, Ejaz S, Cazacu IM, Singh BS, Shafi M, Stroehlein JR, Mehran RJ, Walsh G, Vaporciyan A, Swisher SG, Hofstetter W. Endoscopic Intrapyloric Botulinum Toxin Injection with Pyloric Balloon Dilation for Symptoms of Delayed Gastric Emptying after Distal Esophagectomy for Esophageal Cancer: A 10-year Experience. Cancers 14(23):5743, 2022. PMID: 36497224.
4. Deboever N, Feldman HA, Hofstetter WL, Mehran RJ, Rajaram R, Rice DC, Roth JA, Sepesi B, Swisher SG, Vaporciyan AA, Walsh GL, Antonoff MB. The Role of Surgery in the Treatment of Melanoma Pulmonary Metastases in the Modern Era. J Surg Res 277:125-130, 2022. e-Pub 2022. PMID: 35489217.
5. Feldman HA, Feldman JA, Miller CC, Walsh G, Tyson JE. Informed Consent for Placebo-Controlled Trials: Do Ethics and Science Conflict?. Ethics Hum Res 44(5):42-48, 2022. PMID: 36047276.
6. Bayley EM, Ivy ML, Shewale JB, Ge PS, Antonoff MB, Francis AM, Hofstetter WL, Mehran RJ, Rajaram R, Rice DC, Roth JA, Sepesi B, Vaporciyan AA, Walsh GL, Lee JJ, Louie BE, Swisher SG. High-Risk Features of Esophageal Adenocarcinoma Following Neoadjuvant Chemoradiation: Patients for whom Surgery Should Not Be Delayed. Ann Surg. e-Pub 2022. PMID: 36052678.
7. Mills AC, Hofstetter WL, Mehran RJ, Rajaram R, Rice DC, Sepesi B, Swisher SG, Vaporciyan AA, Walsh GL, Antonoff MB. Repeated Pulmonary Metastasectomy: Third Operations and Beyond. Ann Thorac Surg. e-Pub 2022. PMID: 35926641.
8. Bayley EM, Zhou N, Mitchell KG, Antonoff MB, Mehran RJ, Rice DC, Sepesi B, Swisher SG, Vaporciyan AA, Walsh GL, Cinciripini PM, Karam-Hage M, Roth JA, Hofstetter WL. Modern Perioperative Practices May Mitigate Effects of Continued Smoking Among Lung Cancer Patients. Ann Thorac Surg S0003-4975(21):01317-5, 2022. e-Pub 2021. PMID: 34358522.
9. Blumenthaler AN, Hofstetter WL, Mehran RJ, Rajaram R, Rice DC, Roth JA, Sepesi B, Swisher SG, Vaporciyan AA, Walsh GL, Strange CD, Antonoff MB. Preoperative Maximum Standardized Uptake Value Associated with Recurrence Risk In Early Lung Cancer. Ann Thorac Surg 113(6):1835-1844, 2022. e-Pub 2021. PMID: 34252403.
10. Bostock IC, Zhou N, Antonoff MB, Murphy MB, Lin S, Maru D, Mehran R, Rajaram R, Rice D, Sepesi B, Swisher S, Vaporciyan A, Walsh G, Hofstetter W. Prolonged Neutrophilia is associated with worse outcomes after Esophagectomy. Dis Esophagus 35(4), 2022. e-Pub 2021. PMID: 34897440.
11. Olive JK, Zhou N, Mitchell KG, Corsini EM, Hofstetter WL, Mehran RJ, Rice DC, Sepesi B, Swisher SG, Vaporciyan AA, Walsh GL, Antonoff MB. Impact of Psychiatric Comorbidities on Surgical Outcomes for Non-Small Cell Lung Cancer. Ann Thorac Surg 113(3):1008-1014, 2022. e-Pub 2021. PMID: 33774003.
12. Zhou N, Corsini EM, Antonoff MB, Hofstetter WL, Mehran RJ, Rajaram R, Roth JA, Sepesi B, Swisher SG, Vaporciyan AA, Walsh GL, Rice DC. Robotic Surgery and Anatomic Segmentectomy: An Analysis of Trends, Patient Selection, and Outcomes. Ann Thorac Surg 113(3):975-983, 2022. e-Pub 2021. PMID: 33838123.
13. Antonoff MB, Feldman HA, Mitchell KG, Farooqi A, Ludmir EB, Hofstetter WL, Mehran RJ, Rajaram R, Rice DC, Sepesi B, Swisher SG, Walsh GL, Gandhi S, Gomez DR, Vaporciyan AA. Surgical Complexity of Pulmonary Resections Performed for Oligometastatic NSCLC. JTO Clin Res Rep 3(3):100288, 2022. e-Pub 2022. PMID: 35252897.
14. Deboever N, McGrail DJ, Lee Y, Tran HT, Mitchell KG, Antonoff MB, Hofstetter WL, Mehran RJ, Rice DC, Roth JA, Swisher SG, Vaporciyan AA, Walsh GL, Bernatchez C, Vailati Negrao M, Zhang J, Wistuba II, Heymach JV, Cascone T, Gibbons DL, Haymaker CL, Sepesi B. Surgical Approach Does Not Influence Changes in Circulating Immune Cell Populations Following Lung Cancer Resection. Lung Cancer 164:69-75, 2022. e-Pub 2022. PMID: 35038676.
15. Zorrilla-Vaca A, Rice D, Brown JK, Antonoff M, Sepesi B, Hofstetter W, Swisher S, Walsh G, Vaporciyan A, Mehran R, Hagberg C, Mena GE. Sustained reduction of discharge opioid prescriptions in an enhanced recovery after thoracic surgery program: A multilevel generalized linear model. Surgery 171(2):504-510, 2022. e-Pub 2021. PMID: 34740455.
16. Zhou N, Rice DC, Tsao AS, Lee PP, Haymaker CL, Corsini EM, Antonoff MB, Hofstetter WL, Rajaram R, Roth JA, Swisher SG, Vaporciyan AA, Walsh GL, Mehran RJ, Sepesi B. Extrapleural Pneumonectomy versus Pleurectomy/Decortication for Malignant Pleural Mesothelioma. Ann Thorac Surg 113(1):200-208, 2022. e-Pub 2021. PMID: 33971174.
17. Federico L, McGrail DJ, Bentebibel SE, Haymaker C, Ravelli A, Forget MA, Karpinets T, Jiang P, Reuben A, Negrao MV, Li J, Khairullah R, Zhang J, Weissferdt A, Vaporciyan AA, Antonoff MB, Walsh G, Lin SY, Futreal A, Wistuba I, Roth J, Byers LA, Gaudreau PO, Uraoka N, Cruz AF, Dejima H, Lazcano RN, Solis LM, Parra ER, Lee JJ, Swisher S, Cascone T, Heymach JV, Zhang J, Sepesi B, Gibbons DL, Bernatchez C. Distinct tumor-infiltrating lymphocyte landscapes are associated with clinical outcomes in localized non-small cell lung cancer. Ann Oncol S0923-7534(21):04519-1, 2022. e-Pub 2021. PMID: 34653632.
18. Sepesi B, Zhou N, William WN, Lin HY, Leung CH, Weissferdt A, Mitchell KG, Pataer A, Walsh GL, Rice DC, Roth JA, Mehran RJ, Hofstetter WL, Antonoff MB, Rajaram R, Negrao MV, Tsao AS, Gibbons DL, Lee JJ, Heymach JV, Vaporciyan AA, Swisher SG, Cascone T. Surgical outcomes after nivolumab or nivolumab with ipilimumab treatment in patients with non-small cell lung cancer. J Thorac Cardiovasc Surg. e-Pub 2022. PMID: 35190177.
19. Rice D, Rodriguez-Restrepo A, Mena G, Cata J, Thall P, Milton D, Correa A, Woodard T, Antonoff M, Hofstetter W, Roth J, Sepesi B, Swisher S, Walsh G, Vaporciyan A, Mehran R. Matched Pairs Comparison of an Enhanced Recovery Pathway Versus Conventional Management on Opioid Exposure and Pain Control in Patients Undergoing Lung Surgery. Ann Surg 274(6):1099-1106, 2021. e-Pub 2020. PMID: 32229762.
20. Zhou N, Hofstetter WL, Esophageal Squamous Cell Carcinoma Working Group. Salvage Esophagectomy Definition Influences Comparative Outcomes in Esophageal Squamous Cell Cancers. Ann Thorac Surg. e-Pub 2021. PMID: 34883083.
21. Pennathur A, Brunelli A, Criner GJ, Keshavarz H, Mazzone P, Walsh G, Luketich J, Liptay M, Wafford QE, Murthy S, Marshall MB, Tong B, Lanuti M, Wolf A, Pettiford B, Loo BW, Merritt RE, Rocco G, Schuchert M, Varghese TK, Swanson SJ, AATS Clinical Practice Standards Committee: Thoracic Surgery. Definition and assessment of high risk in patients considered for lobectomy for stage I non-small cell lung cancer: The American Association for Thoracic Surgery expert panel consensus document. J Thorac Cardiovasc Surg 162(6):1605-1618.e6, 2021. e-Pub 2021. PMID: 34716030.
22. Bostock IC, Hofstetter W, Mehran R, Rajaram R, Rice D, Sepesi B, Swisher S, Vaporciyan A, Walsh G, Antonoff MB. Barriers to surveillance imaging adherence in early-staged lung cancer. J Thorac Dis 13(12):6848-6854, 2021. PMID: 35070369.
23. Chang JY, Mehran RJ, Feng L, Verma V, Liao Z, Welsh JW, Lin SH, O'Reilly MS, Jeter MD, Balter PA, McRae SE, Berry D, Heymach JV, Roth JA, Antonoff M, Hofstetter W, Rajaram R, Rice D, Sepesi B, Swisher S, Vaporciyan A, Walsh G, DeGraaf C, Correa A, Chen A, Gandhi S, Komaki R, Lee P, Nguyen Q, Ning M, Gao S, Pollard-Larkin J, Nitsch P, Sadagopan R, Wang X. Stereotactic ablative radiotherapy for operable stage I non-small-cell lung cancer (revised STARS): long-term results of a single-arm, prospective trial with prespecified comparison to surgery. Lancet Oncol 22(10):1448-1457, 2021. PMID: 34529930.
24. Feldman HA, Erasmus JJ, Zhou N, Antonoff MB, Mehran RJ, Rajaram R, Rice DC, Sepesi B, Swisher SG, Vaporciyan AA, Walsh GL, Hofstetter WL, Betancourt Cuellar SL. Clinical Significance of FDG-PET/CT Avid Hilar Lymph Nodes in Esophageal Carcinoma Patients. Ann Thorac Surg. e-Pub 2021. PMID: 34634240.
25. Blumenthaler AN, Zhou N, Parikh K, Hofstetter WL, Mehran RJ, Rajaram R, Rice DC, Sepesi B, Swisher SG, Vaporciyan AA, Walsh GL, Antonoff MB. Optimizing Discharge After Shorter Hospitalizations: Lessons Learned Through After-Hours Calls with Thoracic Surgical Patients. Innovations (Phila):15569845211041343. e-Pub 2021. PMID: 34494925.
26. Corsini EM, Mitchell KG, Zhou N, Antonoff MB, Mehran RJ, Mena GE, Rajaram R, Roth JA, Sepesi B, Swisher SG, Vaporciyan AA, Walsh GL, Rice DC, Hofstetter WL. Liposomal Bupivacaine Intercostal Block is Important for Reduction of Pulmonary Complications. Ann Thorac Surg 112(2):423-429, 2021. PMID: 33129774.
27. Zuckerman S, Obotta S, Chang, GJ, Walsh GL, Mehra RJ, Ziya G, Rao G, Tatsui, CE, Rhines LD. Outcomes of Surgery for Sacral Chordoma and Impact of Complications: A Report of 50 Consecutive Patients with Long-term Follow-up. Global Spine Journal 11(5):740-750, 2021. PMID: 34047643.
28. Zhou N, Mitchell KG, Corsini EM, Truong VTT, Antonoff MB, Mehran RJ, Rajaram R, Rice DC, Roth JA, Sepesi B, Swisher SG, Vaporciyan AA, Walsh GL, Ajani JA, Hofstetter WL. Analysis of trimodal and bimodal therapy in a selective-surgery paradigm for locally advanced oesophageal squamous cell carcinoma. Br J Surg. e-Pub 2021. PMID: 34095952.
29. Corsini EM, Mitchell KG, Zhou N, Bernatchez C, Forget MA, Haymaker CL, Hofstetter WL, Mehran RJ, Rajaram R, Rice DC, Roth JA, Sepesi B, Swisher SG, Vaporciyan AA, Walsh GL, Amaria RN, Jazaeri AA, Antonoff MB. Pulmonary resection for tissue harvest in adoptive tumor-infiltrating lymphocyte therapy: Safety and feasibility. J Surg Oncol. e-Pub 2021. PMID: 34057733.
30. Corsini EM, Zhou N, Antonoff MB, Mehran RJ, Rice DC, Roth JA, Sepesi B, Swisher SG, Vaporciyan AA, Walsh GL, Hofstetter WL. Postoperative Bleeding and Acute Kidney Injury in Esophageal Cancer Patients Receiving Ketorolac. Ann Thorac Surg 111(4):1111-1117, 2021. PMID: 32980327.
31. Corsini EM, Hofstetter WL; MD Anderson Esophageal Cancer Working Group.. Ketorolac use and anastomotic leak in esophageal cancer patients. J Thorac Cardiovasc Surg 161(2):448-454, 2021. PMID: 32340809.
32. Cascone T, William WN, Weissferdt A, Leung CH, Lin HY, Pataer A, Godoy MCB, Carter BW, Federico L, Reuben A, Khan MAW, Dejima H, Francisco-Cruz A, Parra ER, Solis LM, Fujimoto J, Tran HT, Kalhor N, Fossella FV, Mott FE, Tsao AS, Blumenschein G, Le X, Zhang J, Skoulidis F, Kurie JM, Altan M, Lu C, Glisson BS, Byers LA, Elamin YY, Mehran RJ, Rice DC, Walsh GL, Hofstetter WL, Roth JA, Antonoff MB, Kadara H, Haymaker C, Bernatchez C, Ajami NJ, Jenq RR, Sharma P, Allison JP, Futreal A, Wargo JA, Wistuba II, Swisher SG, Lee JJ, Gibbons DL, Vaporciyan AA, Heymach JV, Sepesi B. Neoadjuvant nivolumab or nivolumab plus ipilimumab in operable non-small cell lung cancer: the phase 2 randomized NEOSTAR trial. Nat Med. e-Pub 2021. PMID: 33603241.
33. Corsini EM, Mitchell KG, Zhou N, Antonoff MB, Mehran RJ, Rajaram R, Rice DC, Roth JA, Sepesi B, Swisher SG, Vaporciyan AA, Walsh GL, Hofstetter WL. Intestinal Metaplasia in the Esophageal Remnant Is Rare After Ivor Lewis Esophagectomy. J Gastrointest Surg. e-Pub 2021. PMID: 33555525.
34. Corsini EM, Weissferdt A, Pataer A, Zhou N, Antonoff MB, Hofstetter WL, Mehran RJ, Rajaram R, Rice DC, Roth JA, Vaporciyan AA, Walsh GL, Cascone T, Heymach JV, Swisher SG, Sepesi B. Pathological nodal disease defines survival outcomes in patients with lung cancer with tumour major pathological response following neoadjuvant chemotherapy. Eur J Cardiothorac Surg 59(1):100-108, 2021. e-Pub 2020. PMID: 32864702.
35. Woodard TYD, Patel CM, Walsh GL. Roadmap to the Enhanced Thoracic Surgical Journey. J Adv Pract Oncol 12(1):39-51, 2021. e-Pub 2021. PMID: 33552661.
36. Gaudreau PO, Negrao MV, Mitchell KG, Reuben A, Corsini EM, Li J, Karpinets TV, Wang Q, Diao L, Wang J, Federico L, Parra-Cuentas ER, Khairullah R, Behrens C, Correa AM, Gomez D, Little L, Gumbs C, Kadara HN, Fujimoto J, McGrail DJ, Vaporciyan AA, Swisher SG, Walsh G, Antonoff MB, Weissferdt A, Tran H, Roarty E, Haymaker C, Bernatchez C, Zhang J, Futreal PA, Wistuba II, Cascone T, Heymach JV, Sepesi B, Zhang J, Gibbons DL. Neoadjuvant Chemotherapy Increases Cytotoxic T Cell, Tissue Resident Memory T Cell, and B Cell Infiltration in Resectable NSCLC. J Thorac Oncol. e-Pub 2020. PMID: 33096269.
37. Mitchell KG, Parra Cuentas, ER, Lee, IJ, Vaporciyan AA, Hofstetter W, Mehran, RJ, Swisher SG, Rice DC, Sepesi B, Walsh GL, Behrens C, Kalhor N, Weissferdt A, Moran C, Skoulidis F, Wistuba II, Antonoff MB, Heymach JV, MD Anderson Lung Cancer Immune Microenvironment Working Group. LKB1/STK11 Expression in Lung Adenocarcinoma and Associations With Patterns of Recurrence. Ann Thorac Surg 110(4):1131-1138, 2020. e-Pub 2020. PMID: 32442617.
38. Corsini EM, Mitchell KG, Hofstetter WL, Mehran RJ, Roth JA, Sepesi B, Swisher SG, Vaporciyan AA, Walsh GL, Antonoff MB, Rice DC. Importance of Resection for Locoregional Disease Control in Masaoka Stage IVa Thymic Neoplasms. J Surg Oncol 122(3):515-522, 2020. e-Pub 2020. PMID: 32468580.
39. Corsini EM, Foo WC, Mitchell KG, Zhou N, Maru DM, Ajani JA, Hofstetter WL; Esophageal Adenocarcinoma Working Group. Esophageal adenocarcinoma with any component of signet ring cells portends poor prognosis and response to neoadjuvant therapy. J Thorac Cardiovasc Surg S0022-5223(20):32562-9, 2020. PMID: 33010880.
40. Vedantam A, Vigneswaran K, Rao G, Walsh GL, Rhines LD, Tatsui CE. Use of Navigated Ultrasonic Bone Cutting Tool for En Bloc Resection of Thoracic Chondrosarcoma: Technical Report. Oper Neurosurg (Hagerstown). e-Pub 2020. PMID: 32745212.
41. Corsini EM, Wang Q, Tran HT, Mitchell KG, Antonoff MB, Hofstetter WL, Mehran RJ, Rice DC, Roth JA, Swisher SG, Vaporciyan AA, Walsh GL, Reuben A, Vasquez ME, Bernatchez C, Wang J, Cascone T, Zhang J, Heymach JV, Gibbons DL, Haymaker CL, Sepesi B. Peripheral cytokines are not influenced by the type of surgical approach for non-small cell lung cancer by four weeks postoperatively. Lung Cancer 146:303-309, 2020. e-Pub 2020. PMID: 32619781.
42. Corsini EM, Mitchell KG, Zhou N, Antonoff MB, Mehran RJ, Rice DC, Roth JA, Sepesi B, Swisher SG, Vaporciyan AA, Walsh GL, Maru DM, Lin SH, Ajani JA, Hofstetter WL. Modified En bloc Esophagectomy Compared to Standard Resection after Neoadjuvant Chemoradiation. Ann Thorac Surg. e-Pub 2020. PMID: 32857997.
43. Mericli AF, Murariu D, Nemir S, Rhines LD, Walsh G, Adelman DM, Baumann DP, Butler CE. Soft-Tissue Reconstruction after Composite Vertebrectomy and Chest Wall Resection for Spinal Tumors. Plast Reconstr Surg 145(5):1275-1286, 2020. PMID: 32332552.
44. Mitchell KG, Amini B, Wang Y, Carter BW, Godoy MCB, Parra ER, Behrens C, Villalobos P, Reuben A, Lee JJ, Weissferdt A, Moran CA, Fujimoto J, Sepesi B, Walsh GL, Vaporciyan AA, Hofstetter WL, William WN, Gibbons DL, Wang J, Hwu P, Swisher SG, Piwnica-Worms D, Kadara H, Wistuba II, Heymach JV, Peng W, Cascone T. 18F-Fluorodeoxyglucose Positron Emission Tomography Correlates With Tumor Immunometabolic Phenotypes In Resected Lung Cancer. Cancer Immunol Immunother. e-Pub 2020. PMID: 32300858.
45. Shewale JB, Correa AM, Brown EL, Novelo Leon LG , Nyitray AG, Antonoff MB, Hofstetter, WL, Mehran RJ, Rice DC, Walsh GL, Roth J, Vaporciyan AA, Swisher SG , Sepesi B. Time Trends and Predictors of Survival in Surgically Resected Early-Stage Non-Small Cell Lung Cancer Patients. Journal of Surgical Oncology 122(3):495-505, 2020. PMID: 32356321.
46. Moran CA, Lindholm KE, Brunnström H, Langman G, Jang SJ, Spagnolo D, Chai SM, Laycock A, Falconieri G, Pizzolitto S, de Pellegrin A, Medeiros F, Edmunds L, Catarino A, Cunha F, Ro J, Pina-Oviedo S, Torrealba J, Coppola D, Petersson F, Oon ML, Elmberger G, Y Cajal SR, Valero IS, Dalurzo L, Soares F, Campos AH, Vranic S, Skenderi F, Correa AM, Sepesi B, Rice D, Mehran R, Walsh G. Typical and atypical carcinoid tumors of the lung: a clinicopathological correlation of 783 cases with emphasis on histological features. Hum Pathol 98:98-109. e-Pub 2020. PMID: 32145220.
47. Van Haren RM, Correa AM, Sepesi B, Rice DC, Hofstetter WL, Roth JA, Swisher SG, Walsh GL, Vaporciyan AA, Mehran RJ, Antonoff MB. Hospital readmissions after pulmonary resection: post-discharge nursing telephone assessment identifies high risk patients. J Thorac Dis 12(3):184-190, 2020. PMID: 32274083.
48. Nelson DB, Mitchell KG, Wang J, Fujimoto J, Godoy M, Behrens C, Zheng X, Zhang J, Sepesi B, Vaporciyan AA, Hofstetter WL, Mehran RJ, Rice DC, Walsh GL, Swisher SG, Moran CA, Kalhor N, Weissferdt A, Wistuba II, Roth JA, Antonoff MB. Immune regulatory markers of lepidic-pattern adenocarcinomas presenting as ground glass opacities. J Thorac Dis 12(3):329-337, 2020. PMID: 32274099.
49. Corsini EM, Datar SS, Mitchell KG, Zhou N, Hofstetter WL, Mehran RJ, Rajaram R, Rice DC, Roth JA, Sepesi B, Swisher SG, Vaporciyan AA, Walsh GL, Blackmon SH, Loree JM, Morris VK, Antonoff MB. High mutational concordance between primary colorectal tumors and associated pulmonary metastases. J Surg Oncol. e-Pub 2020. PMID: 32077113.
50. Shewale JB, Correa AM, Brown EL, Novelo Leon LG , Nyitray AG, Antonoff MB, Hofstetter, WL, Mehran RJ, Rice DC, Walsh GL, Roth J, Vaporciyan AA, Swisher SG , Sepesi B. Time trends of perioperative outcomes in early-stage non-small cell lung cancer resection patients. Ann Thorac Surg 109(2):404-411, 2020. e-Pub 2020. PMID: 31539514.
51. Rajaram R, Correa AM, Xu T, Nguyen QN, Antonoff MB, Rice D, Mehran R, Roth J, Walsh G, Swisher S, Hofstetter WL, Vaporciyan A, Cascone T, Tsao AS, Papadimitrakopoulou VA, Gandhi S, Liao Z, Sepesi B. Locoregional Control, Overall Survival, and Disease-Free Survival in Stage IIIA (N2) Non-Small-Cell Lung Cancer: Analysis of Resected and Unresected Patients. Clin Lung Cancer. e-Pub 2020. PMID: 32089476.
52. Corsini EM, Mitchell KG, Mehran RJ, Rice DC, Sepesi B, Walsh GL, Swisher SG, Roth JA, Hofstetter WL, Vaporciyan AA, Morris VK, Antonoff MB. Colorectal cancer mutations are associated with survival and recurrence after pulmonary metastasectomy. J Surg Oncol 120(4):729-735, 2019. e-Pub 2019. PMID: 31290159.
53. Corsini EM, Mitchell KG, Sceusi EL, Mehran RJ, Rice DC, Sepesi B, Walsh GL, Swisher SG, Roth JA, Vaporciyan AA, Hofstetter WL, Antonoff MB. Multidisciplinary treatment of thymic neuroendocrine tumors: surgery remains a key component. J Thorac Dis 11(8):3391-3398, 2019. PMID: 31559043.
54. Chen Y, Zhang R, Wang L, Correa AM, Pataer A, Xu Y, Zhang X, Ren C, Wu S, Meng QH, Fujimoto J, Jensen VB, Antonoff MB, Hofstetter WL, Mehran RJ, Pisimisis G, Rice DC, Sepesi B, Vaporciyan AA, Walsh GL, Swisher SG, Roth JA, Heymach JV, Fang B. Tumor characteristics associated with engraftment of patient-derived non-small cell lung cancer xenografts in immunocompromised mice. Cancer. e-Pub 2019. PMID: 31287557.
55. Mitchell KG, Nelson DB, Corsini EM, Vaporciyan AA, Antonoff MB, Mehran RJ, Rice DC, Roth JA, Sepesi B, Walsh GL, Bhutani MS, Maru DM, Wu CC, Nguyen QN, Ajani JA, Swisher SG, Hofstetter WL. Morbidity following salvage esophagectomy for squamous cell carcinoma: the MD Anderson experience. Dis Esophagus. e-Pub 2019. PMID: 31313820.
56. Mitchell KG, Ikoma N, Nelson DB, Maru DM, Erasmus JJ, Weston BR, Vaporciyan AA, Antonoff MB, Mehran RJ, Rice DC, Roth JA, Swisher SG, Sepesi B, Walsh GL, Correa AM, Das P, Blum MA, Badgwell BD, Hofstetter WL. Mediastinal Nodal Involvement After Neoadjuvant Chemoradiation For Siewert II/III Adenocarcinoma. Ann Thorac Surg. e-Pub 2019. PMID: 31102632.
57. Nelson DB, Mehran RJ, Mitchell KG, Rajaram R, Correa AM, Bassett RL, Antonoff MB, Hofstetter WL, Roth JA, Sepesi B, Swisher SG, Walsh GL, Vaporciyan AA, Rice DC. Robotic-Assisted Lobectomy for Non-Small Cell Lung Cancer: A Comprehensive Institutional Experience. Ann Thorac Surg. e-Pub 2019. PMID: 31004583.
58. Nelson DB, Rice DC, Mitchell KG, Tsao AS, Vaporciyan AA, Antonoff MB, Hofstetter WL, Walsh GL, Swisher SG, Roth JA, Gomez DR, Mehran RJ, Sepesi B. Defining the role of adjuvant radiotherapy for malignant pleural mesothelioma: a propensity-matched landmark analysis of the National Cancer Database. J Thorac Dis 11(4):1269-1278, 2019. PMID: 31179069.
59. Nelson DB, Mitchell KG, Weston BR, Betancourt S, Maru D, Rice DC, Mehran RJ, Sepesi B, Antonoff MB, Walsh GL, Swisher SG, Roth JA, Vaporciyan AA, Blum M, Hofstetter WL. Should endoscopic mucosal resection be attempted for cT2N0 esophageal cancer?. Dis Esophagus. e-Pub 2019. PMID: 30888418.
60. Mitchell KG, Corsini EM, Van Haren RM, Walsh GL, Sepesi B. A Case Report of a Midesophageal Diverticulum Mimicking a Fibrovascular Esophageal Polyp. Int J Surg Case Rep 59:205-207, 2019. e-Pub 2019. PMID: 31181388.
61. Baity M, Wang L, Correa AM, Zhang X, Zhang R, Pataer A, Wu S, Meng QH, Antonoff MB, Hofstetter WL, Mehran RJ, Rice DC, Roth JA, Sepesi B, Swisher SG, Vaporciyan AA, Walsh GL, Zhao M, Gu J, Fang B. Glutathione reductase (GSR) gene deletion and chromosome 8 aneuploidy in primary lung cancers detected by fluorescence in situ hybridization. Am J Cancer Res 9(6):1201-1211, 2019. e-Pub 2019. PMID: 31285952.
62. Van Haren RM, Rajaram R, Correa AM, Mehran RJ, Antonoff MB, Hofstetter WL, Sepesi B, Swisher SG, Vaporciyan AA, Walsh GL, Rice DC, Roth JA. Preoperative Heparin for Lung Cancer Resection Increases Risk of Reoperation for Bleeding. Semin Thorac Cardiovasc Surg, 2019. e-Pub 2019. PMID: 31857153.
63. Mitchell KG, Nelson DB, Corsini EM, Correa AM, Erasmus JJ, Hofstetter WL, Mehran RJ, Roth JA, Swisher SG, Sepesi B, Walsh GL, Vaporciyan AA, Rice DC, Nguyen QN, Antonoff MB. Surveillance After Treatment of Non-Small-Cell Lung Cancer: A Call for Multidisciplinary Standardization. Innovations (Phila):1556984519886281, 2019. e-Pub 2019. PMID: 31875755.
64. Kim MP, Correa AM, Hofstetter WL, Mehran RJ, Rice DC, Roth JA, Vaporciyan AA, Walsh GL, Erasmus JJ, Swisher SG. Occult stage IIIA-N2 patients have excellent overall survival with initial surgery. J Thorac Dis 10(12):6670-6676, 2018. PMID: 30746212.
65. Nelson DB, Tayob N, Mitchell KG, Correa AM, Hofstetter WL, Sepesi B, Walsh GL, Vaporciyan AA, Swisher SG, Antonoff MB, Roth JA, Rice DC, Vauthey JN, Mehran RJ. Surgical margins and risk of local recurrence after wedge resection of colorectal pulmonary metastases. J Thorac Cardiovasc Surg. e-Pub 2018. PMID: 30635188.
66. Casal RF, Walsh G, McArthur M, Hill LR, Landaeta MF, Armas Villalba AJ, Ong P, Debiane L, Vakil E, Grosu HB, Jimenez CA, Ost D, Adachi R, Eapen GA. Bronchoscopic Laser Interstitial Thermal Therapy: An Experimental Study in Normal Porcine Lung Parenchyma. J Bronchology Interv Pulmonol 25(4):322-329, 2018. e-Pub 2018. PMID: 29771774.
67. Van Haren RM, Correa AM, Sepesi B, Rice DC, Hofstetter WL, Mehran RJ, Vaporciyan AA, Walsh GL, Roth JA, Swisher SG, Antonoff MB. Ground Glass Lesions on Imaging: Evaluation of Reported Incidence Using Natural Language Processing. Ann Thorac Surg. e-Pub 2018. PMID: 30612991.
68. Shewale JB, Mitchell KG, Nelson DB, Conley AP, Rice DC, Antonoff MB, Hofstetter WL, Walsh GL, Swisher SG, Roth JA, Mehran RJ, Vaporciyan AA, Weissferdt A, Sepesi B. Predictors of survival after resection of primary sarcomas of the chest wall-A large, single-institution series. J Surg Oncol 118(3):518-524, 2018. e-Pub 2018. PMID: 30109699.
69. Ontiveros N, Eapen-John D, Osorio N, Song J, Li L, Sheshadri A, Tiang X, Ghosh N, Vaporciyan A, Correa A, Walsh G, Grosu HB, Ost DE. Predicting Lung Function Following Lobectomy: A New Method to Adjust for Inherent Selection Bias. Respiration:1-12. e-Pub 2018. PMID: 30257257.
70. Nelson DB, Lapid DJ, Mitchell KG, Correa AM, Hofstetter WL, Mehran RJ, Rice DC, Sepesi B, Walsh GL, Vaporciyan AA, Swisher SG, Roth JA, Antonoff MB. Perioperative Outcomes for Stage I Non-Small Cell Lung Cancer: Differences between Men and Women. Ann Thorac Surg. e-Pub 2018. PMID: 30118712.
71. Van Haren RM, Mehran RJ, Mena GE, Correa AM, Antonoff MB, Baker CM, Woodard TC, Hofstetter WL, Roth JA, Sepesi B, Swisher SG, Vaporciyan AA, Walsh GL, Rice DC. Enhanced Recovery Decreases Pulmonary and Cardiac Complications Following Thoracotomy for Lung Cancer. Ann Thorac Surg 106(1):272-279, 2018. e-Pub 2018. PMID: 29530770.
72. Nelson DB, Godoy MCB, Benveniste MF, Shewale JB, Spicer JD, Mitchell KG, Hofstetter WL, Mehran RJ, Rice DC, Sepesi B, Walsh GL, Vaporciyan AA, Swisher SG, Roth JA, Antonoff MB. Clinicoradiographic Predictors of Aggressive Biology in Lung Cancer with Ground Glass Components. Ann Thorac Surg 106(1):235-241, 2018. e-Pub 2018. PMID: 29534957.
73. Shewale JB, Nelson DB, Rice DC, Sepesi B, Hofstetter WL, Mehran RJ, Vaporciyan AA, Walsh GL, Swisher SG, Roth JA, Antonoff MB. Natural History of Ground-Glass Lesions Among Patients With Previous Lung Cancer. Ann Thorac Surg 105(6):1671-1677, 2018. e-Pub 2018. PMID: 29432718.
74. Sepesi B, Ye Y, Mitchell KG, Zhang L, Gu J, Ji L, Antonoff MB, Hofstetter WL, Rice DC, Mehran RJ, Walsh GL, Vaporciyan AA, Swisher SG, Roth JA, Wu X. Genetic variants in cytokine signaling pathways and clinical outcomes in early-stage lung cancer patients. J Thorac Cardiovasc Surg 155(6):2635-2645.e15, 2018. e-Pub 2018. PMID: 29548588.
75. Nelson DB, Rice DC, Niu J, Atay SM, Vaporciyan AA, Antonoff MB, Hofstetter WL, Walsh GL, Swisher SG, Roth JA, Tsao AS, Gomez DR, Giordano SH, Mehran RJ, Sepesi B. Predictors of trimodality therapy and trends in therapy for malignant pleural mesothelioma. Eur J Cardiothorac Surg 53(5):960-966, 2018. e-Pub 2017. PMID: 29211849.
76. Weissferdt A, Kalhor N, Bishop JA, Jang SJ, Ro J, Petersson F, Wu B, Langman G, Bancroft H, Bi Y, Meng Y, Medeiros F, Brunnstrom H, Spagnolo D, Chai SM, Laycock A, Wakely PE, Elmberger G, Soares FA, Campos AH, Gumurdulu D, Alvarado-Cabrero I, Coppola D, Correa AM, Rice D, Mehran RJ, Sepesi B, Walsh G, Kaiser L, Moran CA. THYMOMA: A clinicopathological correlation of 1470 cases. Hum Pathol 73:7-15, 2018. e-Pub 2017. PMID: 28851660.
77. Wang JF, Pu X, Zhang X, Chen K, Xi Y, Wang J, Mao X, Zhang J, Heymach JV, Antonoff MB, Hofstetter WL, Mehran RJ, Rice DC, Roth JA, Sepesi B, Swisher SG, Vaporciyan AA, Walsh GL, Meng QH, Shaw KR, Eterovic AK, Fang B. Variants with a low allele frequency detected in genomic DNA affect the accuracy of mutation detection in cell-free DNA by next-generation sequencing. Cancer 124(5):1061-1069, 2018. e-Pub 2017. PMID: 29178133.
78. Harada K, Wang X, Shimodaira Y, Sagebiel T, Bhutani MS, Lee JH, Weston B, Elimova E, Lin Q, Amlashi FG, Mizrak Kaya D, Lopez A, Blum Murphy MA, Roth JA, Swisher SG, Skinner HD, Hofstetter WL, Rogers JE, Thomas I, Maru DM, Komaki R, Walsh G, Ajani JA. Early Metabolic Change after Induction Chemotherapy Predicts Histologic Response and Prognosis in Patients with Esophageal Cancer: Secondary Analysis of a Randomized Trial. Target Oncol 13(1):99-106, 2018. e-Pub 2017. PMID: 29218623.
79. Shimodaira Y, Slack RS, Harada K, Chen HC, Sagebiel T, Bhutani MS, Lee JH, Weston B, Elimova E, Lin Q, Amlashi FG, Mizrak Kaya D, Blum MA, Roth JA, Swisher SG, Skinner HD, Hofstetter WL, Rogers JE, Mares J, Thomas I, Maru DM, Komaki R, Walsh G, Ajani JA. Influence of induction chemotherapy in trimodality therapy-eligible oesophageal cancer patients: secondary analysis of a randomised trial. Br J Cancer 118(3):331-337, 2018. e-Pub 2017. PMID: 29235564.
80. Sanchez N, Shewale JB, Baker CM, Wilks SA, Correa AM, Sepesi B, Rice DC, Roth JA, Walsh GL, Swisher SG, Vaporciyan AA, Mehran RJ, Hofstetter WL. Early Foley catheter removal in thoracic surgical oncology patients receiving epidural analgesia. Perioperative Care and Operating Room Management 12:1-5, 2018. e-Pub 2018.
81. Atay SM, Correa AM, Hofstetter WL, Mehran RJ, Rice DC, Roth JA, Sepesi B, Swisher SG, Vaporciyan AA, Walsh G, Antonoff MB. Perioperative Outcomes of Patients Undergoing Lobectomy on Clopidogrel. Ann Thorac Surg 104(6):1821-1828, 2017. e-Pub 2017. PMID: 28987393.
82. Blum Murphy M, Xiao L, Patel VR, Maru DM, Correa AM, G Amlashi F, Liao Z, Komaki R, Lin SH, Skinner HD, Vaporciyan A, Walsh GL, Swisher SG, Sepesi B, Lee JH, Bhutani MS, Weston B, Hofstetter WL, Ajani JA. Pathological complete response in patients with esophageal cancer after the trimodality approach: The association with baseline variables and survival-The University of Texas MD Anderson Cancer Center experience. Cancer 123(21):4106-4113, 2017. e-Pub 2017. PMID: 28885712.
83. Nelson DB, Rice DC, Niu J, Atay S, Vaporciyan AA, Antonoff M, Hofstetter WL, Walsh GL, Swisher SG, Roth JA, Tsao A, Gomez D, Giordano SH, Mehran R, Sepesi B. Long-Term Survival Outcomes of Cancer-Directed Surgery for Malignant Pleural Mesothelioma: Propensity Score Matching Analysis. J Clin Oncol 35(29):JCO2017738401, 2017. e-Pub 2017. PMID: 28817374.
84. Antonoff MB, Correa AM, Sepesi B, Nguyen QN, Walsh GL, Swisher SG, Vaporciyan AA, Mehran RJ, Hofstetter WL, Rice DC. Salvage pulmonary resection after stereotactic body radiotherapy: A feasible and safe option for local failure in selected patients. J Thorac Cardiovasc Surg 154(2):689-699, 2017. e-Pub 2017. PMID: 28495066.
85. Bassuner JK, Rice DC, Antonoff MB, Correa AM, Walsh GL, Vaporciyan AA, Garg N, Sepesi B, Swisher SG, Hofstetter WL, Roth JA, Mehran RJ. Polytetrafluoroethylene or Acellular Dermal Matrix for diaphragmatic reconstruction?. Ann Thorac Surg 103(6):1710-1714, 2017. e-Pub 2017. PMID: 28366460.
86. Sepesi B, Cuentes EP, Canales JR, Behrens C, Correa A, Antonoff M, Gibbons DL, Heymach J, Hofstetter W, Mehran R, Rice DC, Roth J, Vaporciyan AA, Walsh G, Weissferdt A, Kalhor N, Moran C, Swisher SG, Wistuba I. Tumor-Infiltrating Lymphocytes and Overall Survival in Surgically Resected Stage II and III Non-Small Cell Lung Cancer. Int J Radiat Oncol Biol Phys 98(1):223, 2017. PMID: 28586974.
87. Antonoff M, Ragalie W, Sepesi B, Roth J, Walsh G, Hofstetter W, Swisher SG, Rice DC, Vaporciyan AA, Mehran R. Patient-Reported Symptoms: Differences Between Men and Women Following Pulmonary Resection. Int J Radiat Oncol Biol Phys 98(1):240, 2017. PMID: 28587019.
88. Mehran RJ, Walsh GL, Zalpour A, Cata JP, Correa AM, Antonoff MB, Rice DC. Intercostal Nerve Blocks With Liposomal Bupivacaine: Demonstration of Safety, and Potential Benefits. Semin Thorac Cardiovasc Surg 29(4):531-537, 2017. e-Pub 2017. PMID: 29698654.
89. Spicer JD, Shewale JB, Antonoff MB, Correa AM, Hofstetter WB, Rice DC, Vaporciyan AA, Mehran RJ, Walsh GL, Roth JA, Swisher SG, Sepesi B. The Influence of Reconstructive Technique on Perioperative Pulmonary and Infectious Outcomes Following Chest Wall Resection. Ann Thorac Surg 102(5):1653-1659, 2016. e-Pub 2016. PMID: 27526650.
90. Antonoff MB, Ragalie W, Correa AM, Spicer JD, Sepesi B, Roth JA, Walsh GL, Hofstetter WL, Swisher SG, Rice DC, Vaporciyan AA, Mehran RJ. Results of Postdischarge Nursing Telephone Assessments: Persistent Symptoms Common Among Pulmonary Resection Patients. Ann Thorac Surg 102(1):276-81, 2016. e-Pub 2016. PMID: 27083250.
91. Sepesi B, Schmidt HE, Lada M, Correa AM, Walsh GL, Mehran RJ, Rice DC, Roth JA, Vaporciyan AA, Ajani JA, Watson TJ, Swisher SG, Low DE, Hofstetter WL. Survival in Patients with Esophageal Adenocarcinoma Undergoing Trimodality Therapy Is Independent of Regional Lymph Node Location. Ann Thorac Surg 101(3):1075-81, 2016. e-Pub 2015. PMID: 26680311.
92. Antonoff MB, Hofstetter WL, Correa AM, Bell JM, Sepesi B, Rice DC, Vaporciyan AA, Walsh GL, Mehran RJ, Swisher SG, Meyers BF. Clinical Prediction of Pathologic Complete Response in Superior Sulcus Non-Small-Cell Lung Cancer. Ann Thorac Surg 101(1):211-7, 2016. e-Pub 2015. PMID: 26279367.
93. Walsh GL, Mehran RJ. A Brief History of Thoracic Surgery at the University of Texas MD Anderson Cancer Center. Semin Thorac Cardiovasc Surg 28(3):719-726, 2016. e-Pub 2016. PMID: 28285679.
94. Ghali S, Chang EI, Rice DC, Walsh GL, Yu P. Microsurgical reconstruction of combined tracheal and total esophageal defects. J Thorac Cardiovasc Surg 150(5):1261-6, 2015. e-Pub 2015. PMID: 25998466.
95. Shewale JB, Correa AM, Baker CM, Villafane-Ferriol N, Hofstetter WL, Jordan VS, Kehlet H, Lewis KM, Mehran RJ, Summers BL, Schaub D, Wilks SA, Swisher SG, University of Texas MD Anderson Esophageal Cancer Collaborative Group. Impact of a Fast-track Esophagectomy Protocol on Esophageal Cancer Patient Outcomes and Hospital Charges. Ann Surg 261(6):1114-23, 2015. PMID: 25243545.
96. Hao C, Wang L, Peng S, Cao M, Li H, Hu J, Huang X, Liu W, Zhang H, Wu S, Pataer A, Heymach JV, Eterovic AK, Zhang Q, Shaw KR, Chen K, Futreal A, Wang M, Hofstetter W, Mehran R, Rice D, Roth JA, Sepesi B, Swisher SG, Vaporciyan A, Walsh GL, Johnson FM, Fang B. Gene mutations in primary tumors and corresponding patient-derived xenografts derived from non-small cell lung cancer. Cancer Lett 357(1):179-85, 2015. e-Pub 2014. PMID: 25444907.
97. Kim MP, Correa AM, Hofstetter W, Mehran R, Rice DC, Roth JA, Vaporciyan AA, Walsh GL, Erasmus JJ, Swisher SG. Limitations of 18F-2-Deoxy-d-Glucose Positron Emission Tomography in N1 Detection in Patients With Pathologic Stage II-N1 and Implications for Management. Ann Thorac Surg 99(2):414-20, 2015. e-Pub 2014. PMID: 25497068.
98. Stephens N, Rice D, Correa A, Hoffstetter W, Mehran R, Roth J, Walsh G, Vaporciyan A, Swisher S. Thoracoscopic lobectomy is associated with improved short-term and equivalent oncological outcomes compared with open lobectomy for clinical Stage I non-small-cell lung cancer: a propensity-matched analysis of 963 cases. Eur J Cardiothorac Surg 46(4):607-13, 2014. e-Pub 2014. PMID: 24603446.
99. Weissferdt A, Walsh G, Kaiser L, Moran CA. Pulmonary adenocarcinoma T1N0M0 and its classification. Semin Diagn Pathol 31(4):260-4, 2014. e-Pub 2014. PMID: 25012478.
100. Sepesi B, Walsh GL. Surgical therapy of ground-glass opacities. Semin Diagn Pathol 31(4):289-292, 2014. e-Pub 2014. PMID: 25239273.
101. Avritscher EB, Cooksley CD, Rolston KV, Swint JM, Delclos GL, Franzini L, Swisher SG, Walsh GL, Mansfield PF, Elting LS. Serious postoperative infections following resection of common solid tumors: outcomes, costs, and impact of hospital surgical volume. Support Care Cancer 22(2):527-35, 2014. e-Pub 2013. PMID: 24141699.
102. Detterbeck FC, Moran C, Huang J, Suster S, Walsh G, Kaiser L, Wick M. [Which way is up? Policies and procedures for surgeons and pathologists regarding resection specimens of thymic malignancy]. Zhongguo Fei Ai Za Zhi 17(2):95-103, 2014. PMID: 24581159.
103. Hellmann MD, Chaft JE, William WN, Rusch V, Pisters KM, Kalhor N, Pataer A, Travis WD, Swisher SG, Kris MG, University of Texas MD Anderson Lung Cancer Collaborative Group. Pathological response after neoadjuvant chemotherapy in resectable non-small-cell lung cancers: proposal for the use of major pathological response as a surrogate endpoint. Lancet Oncol 15(1):e42-50, 2014. PMID: 24384493.
104. Ajani JA, Xiao L, Roth JA, Hofstetter WL, Walsh G, Komaki R, Liao Z, Rice DC, Vaporciyan AA, Maru DM, Lee JH, Bhutani MS, Eid A, Yao JC, Phan AP, Halpin A, Suzuki A, Taketa T, Thall PF, Swisher SG. A phase II randomized trial of induction chemotherapy versus no induction chemotherapy followed by preoperative chemoradiation in patients with esophageal cancer. Ann Oncol 24(11):2844-9, 2013. e-Pub 2013. PMID: 23975663.
105. Ganeshan DM, Correa AM, Bhosale P, Vaporciyan AA, Rice D, Mehran RJ, Walsh GL, Iyer R, Roth JA, Swisher SG, Hofstetter WL. Diaphragmatic Hernia After Esophagectomy in 440 Patients With Long-Term Follow-Up. Ann Thorac Surg 96(4):1138-45, 2013. e-Pub 2013. PMID: 23810174.
106. Francis AM, Sepesi B, Correa AM, Blum MA, Erasmus JJ, Lee JH, Maru DM, Mehran RJ, Rice DC, Roth JA, Vaporciyan AA, Walsh GL, Welsh JW, Swisher SG, Hofstetter WL, University of Texas MD Anderson Esophageal Cancer Group. The Influence of Histopathologic Tumor Viability on Long-term Survival and Recurrence Rates Following Neoadjuvant Therapy for Esophageal Adenocarcinoma. Ann Surg 258(3):500-7, 2013. PMID: 24022442.
107. David E, Thall PF, Kalhor N, Hofstetter WL, Rice DC, Roth JA, Swisher SG, Walsh GL, Vaporciyan AA, Wei C, Mehran RJ. Visceral pleural invasion is not predictive of survival in patients with lung cancer and smaller tumor size. Ann Thorac Surg 95(6):1872-7; discussion 1877, 2013. e-Pub 2013. PMID: 23643547.
108. Blackmon SH, Stephens EH, Correa AM, Hofstetter W, Kim MP, Mehran RJ, Rice DC, Roth JA, Swisher SG, Walsh GL, Vaporciyan AA. Predictors of Recurrent Pulmonary Metastases and Survival After Pulmonary Metastasectomy for Colorectal Cancer. Ann Thorac Surg 94(6):1802-9, 2012. e-Pub 2012. PMID: 23063195.
109. Rodney AJ, Tannir NM, Siefker-Radtke AO, Liu P, Walsh GL, Millikan RE, Swisher SG, Tu SM, Pagliaro LC. Survival outcomes for men with mediastinal germ-cell tumors: The University of Texas M. D. Anderson Cancer Center experience. Urol Oncol 30(6):879-85, 2012. e-Pub 2010. PMID: 20933444.
110. Sepesi B, Swisher SG, Walsh GL, Correa A, Mehran RJ, Rice D, Roth J, Vaporciyan A, Hofstetter WL. Omental reinforcement of the thoracic esophagogastric anastomosis: An analysis of leak and reintervention rates in patients undergoing planned and salvage esophagectomy. J Thorac Cardiovasc Surg 144(5):1146-51, 2012. e-Pub 2012. PMID: 22939861.
111. Marks JL, Hofstetter W, Correa AM, Mehran RJ, Rice D, Roth J, Walsh G, Vaporciyan A, Erasmus J, Chang J, Maru D, Lee JH, Lee J, Ajani JA, Swisher SG. Salvage Esophagectomy After Failed Definitive Chemoradiation for Esophageal Adenocarcinoma. Ann Thorac Surg 94(4):1126-33, 2012. e-Pub 2012. PMID: 22921233.
112. Blackmon SH, Correa AM, Skoracki R, Chevray PM, Kim MP, Mehran RJ, Rice DC, Roth JA, Swisher SG, Vaporciyan AA, Yu P, Walsh GL, Hofstetter WL. Supercharged Pedicled Jejunal Interposition for Esophageal Replacement: A 10-Year Experience. Ann Thorac Surg 94(4):1104-13, 2012. e-Pub 2012. PMID: 22939245.
113. Kant S, Walsh GL. Fibrosing Mediastinitis and consequent Superior Vena Cava syndrome- A Case Report. J Thorac Dis 4(4):428-30, 2012. PMID: 22934147.
114. Pataer A, Kalhor N, Correa AM, Raso MG, Erasmus JJ, Kim ES, Behrens C, Lee JJ, Roth JA, Stewart DJ, Vaporciyan AA, Wistuba II, Swisher SG, University of Texas M. D. Anderson Lung Cancer Collaborative Research Group. Histopathologic response criteria predict survival of patients with resected lung cancer after neoadjuvant chemotherapy. J Thorac Oncol 7(5):825-32, 2012. PMID: 22481232.
115. Moran CA, Walsh G, Suster S, Kaiser L. Thymomas II: a clinicopathologic correlation of 250 cases with a proposed staging system with emphasis on pathologic assessment. Am J Clin Pathol 137(3):451-61, 2012. PMID: 22338058.
116. Harvin JA, Lahat G, Correa AM, Lee J, Maru D, Ajani J, Marom EM, Welsh J, Bhutani MS, Walsh G, Roth J, Mehran R, Vaporciyan A, Rice D, Swisher S, Hofstetter W. Neoadjuvant chemoradiotherapy followed by surgery for esophageal adenocarcinoma: Significance of microscopically positive circumferential radial margins. J Thorac Cardiovasc Surg 143(2):412-20, 2012. e-Pub 2011. PMID: 22172216.
117. Kim JY, Correa AM, Vaporciyan AA, Roth JA, Mehran RJ, Walsh GL, Rice DC, Ajani JA, Maru DM, Bhutani MS, Welsh J, Marom EM, Swisher SG, Hofstetter WL. Does the Timing of Esophagectomy After Chemoradiation Affect Outcome?. Ann Thorac Surg 93(1):207-12; discussion 212-3, 2012. e-Pub 2011. PMID: 21962263.
118. Fernando HC, Jaklitsch MT, Walsh GL, Tisdale JE, Bridges CD, Mitchell JD, Shrager JB. The Society of Thoracic Surgeons practice guideline on the prophylaxis and management of atrial fibrillation associated with general thoracic surgery: executive summary. Ann Thorac Surg 92(3):1144-52, 2011. PMID: 21871327.
119. Hemmati SH, Correa AM, Walsh GL, Swisher SG, Roth JA, Rice DC, Mehran RJ, Vaporciyan AA. The prognostic factors of chest wall metastasis resection. Eur J Cardiothorac Surg 40(2):328-33, 2011. e-Pub 2011. PMID: 21466960.
120. Brouquet A, Vauthey JN, Contreras CM, Walsh GL, Vaporciyan AA, Swisher SG, Curley SA, Mehran RJ, Abdalla EK. Improved survival after resection of liver and lung colorectal metastases compared with liver-only metastases: a study of 112 patients with limited lung metastatic disease. J Am Coll Surg 213(1):62-9; discussion 69-71, 2011. PMID: 21700179.
121. Detterbeck FC, Moran C, Huang J, Suster S, Walsh G, Kaiser L, Wick M. Which way is up? Policies and procedures for surgeons and pathologists regarding resection specimens of thymic malignancy. J Thorac Oncol 6(7 Suppl 3):S1730-8, 2011. PMID: 21847055.
122. Poh M, Selber JC, Skoracki R, Walsh GL, Yu P. Technical challenges of total esophageal reconstruction using a supercharged jejunal flap. Ann Surg 253(6):1122-9, 2011. PMID: 21587114.
123. Mehran R, Rice D, El-Zein R, Huang JL, Vaporciyan A, Goodyear A, Mehta A, Correa A, Walsh G, Roth J, Swisher S, Hofstetter W. Minimally invasive esophagectomy versus open esophagectomy, a symptom assessment study. Dis Esophagus 24(3):147-52, 2011. e-Pub 2010. PMID: 21040152.
124. Stephens EH, Blackmon SH, Correa AM, Roth JA, Rice DC, Hofstetter W, Benjamin R, Mehran R, Swisher SG, Walsh GL, Vaporciyan AA.. Progression after Chemotherapy Is a Novel Predictor of Poor Outcomes after Pulmonary Metastasectomy in Sarcoma Patients. J Am Coll Surg 5(12):1894-1904. e-Pub 2011.
125. Yu P, Clayman GL, Walsh GL. Long-term outcomes of microsurgical reconstruction for large tracheal defects. Cancer 117(4):802-8, 2011. e-Pub 2010. PMID: 20872878.
126. Selvan MS, Subbian S, Cantor S, Rodriguez A, Smith M, Walsh G. Ethics of transparency in research reports. The Indian Journal of Medical Ethics VIII (1)(January - March 2011):31-36, 2011.
127. Gaur P, Sepesi B, Hofstetter WL, Correa AM, Bhutani MS, Watson TJ, Swisher SG, M. D. Anderson Esophageal Cancer Group, University of Rochester School of Medicine and Dentistry Foregut Group. Endoscopic esophageal tumor length: a prognostic factor for patients with esophageal cancer. Cancer 117(1):63-9, 2011. e-Pub 2010. PMID: 20803613.
128. Blackmon SH, Correa AM, Chevray PM, Mehran R, Rice DC, Skoracki R, Vaporciyan AA, Walsh GL, Swisher SG, and Hofstetter WL.. Super-Charged Jejunal Interposition for Esophageal Replacement: A 10 Year Experience. Ann Thorac Surg 94(4):1104, 2011.
129. Hayashi Y, Correa AM, Hofstetter WL, Vaporciyan AA, Rice DC, Walsh GL, Mehran RJ, Lee JH, Bhutani MS, Dekovich A, Swisher SG, Ajani JA. The influence of high body mass index on the prognosis of patients with esophageal cancer after surgery as primary therapy. Cancer 116(24):5619-27, 2010. e-Pub 2010. PMID: 21136578.
130. Gaur P, Sepesi B, Hofstetter WL, Correa AM, Bhutani MS, Vaporciyan AA, Watson TJ, Swisher SG, Members of the MD Anderson Esophageal Cancer Group and the University of Rochester School of Medicine and Dentistry Foregut Group. A clinical nomogram predicting pathologic lymph node involvement in esophageal cancer patients. Ann Surg 252(4):611-7, 2010. PMID: 20881767.
131. Kim MP, Correa AM, Lee J, Rice DC, Roth JA, Mehran RJ, Walsh GL, Ajani JA, Maru DM, Chang JY, Marom EM, Macapinlac HA, Lee JH, Vaporciyan AA, Rice T, Swisher SG, Hofstetter WL. Pathologic T0N1 Esophageal Cancer After Neoadjuvant Therapy and Surgery: An Orphan Status. Ann Thorac Surg 90(3):884-90; discussion 890-1, 2010. PMID: 20732513.
132. Swisher SG, Hofstetter W, Komaki R, Correa AM, Erasmus J, Lee JH, Liao Z, Maru D, Mehran R, Patel S, Rice DC, Roth JA, Vaporciyan AA, Walsh GL, Ajani JA. Improved long-term outcome with chemoradiotherapy strategies in esophageal cancer. Ann Thorac Surg 90(3):892-8; discussion 898-9, 2010. PMID: 20732514.
133. Kim MP, Correa AM, Swisher SG, Hofstetter WL, Mehran RJ, Rice DC, Walsh GL, Erasmus J, Moran C, Vaporciyan AA, Roth JA. Non-small cell lung cancer resection in lymphoma patients. Ann Thorac Surg 90(1):210-6, 2010. PMID: 20609777.
134. Smitherman SM, Tatsui CE, Rao G, Walsh G, Rhines LD. Image-guided multilevel vertebral osteotomies for en bloc resection of giant cell tumor of the thoracic spine: case report and description of operative technique. Eur Spine J 19(6):1021-8, 2010. e-Pub 2010. PMID: 20069317.
135. Gopaldas RR, Bakaeen FG, Dao TK, Walsh GL, Swisher SG, Chu D. Video-assisted thoracoscopic versus open thoracotomy lobectomy in a cohort of 13,619 patients. Ann Thorac Surg 89(5):1563-70, 2010. PMID: 20417778.
136. Ajani JA, Correa AM, Walsh GL, Komaki R, Lee JH, Vaporciyan AA, Rice DC, Yao JC, Maru DM, Hofstetter WL, Phan AT, Swisher SG. Trimodality therapy without a platinum compound for localized carcinoma of the esophagus and gastroesophageal junction. Cancer 116(7):1656-63, 2010. e-Pub 2010. PMID: 20143431.
137. Braiteh F, Correa AM, Hofstetter WL, Rice DC, Vaporciyan AA, Walsh GL, Roth JA, Mehran RJ, Swisher SG, Ajani JA. Association of age and survival in patients with gastroesophageal cancer undergoing surgery with or without preoperative therapy. Cancer 115(19):4450-4458, 2009. e-Pub 2009. PMID: 19562780.
138. Bolton WD, Hofstetter WL, Francis AM, Correa AM, Ajani JA, Bhutani MS, Erasmus J, Komaki R, Maru DM, Mehran RJ, Rice DC, Roth JA, Vaporciyan AA, Walsh GL, Swisher SG. Impact of tumor length on long-term survival of pT1 esophageal adenocarcinoma. J Thorac Cardiovasc Surg 138(4):831-6, 2009. e-Pub 2009. PMID: 19660349.
139. Blackmon SH, Shah N, Roth JA, Correa AM, Vaporciyan AA, Rice DC, Hofstetter W, Walsh GL, Benjamin R, Pollock R, Swisher SG, Mehran R. Resection of pulmonary and extra-pulmonary sarcomatous metastases is associated with long-term survival. Ann Thorac Surg 88(3):877-84; discussion 884-5, 2009. PMID: 19699915.
140. Rice DC, Steliga MA, Stewart J, Eapen G, Jimenez CA, Lee JH, Hofstetter WL, Marom EM, Mehran RJ, Vaporciyan AA, Walsh GL, Swisher SG. Endoscopic ultrasound-guided fine needle aspiration for staging of malignant pleural mesothelioma. Ann Thorac Surg 88(3):862-8; discussion 868-9, 2009. PMID: 19699913.
141. Kassis ES, Vaporciyan AA, Swisher SG, Correa AM, Bekele BN, Erasmus JJ, Hofstetter WL, Komaki R, Mehran RJ, Moran CA, Pisters KM, Rice DC, Walsh GL, Roth JA. Application of the Revised Lung Cancer Staging System (IASLC Staging Project) to a Cancer Center Population. J Thorac Cardiovasc Surg 138(2):412-418.e1-2, 2009. e-Pub 2009. PMID: 19619787.
142. Bolton WD, Rice DC, Correa AM, Hofstetter W, Komaki R, Mehran R, Pisters K, Roth JA, Vaporciyan AA, Walsh GL, Swisher SG. Influence of Age on Choice of Therapy and Surgical Outcomes in Patients with Non-Small Cell Lung Cancer. Am Surg 75(7):598-603; discussion 603-4, 2009. PMID: 19655604.
143. Bakaeen FG, Jaroszewski DE, Rice DC, Walsh GL, Vaporciyan AA, Swisher SS, Benjamin R, Blackmon S, Reardon MJ. Outcomes after Surgical Resection of Cardiac Sarcoma in the Multimodality Treatment Era. J Thorac Cardiovasc Surg 137(6):1454-60, 2009. e-Pub 2009. PMID: 19464464.
144. Bolton WD, Rice DC, Goodyear A, Correa AM, Erasmus J, Hofstetter W, Komaki R, Mehran R, Pisters K, Roth JA, Swisher SG, Vaporciyan AA, Walsh GL, Weaver J, Rhines L. Superior sulcus tumors with vertebral body involvement: a multimodality approach. J Thorac Cardiovasc Surg 137(6):1379-87, 2009. PMID: 19464452.
145. Blackmon SH, Rice DC, Correa AM, Mehran R, Putnam JB, Smythe WR, Walkes JC, Walsh GL, Moran C, Singh H, Vaporciyan AA, Reardon M. Management of primary pulmonary artery sarcomas. Ann Thorac Surg 87(3):977-84, 2009. PMID: 19231448.
146. Yendamuri S, Swisher SG, Correa AM, Hofstetter W, Ajani JA, Francis A, Maru D, Mehran RJ, Rice DC, Roth JA, Walsh GL, Vaporciyan AA. Esophageal Tumor Length is Independently Associated with Long-term Survival. Cancer 115(3):508-16, 2009. PMID: 19117343.
147. Rice D, Swisher S, Pisters K, Fossella F, Herbst R, Hofstetter W, Kies M, Komaki R, Lippman S, Mehran R, Roth J, Stewart D, Vaporciyan A, Walsh G, Cox J. Comment on "Treatment of non-small cell lung cancer stage IIIA: ACCP evidence-based clinical practice guidelines (2nd edition)". Chest 134(6):1349; author reply 1350, 2008. PMID: 19059972.
148. Selvan MS, Skibber JM, Walsh GL. The Surgical Instrument Counting Process: A Statistician's Plea for Terminology Clarification. J Surg Res 150(1):1-2, 2008. e-Pub 2008. PMID: 18619617.
149. Yendamuri S, Vaporciyan AA, Zaidi T, Feng L, Fernandez R, Bekele NB, Hofstetter WL, Jiang F, Mehran RJ, Rice DC, Spitz MR, Swisher SG, Walsh GL, Roth JA, Katz RL. 3p22.1 and 10q22.3 deletions detected by fluorescence in situ hybridization (FISH): a potential new tool for early detection of non-small cell lung Cancer (NSCLC). J Thorac Oncol 3(9):979-84, 2008. PMID: 18758299.
150. Bruzzi JF, Komaki R, Walsh GL, Truong MT, Gladish GW, Munden RF, Erasmus JJ. Imaging of non-small cell lung cancer of the superior sulcus: part 1: anatomy, clinical manifestations, and management. Radiographics 28(2):551-60; quiz 620, 2008. PMID: 18349457.
151. Bruzzi JF, Komaki R, Walsh GL, Truong MT, Gladish GW, Munden RF, Erasmus JJ. Imaging of non-small cell lung cancer of the superior sulcus: part 2: initial staging and assessment of resectability and therapeutic response. Radiographics 28(2):561-72, 2008. PMID: 18349458.
152. Yendamuri S, Komaki RR, Correa AM, Allen P, Wynn B, Blackmon S, Hofstetter WL, Rice DC, Roth JA, Swisher SG, Vaporciyan AA, Walsh GL, Mehran RJ. Comparison of limited surgery and three-dimensional conformal radiation in high-risk patients with stage I non-small cell lung cancer. J Thorac Oncol 2/11(11):1022-8, 2007. PMID: 17975494.
153. Rice DC, Stevens CW, Correa AM, Vaporciyan AA, Tsao A, Forster KM, Walsh GL, Swisher SG, Hofstetter WL, Mehran RJ, Roth JA, Liao Z, Smythe WR. Outcomes after extrapleural pneumonectomy and intensity-modulated radiation therapy for malignant pleural mesothelioma. Ann Thorac Surg 84/5(5):1685-92, 2007. PMID: 17954086.
154. Hittelman WN, Liu DD, Kurie JM, Lotan R, Lee JS, Khuri F, Ibarguen H, Morice RC, Walsh G, Roth JA, Minna J, Ro JY, Broxson A, Hong WK, Lee JJ. Proliferative changes in the bronchial epithelium of former smokers treated with retinoids. J Natl Cancer Inst 7/99 (21)(21):1565-7, 2007. PMID: 17971525.
155. Bakaeen F, Rice D, Correa AM, Walsh GL, Vaporciyan AA, Putnam JB, Swisher SG, Roth JA, Huh J, Chu D, Smythe WR. Use of aprotinin in extrapleural pneumonectomy: effect on hemostasis and incidence of complications. Ann Thorac Surg 84(3)(3):982-986, 2007. PMID: 17720413.
156. Martin LW, Correa AM, Ordonez NG, Roth JA, Swisher SG, Vaporciyan AA, Walsh GL, Rice DC. Sarcomatoid carcinoma of the lung: a predictor of poor prognosis. Ann Thorac Surg 84(3)(3):973-80, 2007. PMID: 17720411.
157. Hofstetter W, Correa AM, Bekele N, Ajani JA, Phan A, Komaki RR, Liao Z, Maru D, Wu TT, Mehran RJ, Rice DC, Roth JA, Vaporciyan AA, Walsh GL, Francis A, Blackmon S, Swisher SG. Proposed modification of nodal status in AJCC esophageal cancer staging system. Ann Thorac Surg 84(2)(2):365-73 discussion 374-5, 2007. PMID: 17643602.
158. Blackmon SH, Correa AM, Wynn B, Hofstetter WL, Martin LW, Mehran RJ, Rice DC, Swisher SG, Walsh GL, Roth JA, Vaporciyan AA. Propensity-matched analysis of three techniques for intrathoracic esophagogastric anastomosis. Ann Thorac Surg 83(5)(5):1805-1813, 2007. PMID: 17462404.
159. Fujitani K, Ajani JA, Crane CH, Feig BW, Pisters PW, Janjan N, Walsh GL, Swisher SG, Vaporciyan AA, Rice D, Welch A, Baker J, Faust J, Mansfield PF. Impact of induction chemotherapy and preoperative chemoradiotherapy on operative morbidity and mortality in patients with locoregional adenocarcinoma of the stomach or gastroesophageal junction. Ann Surg Oncol 14(4)(7):1305-1311, 2007. e-Pub 2007. PMID: 17342569.
160. Malaisrie SC, Hofstetter WL, Correa AM, Ajani JA, Komaki RR, Rice DC, Vaporciyan AA, Walsh GL, Roth JA, Wu TT, Swisher SG. The addition of induction chemotherapy to preoperative concurrent chemoradiotherapy improves tumor response in patients with esophageal adenocarcinoma. Cancer 107(5):967-74, 2006. PMID: 16874819.
161. Wang J, Walsh G, Liu DD, Lee JJ, Mao L. Expression of {Delta}DNMT3B Variants and Its Association with Promoter Methylation of p16 and RASSF1A in Primary Non-Small Cell Lung Cancer. Cancer Res 66(17):8361-8366, 2006. PMID: 16951144.
162. Rohatgi PR, Swisher SG, Correa AM, Wu TT, Liao Z, Komaki R, Walsh GL, Vaporciyan AA, Rice DC, Bresalier RS, Roth JA, Ajani JA. Histologic subtypes as determinants of outcome in esophageal carcinoma patients with pathologic complete response after preoperative chemoradiotherapy. Cancer 106(3):552-8, 2006. PMID: 16353210.
163. Webb BD, Walsh GL, Roberts DB, Sturgis EM. Primary tracheal malignant neoplasms: the University of Texas MD Anderson Cancer Center experience. J Am Coll Surg 202(2):237-46, 2006. PMID: 16427548.
164. Yu P, Clayman GL, Walsh GL. Human tracheal reconstruction with a composite radial forearm free flap and prosthesis. Ann Thorac Surg 81(2):714-6, 2006. PMID: 16427881.
165. Jaroszewski DE, Walsh GL, Mattox KL, Wall MJ Jr, Trastek VF. Simple pitfalls to avoid for today's surgeon. Surg. Rounds, 29:167-172, 2006.
166. Rohatgi PR, Correa AM, Swisher SG, Wu TT, Liao Z, Komaki R, Walsh GL, Vaporciyan AA, Lee JH, Rice DC, Roth JA, Ajani JA. Gender-based analysis of esophageal cancer patients undergoing preoperative chemoradiation: differences in presentation and therapy outcome. Dis Esophagus 19(3):152-7, 2006. PMID: 16722991.
167. Herrera LJ, Correa AM, Vaporciyan AA, Hofstetter WL, Rice DC, Swisher SG, Walsh GL, Roth JA, Mehran RJ. Increased risk of aspiration and pulmonary complications after lung resection in head and neck cancer patients. Ann Thorac Surg 82(6):Pg. 214, 2006. PMID: 17126095.
168. Malaisrie SC, Hofstetter WL, Correa AM, Ajani JA, Komaki RR, Liao Z, Phan A, Rice DC, Vaporciyan AA, Walsh GL, Lahoti S, Lee JH, Bresalier R, Roth JA, Swisher SG. Endoscopic ultrasonography-identified celiac adenopathy remains a poor prognostic factor despite preoperative chemoradiotherapy in esophageal adenocarcinoma. J Thorac Cardiovasc Surg 131(1):65-72, 2006. PMID: 16399296.
169. Chang YS, Wu W, Walsh G, Hong WK, Mao L. Enikase-alpha is frequently down-regulated in non-small cell lung cancer and predicts aggressive biological behavior. Clinical Cancer Research 9:3641-3644, 2006.
170. Martin LW, Correa AM, Hofstetter W, Hong WK, Komaki R, Putnam JB, Rice DC, Smythe WR, Swisher SG, Vaporciyan AA, Walsh GL, Roth JA. The evolution of treatment outcomes for resected stage IIIA non-small cell lung cancer over 16 years at a single institution. J Thorac Cardiovasc Surg 130(6):1601-10, 2005. PMID: 16308005.
171. Rice DC, Erasmus JJ, Stevens CW, Vaporciyan AA, Wu JS, Tsao AS, Walsh GL, Swisher SG, Hofstetter WL, Ordonez NG, Smythe WR. Extended surgical staging for potentially resectable malignant pleural mesothelioma. Ann Thorac Surg 80(6):1988-92; discussion 1992-3, 2005. PMID: 16305830.
172. Rohatgi P, Swisher SG, Correa AM, Wu TT, Liao Z, Komaki R, Walsh GL, Vaporciyan AA, Rice DC, Roth JA, Ajani JA. Characterization of pathologic complete response after preoperative chemoradiotherapy in carcinoma of the esophagus and outcome after pathologic complete response. Cancer 104(11):2365-72, 2005. PMID: 16245310.
173. Ascioti AJ, Hofstetter WL, Miller MJ, Rice DC, Swisher SG, Vaporciyan AA, Roth JA, Putnam JB, Smythe WR, Feig BW, Mansfield PF, Pisters PW, Torres MT, Walsh GL. Long-segment, supercharged, pedicled jejunal flap for total esophageal reconstruction. J Thorac Cardiovasc Surg 130(5):1391-8, 2005. e-Pub 2005. PMID: 16256794.
174. Rohatgi PR, Swisher SG, Correa AM, Wu TT, Liao Z, Komaki R, Walsh G, Vaporciyan A, Lynch PM, Rice DC, Roth JA, Ajani JA. Failure patterns correlate with the proportion of residual carcinoma after preoperative chemoradiotherapy for carcinoma of the esophagus. Cancer 104(7):1349-55, 2005. PMID: 16130133.
175. Erasmus JJ, Truong MT, Smythe WR, Munden RF, Marom EM, Rice DC, Vaporciyan AA, Walsh GL, Sabloff BS, Broemeling LD, Stevens CW, Pisters KM, Podoloff DA, Macapinlac HA. Integrated computed tomography-positron emission tomography in patients with potentially resectable malignant pleural mesothelioma: Staging implications. J Thorac Cardiovasc Surg 129(6):1364-70, 2005. PMID: 15942579.
176. Lu C, Perez-Soler R, Piperdi B, Walsh GL, Swisher SG, Smythe WR, Shin HJ, Ro JY, Feng L, Truong M, Yalamanchili A, Lopez-Berestein G, Hong WK, Khokhar AR, Shin DM. Phase II study of a liposome-entrapped cisplatin analog (L-NDDP) administered intrapleurally and pathologic response rates in patients with malignant pleural mesothelioma. J Clin Oncol 23(15):3495-501, 2005. PMID: 15908659.
177. Swisher SG, Hofstetter W, Wu TT, Correa AM, Ajani JA, Komaki RR, Chirieac L, Hunt KK, Liao Z, Phan A, Rice DC, Vaporciyan AA, Walsh GL, Roth JA. Proposed revision of the esophageal cancer staging system to accommodate pathologic response (p.P.) following preoperative chemoradiation (CRT). Ann Surg 241(5):810-7; discussion 817-20, 2005. PMID: 15849517.
178. Martin LW, Swisher SG, Hofstetter W, Correa AM, Mehran RJ, Rice DC, Vaporciyan AA, Walsh GL, Roth JA. Intrathoracic leaks following esophagectomy are no longer associated with increased mortality. Ann Surg 242(3):392-9; discussion 399-402, 2005. PMID: 16135925.
179. Rice DC, Correa AM, Vaporciyan AA, Sodhi N, Smythe WR, Swisher SG, Walsh GL, Putnam JB, Komaki R, Ajani JA, Roth JA. Preoperative chemoradiotherapy prior to esophagectomy in elderly patients is not associated with increased morbidity. Ann Thorac Surg 79(2):391-7; discussion 391-7, 2005. PMID: 15680801.
180. Rohatgi PR, Swisher SG, Correa AM, Wu TT, Liao Z, Walsh GL, Vaporciyan AA, Rice DC, Fukami N, Roth JA, Ajani JA. Comparison of clinical stage, therapy response, and patient outcome between squamous cell carcinoma and adenocarcinoma of the esophagus. Int J Gastrointest Cancer 36(2):69-76, 2005. PMID: 16648656.
181. Cohen ZR, Fourney DR, Gokaslan ZL, Walsh GL, Rhines LD. Anterior stabilization of the upper thoracic spine via an "interaortocaval sub innominate window": case report and description of operative technique. J Spinal Disord Tech 17(6):543-8, 2004. PMID: 15570130.
182. Liao Z, Zhang Z, Jin J, Ajani JA, Swisher SG, Stevens CW, Ho L, Smythe R, Vaporciyan AA, Putnam JB, Walsh GL, Roth JA, Yao JC, Allen PK, Cox JD, Komaki R. Esophagectomy after concurrent chemoradiotherapy improves locoregional control in clinical stage II or III esophageal cancer patients. Int J Radiat Oncol Biol Phys 60(5):1484-93, 2004. PMID: 15590179.
183. Mullen JT, Walsh GL, Abdalla EK, Loyer EM, Curley SA, Vauthey JN. Transdiaphragmatic radiofrequency ablation of liver tumors. J Am Coll Surg 199(5):826-9, 2004. PMID: 15501127.
184. Jin J, Liao Z, Zhang Z, Ajani J, Swisher S, Chang JY, Jeter M, Guerrero T, Stevens CW, Vaporciyan A, Putnam J, Jr, Walsh G, Smythe R, Roth J, Yao J, Allen P, Cox JD, Komaki R. Induction chemotherapy improved outcomes of patients with resectable esophageal cancer who received chemoradiotherapy followed by surgery. Int J Radiat Oncol Biol Phys 60(2):427-36, 2004. PMID: 15380576.
185. Swisher SG, Erasmus J, Maish M, Correa AM, Macapinlac H, Ajani JA, Cox JD, Komaki RR, Hong D, Lee HK, Putnam JB, Rice DC, Smythe WR, Thai L, Vaporciyan AA, Walsh GL, Wu TT, Roth JA. 2-Fluoro-2-deoxy-D-glucose positron emission tomography imaging is predictive of pathologic response and survival after preoperative chemoradiation in patients with esophageal carcinoma. Cancer 101(8):1776-85, 2004. PMID: 15386332.
186. Swisher SG, Maish M, Erasmus JJ, Correa AM, Ajani JA, Bresalier R, Komaki R, Macapinlac H, Munden RF, Putnam JB, Rice D, Smythe WR, Vaporciyan AA, Walsh GL, Wu TT, Roth JA. Utility of PET, CT, and EUS to identify pathologic responders in esophageal cancer. Ann Thorac Surg 78(4):1152-60; discussion 1152-60, 2004. PMID: 15464463.
187. Agarwal B, Swisher S, Ajani J, Kelly K, Fanning C, Komaki RR, Putnam JB, Abu-Hamda E, Molke KL, Walsh GL, Correa AM, Ho L, Liao Z, Lynch PM, Rice DC, Smythe WR, Stevens CW, Vaporciyan AA, Yao J, Roth JA. Endoscopic ultrasound after preoperative chemoradiation can help identify patients who benefit maximally after surgical esophageal resection. Am J Gastroenterol 99(7):1258-66, 2004. PMID: 15233663.
188. Ajani JA, Walsh G, Komaki R, Morris J, Swisher SG, Putnam JB, Lynch PM, Wu TT, Smythe R, Vaporciyan A, Faust J, Cohen DS, Nivers R, Roth JA. Preoperative induction of CPT-11 and cisplatin chemotherapy followed by chemoradiotherapy in patients with locoregional carcinoma of the esophagus or gastroesophageal junction. Cancer 100(11):2347-54, 2004. PMID: 15160337.
189. Kim ES, Putnam JB, Komaki R, Walsh GL, Ro JY, Shin HJ, Truong M, Moon H, Swisher SG, Fossella FV, Khuri FR, Hong WK, Shin DM. Phase II study of a multidisciplinary approach with induction chemotherapy, followed by surgical resection, radiation therapy, and consolidation chemotherapy for unresectable malignant thymomas: final report. Lung Cancer 44(3):369-79, 2004. PMID: 15140551.
190. Martin LW, Walsh GL. Vertebral body resection. Thorac Surg Clin 14(2):241-54, 2004. PMID: 15382300.
191. Allen MS, Wood DE, Hawkinson RW, Harpole DH, McKenna RJ, Walsh GL, Vallieres E, Miller DL, Nichols FC, 3rd, Smythe WR, Davis RD. Prospective randomized study evaluating a biodegradable polymeric sealant for sealing intraoperative air leaks that occur during pulmonary resection. Ann Thorac Surg 77(5):1792-801, 2004. PMID: 15111188.
192. Porter GA, Cantor SB, Walsh GL, Rusch VW, Leung DH, DeJesus AY, Pollock RE, Brennan MF, Pisters PW. Cost-effectiveness of pulmonary resection and systemic chemotherapy in the management of metastatic soft tissue sarcoma: a combined analysis from the University of Texas M. D. Anderson and Memorial Sloan-Kettering Cancer Centers. J Thorac Cardiovasc Surg 127(5):1366-72, 2004. PMID: 15115994.
193. Verschraegen CF, Gilbert BE, Loyer E, Huaringa A, Walsh G, Newman RA, Knight V. Clinical evaluation of the delivery and safety of aerosolized liposomal 9-nitro-20(s)-camptothecin in patients with advanced pulmonary malignancies. Clin Cancer Res 10(7):2319-26, 2004. PMID: 15073107.
194. Vaporciyan AA, Correa AM, Rice DC, Roth JA, Smythe WR, Swisher SG, Walsh GL, Putnam JB. Risk factors associated with atrial fibrillation after noncardiac thoracic surgery: analysis of 2588 patients. J Thorac Cardiovasc Surg 127(3):779-86, 2004. PMID: 15001907.
195. Siefker-Radtke AO, Walsh GL, Pisters LL, Shen Y, Swanson DA, Logothetis CJ, Millikan RE. Is there a role for surgery in the management of metastatic urothelial cancer? The M. D. Anderson experience. J Urol 171(1):145-8, 2004. PMID: 14665863.
196. Taylor NA, Liao ZX, Cox JD, Stevens C, Roth J, Walsh G, Chang JY, Guerrero T, Jeter M, Putnam J, Fossella FV, Allen P, Komaki R. Equivalent outcome of patients with clinical stage IIIA non-small-cell lung cancer treated with concurrent chemoradiation compared with induction chemotherapy followed by surgical resection. Int J Radiat Oncol Biol Phys 58(1)(1):204-212, 2004. PMID: 14697440.
197. Lee HK, Vaporciyan AA, Cox JD, Tucker SL, Putnam JB, Ajani JA, Liao Z, Swisher SG, Roth JA, Smythe WR, Walsh GL, Mohan R, Liu HH, Mooring D, Komaki R. Postoperative pulmonary complications after preoperative chemoradiation for esophageal carcinoma: correlation with pulmonary dose-volume histogram parameters. Int J Radiat Oncol Biol Phys 57(5):1317-22, 2003. PMID: 14630268.
198. Ahamad A, Stevens CW, Smythe WR, Liao Z, Vaporciyan AA, Rice D, Walsh G, Guerrero T, Chang J, Bell B, Komaki R, Forster KM. Promising early local control of malignant pleural mesothelioma following postoperative intensity modulated radiotherapy (IMRT) to the chest. Cancer J 9(6):476-84, 2003. PMID: 14740977.
199. Rice D, Kim HW, Sabichi A, Lippman S, Lee JJ, Williams B, Vaporciyan A, Smythe WR, Swisher S, Walsh G, Putnam JB, Hong WK, Roth J. The risk of second primary tumors after resection of stage I non small cell lung cancer. Ann Thorac Surg 76(4):1001-7; discussion 1007-8, 2003. PMID: 14529975.
200. Ajani JA, Faust J, Yao J, Komaki R, Stevens C, Swisher S, Putnam JB, Vaporciyan A, Smythe R, Walsh G, Rice D, Roth J. Irinotecan/cisplatin followed by 5-FU/paclitaxel/radiotherapy and surgery in esophageal cancer. Oncology (Williston Park) 17(9 Suppl 8):20-2, 2003. PMID: 14569843.
201. Sweeney P, Wood CG, Pisters LL, Slaton JW, Vaporciyan A, Munsell M, Carpenter S, Putnam J, Swisher SG, Walsh G, Swanson D, Dinney CP. Surgical management of renal cell carcinoma associated with complex inferior vena caval thrombi. Urol Oncol 21(5):327-33, 2003. PMID: 14670538.
202. Swisher SG, Ajani JA, Komaki R, Nesbitt JC, Correa AM, Cox JD, Lahoti S, Martin F, Putnam JB, Smythe WR, Vaporciyan AA, Walsh GL, Roth JA. Long-term outcome of phase II trial evaluating chemotherapy, chemoradiotherapy, and surgery for loco regionally advanced esophageal cancer. Int J Radiat Oncol Biol Phys 57(1):120-7, 2003. PMID: 12909224.
203. Chang YS, Wu W, Walsh G, Hong WK, Mao L. Enolase-alpha is frequently down-regulated in non-small cell lung cancer and predicts aggressive biological behavior. Clin Cancer Res 1;9(10 Pt 1):3641-4, 2003. PMID: 14506152.
204. Taylor NA, Liao ZX, Stevens C, Walsh G, Roth J, Putnam J, Fossella F, Allen P, Cox JD, Komaki R. Postoperative radiotherapy increases locoregional control of patients with stage IIIA non-small-cell lung cancer treated with induction chemotherapy followed by surgery. Int J Radiat Oncol Biol Phys 56(3):616-25, 2003. PMID: 12788166.
205. Lee HY, Srinivas H, Xia D, Lu Y, Superty R, LaPushin R, Gomez-Manzano C, Gal AM, Walsh GL, Force T, Ueki K, Mills GB, Kurie JM. Evidence that phosphatidylinositol 3-kinase- and mitogen-activated protein kinase kinase-4/c-Jun NH2-terminal kinase-dependent Pathways cooperate to maintain lung cancer cell survival. J Biol Chem 278(26):23630-8, 2003. PMID: 12714585.
206. Kurie JM, Lotan R, Lee JJ, Lee JS, Morice RC, Liu DD, Xu XC, Khuri FR, Ro JY, Hittelman WN, Walsh GL, Roth JA, Minna JD, Hong WK. Treatment of former smokers with 9-cis-retinoic acid reverses loss of retinoic acid receptor-beta expression in the bronchial epithelium: results from a randomized placebo-controlled trial. J Natl Cancer Inst 95(3):206-14, 2003. PMID: 12569142.
207. Singletary SE, Walsh G, Vauthey JN, Curley S, Sawaya R, Weber KL, Meric F, Hortobágyi GN. A role for curative surgery in the treatment of selected patients with metastatic breast cancer. Oncologist 8(3):241-51, 2003. PMID: 12773746.
208. Swisher SG, Roth JA, Komaki R, Gu J, Lee JJ, Hicks M, Ro JY, Hong WK, Merritt JA, Ahrar K, Atkinson NE, Correa AM, Dolormente M, Dreiling L, El-Naggar AK, Fossella F, Francisco R, Glisson B, Grammer S, Herbst R, Huaringa A, Kemp B, Khuri FR, Kurie JM, Liao Z, McDonnell TJ, Morice R, Morello F, Munden R, Papadimitrakopoulou V, Pisters KM, Putnam JB, Sarabia AJ, Shelton T, Stevens C, Shin DM, Smythe WR, Vaporciyan AA, Walsh GL, Yin M. Induction of p53-regulated genes and tumor regression in lung cancer patients after intratumoral delivery of adenoviral p53 (INGN 201) and radiation therapy. Clin Cancer Res 9(1):93-101, 2003. PMID: 12538456.
209. Hofstetter W, Swisher SG, Correa AM, Hess K, Putnam JB, Jr, Ajani JA, Dolormente M, Francisco R, Komaki RR, Lara A, Martin F, Rice DC, Sarabia AJ, Smythe WR, Vaporciyan AA, Walsh GL, Roth JA. Treatment outcomes of resected esophageal cancer. Ann Surg 236(3):376-84; discussion 384-5, 2002. PMID: 12192324.
210. Vaporciyan AA, Rice D, Correa AM, Walsh G, Putnam JB, Swisher S, Smythe R, Roth J. Resection of advanced thoracic malignancies requiring cardiopulmonary bypass. Eur J Cardiothorac Surg 22(1):47-52, 2002. PMID: 12103372.
211. Shaikh ZH, Torres HA, Walsh GL, Champlin RE, Kontoyiannis DP. Open lung biopsy in bone marrow transplant recipients has a poor diagnostic yield for a specific diagnosis. Transpl Infect Dis 4(2):80-4, 2002. PMID: 12220244.
212. Vaporciyan AA, Merriman KW, Ece F, Roth JA, Smythe WR, Swisher SG, Walsh GL, Nesbitt JC, Putnam JB, Jr. Incidence of major pulmonary morbidity after pneumonectomy: association with timing of smoking cessation. Ann Thorac Surg 73(2):420-5; discussion 425-6, 2002. PMID: 11845853.
213. Swisher SG, Wynn P, Putnam JB, Mosheim MB, Correa AM, Komaki RR, Ajani JA, Smythe WR, Vaporciyan AA, Roth JA, Walsh GL. Salvage esophagectomy for recurrent tumors after definitive chemotherapy and radiotherapy. J Thorac Cardiovasc Surg 123(1):175-83, 2002. PMID: 11782772.
214. Jang SJ, Soria JC, Wang L, Hassan KA, Morice RC, Walsh GL, Hong WK, Mao L. Activation of melanoma antigen tumor antigens occurs early in lung carcinogenesis. Cancer Res 61(21):7959-63, 2001. PMID: 11691819.
215. Ajani JA, Komaki R, Putnam JB, Walsh G, Nesbitt J, Pisters PW, Lynch PM, Vaporciyan A, Smythe R, Lahoti S, Raijman I, Swisher S, Martin FD, Roth JA. A three-step strategy of induction chemotherapy then chemoradiation followed by surgery in patients with potentially resectable carcinoma of the esophagus or gastroesophageal junction. Cancer 92(2):279-86, 2001. PMID: 11466680.
216. Lee JJ, Liu D, Lee JS, Kurie JM, Khuri FR, Ibarguen H, Morice RC, Walsh G, Ro JY, Broxson A, Hong WK, Hittelman WN. Long-term impact of smoking on lung epithelial proliferation in current and former smokers. J Natl Cancer Inst 93(14):1081-8, 2001. PMID: 11459869.
217. Fourney DR, Abi-Said D, Rhines LD, Walsh GL, Lang FF, McCutcheon IE, Gokaslan ZL. Simultaneous anterior-posterior approach to the thoracic and lumbar spine for the radical resection of tumors followed by reconstruction and stabilization. J Neurosurg 94(2 Suppl):232-44, 2001. PMID: 11302626.
218. Siegenthaler MP, Pisters KM, Merriman KW, Roth JA, Swisher SG, Walsh GL, Vaporciyan AA, Smythe WR, Putnam JB, Jr. Preoperative chemotherapy for lung cancer does not increase surgical morbidity. Ann Thorac Surg 71(4):1105-11; discussion 1111-2, 2001. PMID: 11308144.
219. Raad I, Hachem R, Hanna H, Abi-Said D, Bivins C, Walsh G, Thornby J, Whimbey E, Huaringa A, Sukumaran A. Treatment of nosocomial postoperative pneumonia in cancer patients: a prospective randomized study. Ann Surg Oncol 8(2):179-86, 2001. PMID: 11258785.
220. Smythe WR, Estrera AL, Swisher SG, Merriman KW, Walsh GL, Putnam JB, Jr, Vaporciyan AA, Roth JA. Surgical resection of non-small cell carcinoma after treatment for small cell carcinoma. Ann Thorac Surg 71(3):962-6, 2001. PMID: 11269481.
221. Walsh GL, Pisters KM, Stevens C. Treatment of stage I lung cancer. Chest Surg Clin N Am 11(1):17-38, vii, 2001. PMID: 11253597.
222. Komaki R, Cox JD, Putnam JB, Jr, Walsh G, Vaporciyan A, Liao Z, Stevens C, Fossella FV, Lee, JS, Hong, HK, Roth, J. The management of superior sulcus tumors. . J. Jpn. Soc. Ther. Radiol. Oncol 13:131-138, 2001.
223. Walsh GL Davis BM, Swisher SG, Vaporciyan AA, Smythe WR, Willis-Merriman K, Roth JA, Putnam JB, Jr. A single-institutional, multidisciplinary approach to primary sarcomas involving the chest wall requiring full-thickness resections. J Thorac Cardiovasc Surg 121(1):48-60, 2001. PMID: 11135159.
224. Komaki R, Janjan NA, Ajani JA, Lynch PM, Fairweather JS, Raijman I, Blumenshein GR, Ho L, Pisters PW, Feig BW, Walsh GL, Pazdur R. Phase I study of irinotecan and concurrent radiation therapy for upper GI tumors. Oncology (Williston Park) 14:34-7, 2000. PMID: 11200147.
225. Cockburn M, Swafford J, Mazur W, Walsh GL, Vauthey JN. Resolution of nonbacterial endocarditis after surgical resection of a malignant liver tumor. Circulation 102(21):2671-2, 2000. PMID: 11085973.
226. Komaki R, Roth JA, Walsh GL, Putnam JB, Vaporciyan A, Lee JS, Fossella FV, Chasen M, Delclos ME, Cox JD. Outcome predictors for 143 patients with superior sulcus tumors treated by multidisciplinary approach at the University of Texas M. D. Anderson Cancer Center. Int J Radiat Oncol Biol Phys 48(2):347-54, 2000. PMID: 10974447.
227. Sueoka N, Lee HY, Walsh GL, Fang B, Ji L, Roth JA, LaPushin R, Hong WK, Cohen P, Kurie JM. Insulin-like growth factor binding protein-6 inhibits the growth of human bronchial epithelial cells and increases in abundance with all-trans-retinoic acid treatment. Am J Respir Cell Mol Biol 23(3):297-303, 2000. PMID: 10970819.
228. Khuri FR, Lotan R, Kemp BL, Lippman SM, Wu H, Feng L, Lee JJ, Cooksley CS, Parr B, Chang E, Walsh GL, Lee JS, Hong WK, Xu XC. Retinoic acid receptor-beta as a prognostic indicator in stage I non-small-cell lung cancer. J Clin Oncol 18(15):2798-804, 2000. PMID: 10920126.
229. Kurie JM, Lee JS, Khuri FR, Mao L, Morice RC, Lee JJ, Walsh GL, Broxson A, Lippman SM, Ro JY, Kemp BL, Liu D, Fritsche HA, Xu X, Lotan R, Hong WK. N-(4-hydroxyphenyl)retinamide in the chemoprevention of squamous metaplasia and dysplasia of the bronchial epithelium. Clin Cancer Res 6(8):2973-9, 2000. PMID: 10955773.
230. Oh Y, Perez-Soler R, Fossella FV, Glisson BS, Kurie J, Walsh GL, Truong M, Shin DM. Phase II study of intravenous Doxil in malignant pleural mesothelioma. Invest New Drugs 18(3):243-5, 2000. PMID: 10958592.
231. Wang L, Lin SH, Wu WG, Kemp BL, Walsh GL, Hong WK, Mao L. C-CAM1, a candidate tumor suppressor gene, is abnormally expressed in primary lung cancers. Clin Cancer Res 6(8):2988-93, 2000. PMID: 10955775.
232. Swisher SG, Deford L, Merriman KW, Walsh GL, Smythe R, Vaporciyan A, Ajani JA, Brown T, Komaki R, Roth JA, Putnam JB. Effect of operative volume on morbidity, mortality, and hospital use after esophagectomy for cancer. J Thorac Cardiovasc Surg 119(6):1126-32, 2000. PMID: 10838528.
233. Miller DJ, Lang FF, Walsh GL, Abi-Said D, Wildrick DM, Gokaslan ZL. Coaxial double-lumen methylmethacrylate reconstruction in the anterior cervical and upper thoracic spine after tumor resection. J Neurosurg 92(2 Suppl):181-90, 2000. PMID: 10763689.
234. Yen N, Ioannides CG, Xu K, Swisher SG, Lawrence DD, Kemp BL, El-Naggar AK, Cristiano RJ, Fang B, Glisson BS, Hong WK, Khuri FR, Kurie JM, Lee JJ, Lee JS, Merritt JA, Mukhopadhyay T, Nesbitt JC, Nguyen D, Perez-Soler R, Pisters KM, Putnam JB, Jr, Schrump DS, Shin DM, Walsh GL, Roth JA. Cellular and humoral immune responses to adenovirus and p53 protein antigens in patients following intratumoral injection of an adenovirus vector expressing wild-type. P53 (Ad-p53). Cancer Gene Ther 7(4):530-6, 2000. PMID: 10811470.
235. Komaki R, Putnam JB, Jr, Walsh G, Lee JS, Cox JD. The management of superior sulcus tumors. Semin Surg Oncol 18(2):152-64, 2000. PMID: 10657917.
236. Nemunaitis J, Swisher SG, Timmons T, Connors D, Mack M, Doerksen L, Weill D, Wait J, Lawrence DD, Kemp BL, Fossella F, Glisson BS, Hong WK, Khuri FR, Kurie JM, Lee JJ, Lee JS, Nguyen DM, Nesbitt JC, Perez-Soler R, Pisters KM, Putnam JB, Richli WR, Shin DM, Walsh GL, Merritt J, Roth J. Adenovirus-mediated p53 gene transfer in sequence with cisplatin to tumors of patients with non-small-cell lung cancer. J Clin Oncol 18(3):609-22, 2000. PMID: 10653876.
237. Putnam JB, Jr, Walsh GL, Swisher SG, Roth JA, Suell DM, Vaporciyan AA, Smythe WR, Merriman KW, DeFord LL. Outpatient management of malignant pleural effusion by a chronic indwelling pleural catheter. Ann Thorac Surg 69(2):369-75, 2000. PMID: 10735665.
238. Walsh GL, Taylor GD, Nesbitt JC, Amato RJ. Intensive chemotherapy and radical resections for primary nonseminomatous mediastinal germ cell tumors. Ann Thorac Surg 69(2):337-43; discussion 343-4, 2000. PMID: 10735660.
239. Gandhi S, Walsh GL, Komaki R, Gokaslan ZL, Nesbitt JC, Putnam JB, Roth JA, Merriman KW, McCutcheon IE, Munden RF, Swisher SG. A multidisciplinary surgical approach to superior sulcus tumors with vertebral invasion. Ann Thorac Surg 68(5):1778-84; discussion 1784-5, 1999. PMID: 10585058.
240. Sueoka N, Lee HY, Walsh GL, Hong WK, Kurie JM. Posttranslational mechanisms contribute to the suppression of specific cyclin:CDK complexes by all-trans retinoic acid in human bronchial epithelial cells. Cancer Res 59(15):3838-44, 1999. PMID: 10447003.
241. York JE, Walsh GL, Lang FF, Putnam JB, McCutcheon IE, Swisher SG, Komaki R, Gokaslan ZL. Combined chest wall resection with vertebrectomy and spinal reconstruction for the treatment of Pancoast tumors. J Neurosurg 91(1 Suppl):74-80, 1999. PMID: 10419372.
242. Swisher SG, Roth JA, Nemunaitis J, Lawrence DD, Kemp BL, Carrasco CH, Connors DG, El-Naggar AK, Fossella F, Glisson BS, Hong WK, Khuri FR, Kurie JM, Lee JJ, Lee JS, Mack M, Merritt JA, Nguyen DM, Nesbitt JC, Perez-Soler R, Pisters KM, Putnam JB, Jr, Richli WR, Savin M, Schrump DS, Shin DM, Shulkin A, Walsh GL, Wait J, Weill D, Waugh MK. Adenovirus-mediated p53 gene transfer in advanced non-small-cell lung cancer. J Natl Cancer Inst 91(9):763-71, 1999. PMID: 10328106.
243. Wu X, Kemp B, Amos CI, Honn SE, Zhang W, Walsh GL, Spitz MR. Associations among telomerase activity, p53 protein overexpression, and genetic instability in lung cancer. Br J Cancer 80(3-4):453-7, 1999. PMID: 10408853.
244. Lee JS, Komaki R, Morice RC, Ro JY, Kalapurakal SK, Schea R, Murphy WK, Shin DM, Fox NT, Walsh GL, Hittelman WN, Hong WK. A pilot clinical laboratory trial of paclitaxel and endobronchial brachytherapy in patients with non-small cell lung cancer. Semin Radiat Oncol 9(2 Suppl 1):121-9, 1999. PMID: 10210551.
245. Gokaslan ZL, York JE, Walsh GL, McCutcheon IE, Lang FF, Putnam JB, Jr, Wildrick DM, Swisher SG, Abi-Said D, Sawaya R. Transthoracic vertebrectomy for metastatic spinal tumors. J Neurosurg 89(4):599-609, 1998. PMID: 9761054.
246. Wu W, Fan YH, Kemp BL, Walsh G, Mao L. Overexpression of cdc25A and cdc25B is frequent in primary non-small cell lung cancer but is not associated with overexpression of c-myc. Cancer Res 58(18):4082-5, 1998. PMID: 9751615.
247. Kurie JM, Lee JS, Morice RC, Walsh GL, Khuri FR, Broxson A, Ro JY, Franklin WA, Yu R, Hong WK. Autofluorescence bronchoscopy in the detection of squamous metaplasia and dysplasia in current and former smokers. J Natl Cancer Inst 90(13):991-5, 1998. PMID: 9665147.
248. Shin DM, Walsh GL, Komaki R, Putnam JB, Nesbitt J, Ro JY, Shin HJ, Ki KH, Wimberly A, Pisters KM, Schrump D, Gregurich MA, Cox JD, Roth JA, Hong WK. A multidisciplinary approach to therapy for unresectable malignant thymoma. Ann Intern Med 129(2):100-4, 1998. PMID: 9669967.
249. Lee HY, Chaudhary J, Walsh GL, Hong WK, Kurie JM. Suppression of c-Fos gene transcription with malignant transformation of human bronchial epithelial cells. Oncogene 16(23):3039-46, 1998. PMID: 9662337.
250. Roth JA, Swisher SG, Merritt JA, Lawrence DD, Kemp BL, Carrasco CH, El-Naggar AK, Fossella FV, Glisson BS, Hong WK, Khurl FR, Kurie JM, Nesbitt JC, Pisters K, Putnam JB, Schrump DS, Shin DM, Walsh GL. Gene therapy for non-small cell lung cancer: a preliminary report of a phase I trial of adenoviral p53 gene replacement. Semin Oncol 25(3 Suppl 8):33-7, 1998. PMID: 9704675.
251. Varon J, Walsh GL, Fromm RE, Jr. Feasibility of noninvasive mechanical ventilation in the treatment of acute respiratory failure in postoperative cancer patients. J Crit Care 13(2):55-7, 1998. PMID: 9627271.
252. Lee HY, Dohi DF, Kim YH, Walsh GL, Consoli U, Andreeff M, Dawson MI, Hong WK, Kurie JM. All-trans retinoic acid converts E2F into a transcriptional suppressor and inhibits the growth of normal human bronchial epithelial cells through a retinoic acid receptor- dependent signaling pathway. J Clin Invest 101(5):1012-9, 1998. PMID: 9486971.
253. Lee HY, Walsh GL, Dawson MI, Hong WK, Kurie JM. All-trans-retinoic acid inhibits Jun N-terminal kinase-dependent signaling pathways. J Biol Chem 273(12):7066-71, 1998. PMID: 9507016.
254. Varon J, Walsh GL, Marik PE, Fromm RE. Should a cancer patient be resuscitated following an in-hospital cardiac arrest?. Resuscitation 36(3):165-8, 1998. PMID: 9627066.
255. Walsh GL, Gokaslan ZL, McCutcheon IE, Mineo MT, Yasko AW, Swisher SG, Schrump DS, Nesbitt JC, Putnam JB, Jr, Roth JA. Anterior approaches to the thoracic spine in patients with cancer: indications and results. Ann Thorac Surg 64(6):1611-8, 1997. PMID: 9436544.
256. Gokaslan ZL, Romsdahl MM, Kroll SS, Walsh GL, Gillis TA, Wildrick DM, Leavens ME. Total sacrectomy and Galveston L-rod reconstruction for malignant neoplasms. Technical note. J Neurosurg 87(5):781-7, 1997. PMID: 9347991.
257. Mao L, Lee JS, Kurie JM, Fan YH, Lippman SM, Lee JJ, Ro JY, Broxson A, Yu R, Morice RC, Kemp BL, Khuri FR, Walsh GL, Hittelman WN, Hong WK. Clonal genetic alterations in the lungs of current and former smokers. J Natl Cancer Inst 89(12):857-62, 1997. PMID: 9196251.
258. Nesbitt JC, Soltero ER, Dinney CP, Walsh GL, Schrump DS, Swanson DA, Pisters LL, Willis KD, Putnam JB, Jr. Surgical management of renal cell carcinoma with inferior vena cava tumor thrombus. Ann Thorac Surg 63(6):1592-600, 1997. PMID: 9205155.
259. Gunes S, Varon J, Walsh G. Mediastinal teratoma presenting as massive hemoptysis in an adult. J Emerg Med 15(3):313-6, 1997. PMID: 9258780.
260. Han GR, Dohi DF, Lee HY, Rajah R, Walsh GL, Hong WK, Cohen P, Kurie JM. All-trans-retinoic acid increases transforming growth factor-beta2 and insulin-like growth factor binding protein-3 expression through a retinoic acid receptor-alpha-dependent signaling pathway. J Biol Chem 272(21):13711-6, 1997. PMID: 9153223.
261. Ferson DZ, Nesbitt JC, Nesbitt K, Walsh GL, Putnam JB, Jr, Schrump DS, Johansen MJ, Jones RL, Roth JA. The laryngeal mask airway: a new standard for airway evaluation in thoracic surgery. Ann Thorac Surg 63(3):768-72, 1997. PMID: 9066399.
262. Lee HY, Dawson MI, Claret FX, Chen JD, Walsh GL, Hong WK, Kurie JM. Evidence of a retinoid signaling alteration involving the activator protein 1 complex in tumorigenic human bronchial epithelial cells and non-small cell lung cancer cells. Cell Growth Differ 8(3):283-91, 1997. PMID: 9056670.
263. Roth JA, Swisher SG, Lawrence DD, Kemp BL, Carrasco CH, El-Naggar AK, Fossela FV, Glisson BS, Hong WK, Khuri FR, Kurie JM, Nesbitt JC, Pisters K, Putnam JB, Jr, Schrump DS, Shin DM, Walsh GL. Gene replacement for lung cancer. Lung Cancer 18:76, 1997.
264. Roth JA, Swisher SG, Lawrence DD, Kemp BL, Carrasco CH, El-Naggar AK, Fossela FV, Glisson BS, Hong WK, Khuri FR, Kurie JM, Nesbitt JC, Pisters K, Putnam Jr, JB, Schrump DS, Shin DM, Walsh GL. Lung Cancer. Gene therapy strategies for lung cancer 18:141, 1997.
265. Lee HY, Dawson MI, Walsh GL, Nesbitt JC, Eckert RL, Fuchs E, Hong WK, Lotan R, Kurie JM. Retinoic acid receptor- and retinoid X receptor-selective retinoids activate signaling pathways that converge on AP-1 and inhibit squamous differentiation in human bronchial epithelial cells. Cell Growth Differ 7(8):997-1004, 1996. PMID: 8853895.
266. Roth JA, Nguyen D, Lawrence DD, Kemp BL, Carrasco CH, Ferson DZ, Hong WK, Komaki R, Lee JJ, Nesbitt JC, Pister, KMW, Putnam JB Jr, Schea R, Shin DM, Walsh GL, Dolormente MM, Han CI., Martin FD, Yen N, Xu K, Stephens LC, McDonnell TJ, Mukhopadhyay T, and Cai D. Retrovirus-mediated wild-type p53 gene transfer to tumors of patients with lung cancer. Nat Med 2(9):985-991, 1996. e-Pub 1996. PMID: 8782455.
267. Kim YH, Dohi DF, Han GR, Zou CP, Oridate N, Walsh GL, Nesbitt JC, Xu XC, Hong WK, Lotan R, et al. Retinoid refractoriness occurs during lung carcinogenesis despite functional retinoid receptors. Cancer Res 55(23):5603-10, 1995. PMID: 7585641.
268. Shin DM, Fossella FV, Umsawasdi T, Murphy WK, Chasen MH, Walsh G, Komaki R, McMurtrey MJ, Hong WK. Prospective study of combination chemotherapy with cyclophosphamide, doxorubicin, and cisplatin for unresectable or metastatic malignant pleural mesothelioma. Cancer 76(11):2230-6, 1995. PMID: 8635025.
269. Walsh GL, O'Connor M, Willis KM, Milas M, Wong RS, Nesbitt JC, Putnam JB, Jr, Lee JJ, Roth JA. Is follow-up of lung cancer patients after resection medically indicated and cost-effective?. Ann Thorac Surg 60(6):1563-70; discussion 1570-2, 1995. PMID: 8787445.
270. Soysal O, Walsh GL, Nesbitt JC, McMurtrey MJ, Roth JA, Putnam JB, Jr. Resection of sternal tumors: extent, reconstruction, and survival. Ann Thorac Surg 60(5):1353-8; discussion 1358-9, 1995. PMID: 8526626.
271. Melnyk A, Graham NJ, Weber D, Walsh GL. Lethal tracheal dissolution during treatment for thyroid lymphoma. Thorax 50(10):1120-1, 1995. PMID: 7491567.
272. Nesbitt JC, Putnam JB, Jr, Walsh GL, Roth JA, Mountain CF. Survival in early-stage non-small cell lung cancer. Ann Thorac Surg 60(2):466-72, 1995. PMID: 7646126.
273. Ajani JA, Roth JA, Putnam JB, Walsh G, Lynch PM, Roubein LD, Ryan MB, Natrajan G, Gould P. Feasibility of five courses of pre-operative chemotherapy in patients with resectable adenocarcinoma of the oesophagus or gastroesophageal junction. Eur J Cancer 31A(5):665-70, 1995. PMID: 7640036.
274. Walsh GL, Nesbitt JC. Tumor implants after thoracoscopic resection of a metastatic sarcoma. Ann Thorac Surg 59(1):215-6, 1995. PMID: 7818327.
275. Carrasco CH, Nesbitt JC, Charnsangavej C, Ryan B, Walsh GL, Yasumori K, Lawrence DD, Wallace S. Management of tracheal and bronchial stenoses with the Gianturco stent. Ann Thorac Surg 58(4):1012-6; discussion 1017, 1994. PMID: 7524459.
276. Walsh GL, Morice RC, Putnam JB, Jr, Nesbitt JC, McMurtrey MJ, Ryan MB, Reising JM, Willis KM, Morton JD, Roth JA. Resection of lung cancer is justified in high-risk patients selected by exercise oxygen consumption. Ann Thorac Surg 58(3):704-10; discussion 711, 1994. PMID: 7944692.
277. Putnam JB, Jr, Suell DM, McMurtrey MJ, Ryan MB, Walsh GL, Natarajan G, Roth JA. Comparison of three techniques of esophagectomy within a residency training program. Ann Thorac Surg 57(2):319-25, 1994. PMID: 8311591.
278. Kroll SS, Walsh G, Ryan B, King RC. Risks and benefits of using Marlex mesh in chest wall reconstruction. Ann Plast Surg 31(4):303-6, 1993. PMID: 8239427.
279. Lo WK, Whimbey EE, Walsh GL. Primary sternal osteomyelitis presenting as a pleural-based mass. Chest 103(6):1912-3, 1993. PMID: 8404133.
280. Marelli D, Paul A, Manolidis S, Walsh G, Odim JN, Burdon TA, Shennib H, Vestweber KH, Fleiszer DM, Mulder DS. Endoscopic guided percutaneous tracheostomy: early results of a consecutive trial. J Trauma 30(4):433-5, 1990. PMID: 2325175.
281. Chiu RC, Kochamba G, Walsh G, Dewar M, Desrosiers C, Dionisopoulos T, Brady P, Ianuzzo CD. Biochemical and functional correlates of myocardium-like transformed skeletal muscle as a power source for cardiac assist devices. J Card Surg 4(2):171-9, 1989. PMID: 2519995.
282. Dewar ML, Walsh G, Chiu RC, Kochamba G, Gutkowska J, Genest J, Cantin M. Atrial natriuretic factor: response to cardiac operation. J Thorac Cardiovasc Surg 96(2):266-70, 1988. PMID: 2969438.
283. Walsh GL, Chiasson P, Hedderich G, Wexler MJ, Meakins JL. The open abdomen. The Marlex mesh and zipper technique: a method of managing intraperitoneal infection. Surg Clin North Am 68(1):25-40, 1988. PMID: 3277306.
284. Dewar M, Walsh G, Abraham R, DeSimon J, Foot E, Stewart J, Fraser R, Chiu RC. Left ventricular full-thickness cardiomyoplasty with pericardial neoendocardium: experimental development of a surgical procedure. Ann Thorac Surg 44(6):618-24, 1987. PMID: 3318739.
285. Chiu RC, Walsh GL, Dewar ML, De Simon JH, Khalafalla AS, Ianuzzo D. Implantable extra-aortic balloon assist powered by transformed fatigue-resistant skeletal muscle. J Thorac Cardiovasc Surg 94(5):694-701, 1987. PMID: 3669697.
286. Errett L, Walsh G. Life salvage with fibrin glue in three cases of exsanguinating hemorrhage. Can J Surg 29(3):214-5, 217, 1986. PMID: 3486704.

Invited Articles

1. Walsh GL. Impact of CT-PET Fusion in Staging Patient with Thoracic Malignancies. presented at Southern Thoracic Surgical Association Annual Meeting, November 2001, San Antonio, Texas. STSA Invited Discussion. Ann. Thorac. Surg 74:160-163, 2002.
2. Nemunaitis J, Swisher SG, Timmons T, Connors D, Mack M, Doerksen L, Savin M, Weill D, Shulkin A, Wait J, Ognoskie N, Lawrence DD, Kemp BL, Fossella F, Glisson BS, Hong WK, Khuri FR, Kurie JM, Lee JJ, Lee JS, Nguyen DM, Nesbitt JC, Perez-Soler R, Pisters DMW, Putnam JB, Jr, Richli WR, Shin DM, Walsh GL, Merritt J, Roth JA. Update "Best of the JCO-2000," Adenovirus-mediated p53 gene transfer in sequence with cisplatin to tumors of patients with non-small cell lung cancer. J Clin Onco. Classic Papers Curr Comm 6:123-138, 2001.
3. Wenker O, Chaloupka L, Joswiak R, Thakar D, Wood C, Walsh G. Interesting cases -a case report: renal cell carcinoma with tumor mass in IVC and heart. The Internet Journal of Anesthesiology Vol4N4: http://www.ispub.com/journals/IJA/Vol4N4/r, 2000.
4. Wenker O, Moehn L, Portera C, Walsh G. Rare cases: tracheobronchial obstruction. . The Internet Journal of Anesthesiology; Vol4N2: http://www.ispub.com/journals/Vol4N2/airwa, 2000.
5. York JE, Walsh GL, Lang FF, Putnam JB, Jr, McCutcheon IE, Swisher SG, Komaki R, Gokaslan ZL. Combined chest wall resection with vertebrectomy and spinal reconstruction for the treatment of Pancoast tumors. . Neurosurg Focus 6:Article 3, 1999.
6. Walsh GL. Surgical techniques offer hope for those with lung cancer. M. D. Anderson OncoLog 43:8, 1998.
7. Walsh GL, Winn RJ. Baseline institutional compliance with NCCN guidelines: non-small-cell lung cancer. Oncology (Williston Park) 11(11A):161-70, 1997. PMID: 9430187.
8. Walsh GL, O'Connor M, Willis KM, Milas M, Wong R, Nesbitt JC, Putnam JB, Jr, Lee JJ, Roth JA. Is follow-up of lung cancer patients following resection medically indicated and cost effective? . R. J. Ginsberg, A. S. Wechsler, and W.G. Williams (eds.) The Year Book of Thoracic and Cardiovascular Surgery, Chicago, Mosby-Year Book, Inc, 1997.
9. Roth JA, Nguyen D, Lawrence DD, Kemp BL, Carrasco CH, Ferson DZ, Hong WK, Komaki R, Lee JJ, Nesbitt JC, Pisters KMW, Putnam JB, Schea R, Shin DM, Walsh GL, Dolormente MM, Han CI, Martin FD, Yen N, Xu K, Stephens LC, McDonnell TJ, Mukhopadhyay T, Cai D. Retrovirus-mediated wild-type p53 gene transfer to tumors of patients with lung cancer. Med Briefs Cancer 2:4-5, 1997.
10. Carrasco HC, Nesbitt JC, Charnsangavej C, Ryan MB, Walsh GL, Yasumori K, Lawrence DD, Wallace S. Management of tracheal and bronchial stenoses with the Gianturco stent. . R.J. Ginsberg, A.S. Wechsler, and W.G. Williams (eds.), The Year Book of Thoracic and Cardiovascular Surgery, Chicago, IL., Mosby-YearBook, Inc:p 102, 1996.
11. Walsh GL, Nesbitt JC. Tumor implants after thoracoscopic resection of a metastatic sarcoma. Endosurgery Today in Russian 1:62, 1996.
12. Walsh GL. Lasers for the early detection of lung cancer. Semin Thorac Cardiovasc Surg 5(3):194-200, 1993. PMID: 8353147.

Editorials

1. Walsh GL. Pancreatic cancer patients and thoracic surgeons: Could/should their clinic templates ever overlap?. J Thorac Cardiovasc Surg 152(1):83-4, 2016. PMID: 27103131.
2. Vauthey JN, Walsh GL, Vlastos G, Lauwers GY. Importance of field cancerization in clinical oncology. Lancet Oncol 1:15-6, 2000. PMID: 11905680.
3. Walsh GL, Nesbitt JC. Inadequacy, mortality, and thoracoscopy. Ann Thorac Surg 60(1):233, 1995. PMID: 7598614.

Abstracts

1. Deboever N, Eisenberg, M, Antonoff M, Hofstetter W, Mehran R, Rice D, Roth J, Sepesi B, Swisher S, Vaporciyan A, Walsh G, Rajaram R. Perspectives, Risk Factors, and Coping Mechanisms in Patients with Self-Reported Financial Burden Following Surgical Management of Non-Small Cell Lung Cancer. American Association for Thoracic Surgery 103rd Annual Meeting, 2023.
2. Deboever N, Correa A, Feldman H, Eisenberg, M, Antonoff M, Mehran R, Rajaram R, Rice D, Roth J, Sepesi B, Swisher S, Vaporciyan A, Walsh G, Hofstetter W. Early Interventional Treatment of High Output Chyle Leak Following Esophagectomy is Associated with Improved Survival. American Association for Thoracic Surgery 103rd Annual Meeting, 2023.
3. Eisenberg MA, Egyud MR, Deboever N, Hofstetter WL, Mehran RJ, Rice DC, Rajaram R, Sepesi B, Swisher SG, Vaporciyan AA, Walsh GL, Antonoff MB. Impact of Travel Distance on Receipt of Indicated Adjuvant Therapy in Resected Non-Small Cell Lung Cancer. American Association for Thoracic Surgery 103rd Annual Meeting, 2023.
4. Graber W, Deboever N, Niu J, Eisenberg M, Antonoff M, Hofstetter W, Mehran R, Roth R, Sepesi B, Swisher S, Walsh G, Vaporciyan A, Giordano S, Rajaram R, Rice D. Evaluating The Conditional Survival Benefit Of Minimally Invasive Lobectomy In Early-stage Non-small Cell Lung Cancer. ISMICS 2023, 2023.
5. Deboever N, Al-Tashi Q, Eisenberg M, Antonoff M, Hofstetter W, Mehran R, Rice D, Roth J, Sepesi B, Swisher S, Vaporciyan A, Walsh G, Wu J, Rajaram R. Machine Learning Prediction of Financial Toxicity in Patients with Resected Lung Cancer. AACR Annual Meeting 2023, 2023.
6. Lenskaya V, Jiang X, Foo WC, Abraham SC, Taggart MW, Walsh GL, Swisher S, Ning J, Aung PP, Curry JL, Cho WC, Torres-Cabala CA, Ivan D, Prieto VG, Amaria RN, Tawbi HA, Nagarajan P,. Primary Mucosal Melanoma of the Esophagus: Clinicopathologic and Molecular Analysis. United States & Canadian Academy of Pathology’s 112th Annual Meeting, 2023.
7. Deboever N, Mitchell K, Farooqi A., Ludmir E., Hofstetter W., Mehran R, Rajaram R, Rice D, Sepesi B, Swisher S, Vaporciyan A, Walsh G, Antonoff M. Pulmonary Resection in Oligometastatic Lung Cancer: Does Extent of Resection Matter in the Setting of Systemic Disease?. GTSC 35th Annual Meeting, 2023.
8. Nelson DB, Pataer A, Correa AM, Weissferdt A, Antonoff MB, Cascone T, Hofstetter WL, Mehran RJ, Rajaram R, Rice DC, Walsh GL, Roth JA, Vaporciyan AA, Heymach JV, Sepesi B, Swisher SG. Relevance of Pathologic Downstaging After Neoadjuvant Chemotherapy for Lung Cancer. GTSC 35th Annual Meeting, 2023.
9. Deboever N, Eisenberg M, Hofstetter W, Mehran R, Rajaram R, Rice D, Swisher S, Walsh G, Vaporciyan A, Sepesi B, Antonoff M. Clinical Overstaging in Pathologic Stage I Non-Small Cell Lung Cancer: Prognostic Implications. European Lung Cancer Congress, 2023.
10. Eisenberg MA, Deboever N, Hofstetter WL, Mehran RJ, Rice DC, Rajaram R, Sepesi B, Swisher SG, Vaporciyan AA, Walsh GL, Antonoff MB. Circulomics as a Predictive Tool for Post-Operative Atrial Fibrillation After Lung Cancer Resection. 18th Annual Academic Surgical Conference, 2023.
11. Eisenberg MA, Deboever N, Hofstetter WL, Mehran RJ, Rice DC, Rajaram R, Roth JA, Sepesi B, Swisher SG, Vaporciyan AA, Walsh GL, Antonoff MB. The Pre-Operative Inflammasome Predicts Infectious Complications Following Lung Resection in Patients with NSCLC. UT Austin/MD Anderson Collaborative Research Summit, 2022.
12. Deboever N, Eisenberg MA, Hofstetter WL, Mehran RJ, Rice DC, Rajaram R, Roth JA, Sepesi B, Swisher SG, Vaporciyan AA, Walsh GL, Antonoff MB. Circulomic Variables may Predict Pathologic Staging Preoperatively in Treatment-naïve Non-small Cell Lung Cancer. UT Austin/MD Anderson Collaborative Research Summit, 2022.
13. Deboever N, Bayley, EM, Eisenberg MA, Hofstetter WL, Mehran RJ, Rice DC, Rajaram R, Roth JA, Sepesi B, Swisher SG, Vaporciyan AA, Walsh GL, Bednarski BK, Morris VK, Antonoff MB. Optimal Timing for Surveillance Imaging in Colorectal Pulmonary Metastatic Disease: Evidence for a Clinicopathologic-driven Algorithm. UT Austin/MD Anderson Collaborative Research Summit, 2022.
14. Lim J, Zorrilla-Vaca A, Feldman H, Brown J, Lasala JD, Patel C, Woodard T, Kruse B, Mehran R, Walsh G, Rice D, Vaporciyan A, Mena G. In-Hospital Opioid Use and Opioid Prescriptions at Discharge in Robotic-Assisted Thoracic Surgery versus Open Thoracotomy in an Enhanced Recovery After Surgery (ERAS) Program. 2022 RAMSES Annual Meeting, 2022.
15. Deboever N, Bayley EM, Feldman HA, Hofstetter WL, Mehran RJ, Rice DC, Rajaram R, Roth JA, Sepesi B, Swisher SG, Vaporciyan AA, Walsh GL, Bednarski BK, Morris VK, Antonoff MB. Lymph Node Ratio is Associated with Time to Pulmonary Metastasis in Patients with Resected Colorectal Cancer. American College of Surgeons Clinical Congress 2022, 2022.
16. Deboever N, Bayley EM, Feldman HA, Hofstetter WL, Mehran RJ, Rice DC, Rajaram R, Roth JA, Sepesi B, Swisher SG, Vaporciyan AA, Walsh GL, Bednarski BK, Morris VK, Antonoff MB. Do Resected Colorectal Cancer Patients Need Early Chest Imaging? Impact of Clinicopathologic Characteristics on Time to Development of Pulmonary Metastases. American College of Surgeons Clinical Congress 2022, 2022.
17. Deboever N, Mitchell, KG, Eisenberg MA, Hofstetter WL, Mehran RJ, Rice DC, Rajaram R, Roth JA, Swisher SG, Vaporciyan AA, Walsh GL, Antonoff MB, Sepesi B. Aspirin's Protective Effect in Resectable Non-Small Cell Lung Cancer is Mediated by Circulomics. Transcend Cancer Initiative MDA Symposium, 2022.
18. Deboever N, Bayley, EM, Eisenberg MA, Hofstetter WL, Mehran RJ, Rice DC, Rajaram R, Roth JA, Sepesi B, Swisher SG, Vaporciyan AA, Walsh GL, Bednarski BK, Morris VK, Antonoff MB. Optimal Timing for Surveillance Imaging in Colorectal Pulmonary Metastatic Disease: Evidence for a Clinicopathologic-driven Algorithm. Transcend Cancer Initiative MDA Symposium, 2022.
19. Eisenberg MA, Deboever N, Hofstetter WL, Mehran RJ, Rice DC, Rajaram R, Roth JA, Sepesi B, Swisher SG, Vaporciyan AA, Walsh GL, Antonoff MB. The Pre-Operative Inflammasome Predicts Infectious Complications Following Lung Resection in Patients with NSCLC. Transcend Cancer Initiative MDA Symposium, 2022.
20. Deboever N, Eisenberg MA, Hofstetter WL, Mehran RJ,Rajaram R, Rice DC, Roth JA, Sepesi B, Swisher SG, Vaporciyan AA, Walsh GL, Antonoff MB. Circulomic Variables May Predict Pathologic Staging Preoperatively in Treatment-naïve Non-small Cell Lung Cancer. North American Conference on Lung Cancer, 2022.
21. Eisenberg MA, Deboever N, Hofstetter WL, Mehran RJ, Rice DC, Rajaram R, Roth JA, Sepesi B, Swisher SG, Vaporciyan AA, Walsh GL, Antonoff MB. The Pre-Operative Inflammasome Predicts Infectious Complications Following Lung Resection in Patients with NSCLC. AATS International Thoracic Surgical Oncology Summit 2022, 2022.
22. Mitchell KG, Farooqi A, Ludmir EB, Hofstetter WL, Mehran RJ, Rajaram R, Rice DC, Sepesi B, Swisher SG, Vaporciyan AA, Walsh GL, Heymach JV, Gomez DR, Gandhi SJ, Antonoff MB. Perioperative and Oncologic Outcomes of Pulmonary Resection for Synchronous Oligometastatic Non-Small Cell Lung Cancer: Evidence for Surgery in Advanced Disease. AATS International Thoracic Surgical Oncology Summit 2022, 2022.
23. Deboever N, Mitchell, KG, Eisenberg MA, Hofstetter WL, Mehran RJ, Rice DC, Rajaram R, Roth JA, Swisher SG, Vaporciyan AA, Walsh GL, Antonoff MB, Sepesi B. Aspirin's Protective Effect in Resectable Non-Small Cell Lung Cancer is Mediated by Circulomics. AATS International Thoracic Surgical Oncology Summit 2022, 2022.
24. Deboever N, Bayley, EM, Eisenberg MA, Hofstetter WL, Mehran RJ, Rice DC, Rajaram R, Roth JA, Sepesi B, Swisher SG, Vaporciyan AA, Walsh GL, Bednarski BK, Morris VK, Antonoff MB. Optimal Timing for Surveillance Imaging in Colorectal Pulmonary Metastatic Disease: Evidence for a Clinicopathologic-driven Algorithm. AATS International Thoracic Surgical Oncology Summit 2022, 2022.
25. Bayley EM, Ivy ML, Ge PS, Shewale JB, Antonoff MB, Francis AM, Hofstetter WL, Mehran RJ, Rajaram R, Rice DC, Roth JA, Sepesi B, Vaporciyan AA, Walsh GL, Lee JJ, Louie BE, Swisher SG. High-Risk Features of Esophageal Adenocarcinoma Following Neoadjuvant Chemoradiation: Patients for whom Surgery Should Not Be Delayed. Digestive Disease Week 2022, 2022.
26. Deboever N, Feldman H, Vaporciyan A, Hofstetter W, Roth J, Mehran R, Swisher S, Walsh G, Rajaram R, Rice D, Antonoff M. The Role of Surgery in the Treatment of Pulmonary Melanoma Metastases Amidst Modern Therapies. 17th Annual Academic Surgical Congress, 2022.
27. Zhou N, Niu J, Feldman HA, Antonoff MB, Hofstetter WL, Mehran RJ, Rice DC, Sepesi B, Swisher SG, Walsh GL, Giordano S, Rajaram R. Impact of Minimally-Invasive Surgery on Persistent Opioid Use after Lung Surgery. STS 58th Annual Meeting 2022, 2022.
28. Mills, AC; Hofstetter, WL; Mehran, RJ; Rajaram, R; Rice, DC; Sepesi, B; Swisher, SG; Vaporciyan, AA; Walsh GL; Antonoff, MB. Repeat Pulmonary Metastasectomy: Third Operations and Beyond. STS 58th Annual Meeting 2022, 2022.
29. Feldman H, Niu J, Zhou N, Hofstetter WL, Mehran RJ, Rice DC, Vaporciyan AA, Walsh GL, Giordano S, Rajaram R,. Conditional Survival After Trimodality Therapy For Esophageal Cancer: A Reevaluation Of Prognostic Factors Over Time. 107th American College of Surgeons Annual Clinical Congress 2021, 2021.
30. Antonoff M, Feldman H, Mitchell K, Farooqi A, Ludmir E, Hofstetter W, Mehran R, Rajaram R, Rice D, Sepesi B, Swisher S, Vaporciyan A, Walsh G, Gandhi S, Gomez D. Surgical Complexity of Pulmonary Resections Performed for Oligometastatic Non-Small Cell Lung Cancer. IASLC World Conference on Lung Cancer 2021, 2021.
31. Zhou N, Feldman HA, Corsini EM, Antonoff MB, Mehran RJ, Rajaram R, Rice RC, Roth JA, Sepesi B, Swisher SG, Vaporciyan AA, Walsh GL, Ajani JA, Hofstetter WL. Definition of Salvage Esophagectomy Influences Survival for Trimodality and Bimodality Therapy for Esophageal Squamous Cell Carcinoma. STS 57th Virtual Annual Meeting 2021, 2021.
32. Parikh K, Zhou N, Hofstetter WL, Mehran RJ, Rajaram R, Rice DC, Sepesi B, Swisher SG, Vaporciyan AA, Walsh GL. After Hours Phone Calls from Postoperative Patients: Addressing Common Issues to Improve Early Discharge Planning. STS 57th Virtual Annual Meeting, 2021.
33. Bostock IC, Zhou N, Antonoff MB, Blum Murphy M, Lin S, Maru D, Mehran RJ, Rajaram R, Rice DC, Sepesi B, Swisher S, Vaporciyan A, Walsh GL, Hofstetter WL. Prolonged Neutrophilia is associated with worse outcomes after Esophagectomy. STS 57th Virtual Annual Meeting, 2021.
34. Blumenthaler AN, Hofstetter WL, Mehran RJ, Rajaram R, Rice DC, Roth JA, Sepesi B, Swisher SG, Vaporciyan AA, Walsh GL, Antonoff MB. Maximum Standardized Uptake Value (SUVmax) on Preoperative PET: Role in Guiding Postoperative Surveillance for Patients with Stage I NSCLC. STS 57th Virtual Annual Meeting, 2021.
35. Bostock IC, Hofstetter W, Mehran R, Rajaram R, Rice D, Sepesi B, Swisher S, Vaporciyan A, Walsh G, Antonoff, MB. Travel Distance as a Barrier for Surveillance Imaging in Early Staged Lung Cancer. STS 57th Annual Meeting, 2021.
36. Bostock IC, Hofstetter W, Mehran R, Rajaram R, Rice D, Sepesi B, Swisher S, Vaporciyan A, Walsh G, Antonoff MB. Travel Distance as a Barrier for Surveillance Imaging in Early Staged Lung Cancer. STSA 2020, 2020.
37. Sepesi B, Corsini EM, Weissferdt A, Pataer A, Leung CH, Lin H, Le X, Mott F, Fossella F, Altan M, Tsao A, Skoulidis F, Blumenschein G, Kurie J, Zhang J, Glisson B, Lu C, Elamin Y, Antonoff MB, Hofstetter WL, Mehran RJ, Rice DC, Roth JA, Swisher SG, Vaporciyan AV, Walsh GL, Gibbons DL, Heymach JV, Cascone T.. Combined Neoadjuvant Chemo-Immunotherapy Therapy Achieves Superior Downstaging of Resectable Non-Small Cell Lung Cancer as Compared to Chemotherapy, Mono Or Dual Immunotherapy. Society for Immunotherapy of Cancer Annual Meeting, 2020.
38. Zhou N, Rice DC, Corsini EM, Antonoff MB, Hofstetter WL, Rajaram R, Roth JA, Swisher SG, Vaporciyan AA, Walsh GL, Mehran RJ, Sepesi B. Perioperative and Long Term Survival of Extrapleural Pneumonectomy and Extended Pleurectomy/Decortication in Epithelioid Mesothelioma. Southern Thoracic Surgical Association Annual Meeting, 2020.
39. Corsini EM, Weissferdt A, Pataer A, Zhou N, Antonoff MB, Hofstetter WL, Mehran RJ, Rajaram R, Rice DC, Roth JA, Vaporciyan AA, Walsh GL, Cascone T, Heymach JV, Swisher SG, Sepesi B. Timing And Patterns Of Recurrence In Lung Cancer Patients With Major Pathologic Response Following Neoadjuvant Chemotherapy – The Influence Of Persistent Pathologic Nodal Disease. ESTS 2020, 2020.
40. Zhou N, Mitchell KG, Corsini EM, Chun SG, Gay CM, Antonoff MB, Hofstetter WL, Mehran RJ, Rice DC, Swisher SG, Vaporciyan AA, Wash GL, Wilshire CL, Vallières E, Yasufuku K, Spicer JD, Bott M, Park BJ, Jones DR, Sepesi B. Predictors of survival following surgical resection of limited stage small cell lung cancer. University of Texas McGovern Medical School Department of Surgery Research Forum, 2020.
41. Corsini EM, Foo WC, Mitchell KG, Correa A, Zhou N, Rajaram R, Sepesi B, Swisher SG, Roth JA, Walsh GL, Antonoff MB, Vaporciyan AA, Mehran RJ, Rice DC, Lin SH, Maru DM, Ajani JA, Hofstetter WL. Even scant signet ring cell component portends poor prognosis after resection of esophageal adenocarcinoma. Michael E. DeBakey Department of Surgery Research Symposium, Houston, Texas, 2020.
42. Corsini EM, Mitchell KG, Zhou N, Sepesi B, Antonoff MB, Walsh GL, Swisher SG, Mehran RJ, Vaporciyan AA, Karam-Hage M, Roth JA, Rice DC, Hofstetter WL. Ongoing tobacco use in the setting of ERAS does not affect postoperative pulmonary complications. American Association for Thoracic Surgery 100th Annual Meeting, 2020.
43. Zhou N, Mitchell KG, Corsini EM, Jones DR, Bott M, Wilshire CL, Swisher SG, Antonoff MB, Rice DC, Walsh GL, Mehran RJ, Hofstetter WL, Roth JA, Vaporciyan AA, Vallieres E, Park BJ, Sepesi B. Predictors of survival following surgical resection of small cell lung cancer. American Association for Thoracic Surgery 100th Annual Meeting, 2020.
44. Corsini EM, Foo WC, Mitchell KG, Correa A, Zhou N, Rajaram R, Sepesi B, Swisher SG, Roth JA, Walsh GL, Antonoff MB, Vaporciyan AA, Mehran RJ, Rice DC, Lin SH, Maru DM, Ajani JA, Hofstetter WL. Even scant signet ring cell component portends poor prognosis after resection of esophageal adenocarcinoma. American Association for Thoracic Surgery Annual Meeting 2020, 2020.
45. Datar SS, Corsini EM, Mitchell KG, Mehran RJ, Rice DC, Sepesi B, Walsh GL, Swisher SG, Roth JA, Vaporciyan AA, Hofstetter WL, Loree JM, Morris VK, Antonoff MB. Are Mutational Profiles of Colorectal Cancer And Pulmonary Metastases Concordant?. American College of Surgeons South Texas Chapter Annual Meeting, 2020.
46. Zhou N, Mitchell KB, Corsini EM, Hofstetter WL, Mehran RJ, Rice DC, Roth JA, Sepesi B, Swisher SG, Vaporciyan AA, Walsh GL, Antonoff MB. Impact of Psychiatric Comorbidities on Surgical Outcomes for Non-Small Cell Lung Cancer. General Thoracic Surgery Club 33rd Annual Meeting, 2020.
47. Corsini EM, Mitchell KG, Mehran RJ, Rice DC, Sepesi B, Walsh GL, Swisher SG, Roth JA, Hofstetter WL, Vaporciyan AA, Morris V, Antonoff MB. Is Laterality of Primary Colorectal Cancer Associated with Survival After Pulmonary Metastasectomy?. American College of Surgeons South Texas Chapter Annual Meeting, 2020.
48. Corsini EM, Wang Q, Tran HT, Mehran RJ, Antonoff MB, Rice DC, Walsh GL, Roth JA, Vaporciyan AA, Swisher SG, Hofstetter WL, Reuben A, Bernatchez C, Wang J, Landry L, Roarty E, Zhang J, Heymach JV, Gibbons DL, Haymaker CL, Sepesi B,. The Influence of Thoracic Surgical Approach on Peripheral Cytokines Over Time. STS 56th Annual Meeting, 2020.
49. Corsini E, Mitchell KG, Zhou N, Antonoff MB, Rice DC, Sepesi B, Walsh GL, Roth JA, Mehran RJ, Swisher SG, Vaporciyan AA, Maru D, Lin SH, Ajani JA, Hofstetter WL. En-Bloc Esophagectomy Demonstrates Superior Locoregional Control with Equivalent Morbidity in Era of Neoadjuvant Therapy. STS 56th Annual Meeting, 2020.
50. Corsini EM, Mitchell KG, Mehran RJ, Sepesi B, Walsh GL, Antonoff MB, Rice DC, Swisher SG, Roth JA, Vaporciyan AA, Hofstetter WL. Endoscopic Biopsy Poorly Identifies Signet Ring Cell Histology In Untreated Esophageal Adenocarcinoma. STSA 2019, 2019.
51. Data SS, Corsini EM, Mitchell KG, Mehran RJ, Rice DC, Sepesi B, Walsh GL, Swisher SG, Roth JA, Vaporciyan AA, Hofstetter WL, Loree JM, Morris VK, Antonoff MB. High Mutational Concordance Between Next Generation Sequencing Profiles of Colorectal Cancer and Pulmonary Metastases. STSA 2019, 2019.
52. Corsini E, Mitchell K, Mehran RJ, Sepesi B, Walsh GL, Rice DC, Swisher SG, Roth JA, Vaporciyan AA, Hofstetter WL, Morris V, Antonoff MB. Primary Colorectal Cancer Laterality Predicts Survival After Pulmonary Metastasectomy. STSA 2019, 2019.
53. Saddoughi SA, Mitchell K, Fruth KM, Taswell J, Mounajjed T, Harmsen WS, Allen MS, Cassivi SD, Nichols FC, Shen KR, Wigle DA, Walsh GL, Mehran RJ, Hofstetter WL, Swisher SG, Roth JA, Sepesi B, Vaporciyan AA, Rice DC, Antonoff MB, Blackmon SH. Re-resecting to a Negative Margin after an Initial Positive Esophagectomy Margin Enhances Progression Free Survival. STSA 2019, 2019.
54. Saddoughi S, Mitchell KG, Fruth K, Allen MS, Nichols FC, Harmsen S, Cassivi S, Wigle D, Taswell J, Mounajjed T, Walsh GL, Mehran RJ, Hofstetter WL, Swisher SG, Roth JA, Sepesi B, Vaporciyan AA, Rice DC, Antonoff MB, Blackmon SH. Re-resecting to a Negative Margin Enhances Progression Free Survival. Southern Thoracic Surgical Association 66th Annual Meeting 2019, 2019.
55. Corsini EM, Mitchell KG, Mehran RJ, Rice DC, Sepesi B, Antonoff MB, Walsh GL, Roth JA, Swisher SG, Vaporciyan AA, Hofstetter WL. Evaluation of Ketorolac Use with Occurrence of Esophageal Anastomotic Leak After Esophagectomy. 2019 AATS International Thoracic Surgical Oncology, 2019.
56. Corsini EM, Mitchell KG, Van Haren RM, Mehran RJv, Rice DC, Sepesi B, Antonoff MB, Walsh GL, Swisher SG, Vaporciyan AA, Roth JA, Hofstetter WL. Patient-Related Factors Are The Greatest Determinant Of Pulmonary Morbidity Following Lung Cancer Resection In Enhanced Recovery Setting. 2019 AATS International Thoracic Surgical Oncology Summit, 2019.
57. Corsini EM, Mitchell KG, Mehran RJ, Rice DC, Sepesi B, Walsh GL, Swisher SG, Roth JA, Hofstetter WL, Vaporciyan AA, Morris V, Antonoff MB. Primary Colorectal Cancer Laterality Predicts Survival After Pulmonary Metastasectomy. American Association of Thoracic Surgery International Thoracic Surgical Oncology Summit 2019, 2019.
58. Sepesi B, Cascone T, William WN, Lin H, Leung CH, Weissferdt A, Walsh GL, Rice D, Roth J, Mehran R, Hofstetter W, Antonoff M, Heymach JV, Gibbons D, Papadimitrakopolou V, Fossella F, Mott F, Le X, Blumenschein G, Vaporciyan AA, Swisher SG. Surgical Outcomes Following Neoadjuvant Nivolumab or Nivolumab Plus Ipilimumab In Non-Small Cell Lung Cancer - NEOSTAR Study. WLCC 2019, 2019.
59. Corsini EM, Mitchell KG, Mehran RJ, Rice DC, Sepesi B, Walsh GL, Swisher SG, Roth JA, Hofstetter WL, Vaporciyan AA, Morris VK, Antonoff MB. Primary Colorectal Cancer Mutations Predict Survival and Recurrence After Pulmonary Metastasectomy. Baylor College of Medicine Department of Surgery Research Day, 2019.
60. Mitchell KG, Parra ER, Nelson DB, Corsini EM, Zhang J, Vaporciyan AA, Hofstetter WL, Mehran RJ, Swisher SG, Rice DC, Sepesi B, Walsh GL, Behrens C, Kalhor N, Weissferdt A, Moran CA, Skoulidis F, Wistuba II, Fujimoto J, Roth JA, Antonoff MB. Intratumoral LKB1/STK11 Expression Correlates With Immune Cell Infiltration and Oncologic Outcomes Following Resection of Lung Adenocarcinoma. University of Texas McGovern Medical School Department of Surgery Research Forum, 2019.
61. Van Haren RM, Rajaram R, Correa AM, Mehran RJ, Antonoff MB, Hofstetter WL, Sepesi B, Swisher SG, Vaporciyan AA, Walsh GL, Rice DC, Roth JA. Preoperative Heparin For Lung Cancer Resection Increases Risk of Reoperation For Bleeding. AATS 99th Annual Meeting, 2019.
62. Corsini EM, Mitchell KG, Mehran RJ, Rice DC, Sepesi B, Walsh GL, Swisher SG, Roth JA, Hofstetter WL, Vaporciyan AA, Antonoff MB. Multidisciplinary Treatment of Thymic Neuroendocrine Tumors: Evaluation of Surgery, Chemotherapy, and Radiation. Multidisciplinary Thoracic Cancers Symposium, 2019.
63. Corsini EM, Mitchell KG, Mehran RJ, Sepesi B, Walsh GL, Swisher SG, Roth JA, Vaporciyan AA, Hofstetter WL, Antonoff MB, Rice DC. Outcomes After Resection Of Thymic Neoplasms With Pleural Metastases. GTSC 2019, 2019.
64. Mitchell KG, Parra ER, Nelson DB, Corsini EM, Zhang J, Vaporciyan AA, Hofstetter WL, Mehran RJ, Swisher SG, Rice DC, Sepesi B, Walsh GL, Behrens C, Kalhor N, Weissferdt A, Moran CA, Skoulidis F, Wistuba II, Fujimoto J, Roth JA, Antonoff MB. Intratumoral LKB1/STK11 Expression Correlates With Immune Cell Infiltration and Oncologic Outcomes Following Resection of Lung Adenocarcinoma. STS 55th Annual Meeting, 2019.
65. Nelson DB, Niu J, Mitchell KG, Sepesi B, Vaporciyan AA, Hofstetter WL, Walsh GL, Swisher SG, Roth JA, Antonoff MB, Mehran RJ, Rice DC. Persistent Opiod Use Among the Elderly After Lung Resection: A SEER-Medicare Study. STS 55th Annual Meeting - San Diego, CA, 2019.
66. Corsini EM, Mitchell KG, Mehran RJ, Rice DC, Sepesi B, Walsh GL, Swisher SG, Roth JA, Hofstetter WL, Vaporciyan AA, Morris VK, Antonoff MB. Primary Colorectal Cancer Laterality Predicts Survival After Pulmonary Metastasectomy. STS 55th Annual Meeting, 2019.
67. Nelson DB, Mitchell KG, Wang J, Fujimoto J, Behrens MC, Zheng X, Zhang J, Sepesi B, Vaporciyan AA, Hofstetter WL, Mehran RJ, Rice DC, Walsh GL, Swisher SG, Moran C, Kalhor N, Weissferdt A, Wistuba II, Roth JA, Antonoff MB. Immune Regulatory Markers of Lepidic-Pattern Adenocarcinomas Presenting as Ground Glass Opacities. STS 55th Annual Meeting, 2019.
68. Nelson DB, Niu J, Mitchell KG, Sepesi B, Vaporciyan AA, Hofstetter WL, Walsh GL, Swisher SG, Roth JA, Antonoff MB, Mehran RJ, Rice DC. Persistent Opioid Use Among The Elderly After Lung Resection: A SEER-Medicare Study. Society of Thoracic Surgeons 55th Annual Meeting 2019, 2019.
69. Corsini EM, Mitchell KG, Mehran RJ, Rice DC, Sepesi B, Walsh GL, Swisher SG, Roth JA, Hofstetter WL, Vaporciyan AA, Morris VK, Antonoff MB. Primary Colorectal Cancer Mutations Predict Survival and Recurrence After Pulmonary Metastasectomy. Society of Thoracic Surgeons 55th Annual Meeting, 2019.
70. Mitchell KG, Ikoma N, Nelson DB, Maru DM, Erasmus JJ, Vaporciyan AA, Antonoff MB, Mehran RJ, Rice DC, Roth JA, Swisher SG, Sepesi B, Walsh GL, Correa AM, Badgwell BD, Hofstetter WL. Predictors Of Mediastinal Involvement After Neoadjuvant Chemoradiation In Adenocarcinoma Of The Gastroesophageal Junction. STSA 2018 65th Annual Meeting, 2018.
71. Mitchell KG, Nelson DB, Hofstetter WL, Mehran RJ, Roth JA, Sepesi B, Swisher SG, Vaporciyan AA, Walsh GL, Rice DC, Antonoff MB. Surveillance Patterns After Treatment Of Non-Small Cell Lung Cancer With Lobectomy And Stereotactic Body Radiotherapy. STSA 2018, 2018.
72. Federico L, Ravelli A, Haymaker C, Forget MA, Karpinets T, Roszik J, Sakellariou-Thompson D, Kim YU, Bhatta A, Celestino M, Reuben A, Weissferdt A. Vaporciyan AA, Antonoff MB. Walsh G, Futreal A, Wistuba I, Roth J, Jianjun Z, Roarty E, de Lacerda-Landry LA, Swisher SG, Cascone T, Lizer GA, Heymach JV, Sepesi B, Gibbons D, Bernatchez C. Poster: CD8+ tumor-infiltrating lymphocytes expanded from a NSCLC immunosuppressive environment display neoantigen-specific recognition. The Society for Immunotherapy of Cancer's (SITC) 33rd Annual Meeting, 2018.
73. Mohammad ZB, Nelson DB, Lapid D, Correa AM, Mitchell KG, Hofstetter WL, Mehran RJ, Sepesi B, Walsh GL, Vaporciyan AA, Swisher SG, Roth JA, Rice DC, Antonoff MB. Sex-Related Outcomes after Lobectomy for Stage I Non-Small Cell Lung Cancer: A Single Institution Experience. AATS International Oncology Summit 2018, 2018.
74. Nelson DB, Rice DC, Mitchell KG, Tsao AS, Vaporciyan AA, Antonoff MB, Hofstetter WL, Walsh GL, Swisher SG, Roth JA, Gomez DR, Mehran RJ, Sepesi B. Defining the role of adjuvant radiotherapy for malignant pleural mesothelioma: A propensity matched landmark analysis of the national cancer database. AATS International Thoracic Surgical Oncology Summit 2018, 2018.
75. Mitchell KG, Nelson DB, Hofstetter WL, Mehran RJ, Roth JA, Sepesi B, Swisher SG, Vaporciyan AA, Walsh GL, Rice DC, Antonoff MB. Tumor cellular proliferation correlates with immune checkpoint expression and lymphocyte infiltration in resected non-small cell lung cancer. AATS International Thoracic Surgical Oncology Summit 2018, 2018.
76. Nelson DB, Mitchell KG, Van Haren RM, Mena GE, Woodard T, Correa AM, Hofstetter WL, Sepesi B, Walsh GL, Vaporciyan AA, Swisher SG, Antonoff MB, Roth JA, Heymach JV, Mehran RJ, Rice DC. Adjuvant Chemotherapy Is Facilitated by Enhanced Recovery After Thoracic Surgery: A Time-Series Analysis. AATS International Thoracic Surgical Oncology Summit 2018, 2018.
77. Nelson DB, Rice DC, Mitchell KG, Hofstetter WL, Walsh GL, Vaporciyan AA, Swisher SG, Antonoff MB, Roth JA, Tsao AS, Gomez DR, Sepesi B, Mehran RJ. Return to intended oncologic treatment (RIOT) after extrapleural pneumonectomy or pleurectomy/decortication for malignant pleural mesothelioma. AATS International Thoracic Surgical Oncology Summit 2018, 2018.
78. Sepesi, Federico, Mitchell, Andrea Ravelli, Cara Haymaker, Karpinets, Parra, Cascone, Weissferdt, Antonoff, Walsh, Bernatchez, Roth, Zhang, Roarty, Lacerda, Vaporciyan, Swisher, Heymach, Wistuba, Gibbons. PD-L1 Expression is Restricted to Tumor-Associated Macrophages Rather Than Tumor In Early Non-Small Cell Lung Cancers. World Lung Conference 2018, 2018.
79. Weissferdt A, Cascone T, Pataer A, Kalhor N, Moran C, Antonoff MB, Walsh GL, Bernatchez C, Gibbons DL, Wistuba II, Roth JA, Zhang J, Roarty E, Landry L, Vaporciyan AA, Heymach JV, Swisher S, Sepesi B. Histopathologic parameters define features of treatment response to neoadjuvant chemotherapy in non-small cell lung cancer. WCLC 2018, 2018.
80. Lam VK, Tran HT, Vasquez ME, Li K, Yuen K, Vang F, Jaimovich A, Kennedy D, Odegaard J, Mortimer S, Olsen SR, Raymond VM, Vaporciyan AA, Antonoff MB, Walsh GL, Roarty E, Lacerda L, Roth JA, Swisher S, Bernatchez C, Sepesi B, Gibbons DL, Zhang J, Heymach JV. Circulating Tumor DNA Analysis with a Novel Variant Classifier for Recurrence Detection in Resected, Early-Stage Lung Cancer. WCLC 2018, 2018.
81. Nelson DB, Tayob N, Mitchell KG, Correa AM, Hofstetter WL, Sepesi B, Walsh GL, Vaporciyan AA, Swisher SG, Antonoff MB, Roth JA, Rice DC, Mehran RJ. Close Surgical Margins and Risks of Local Treatment Failure after Wedge Resection of Colorectal Pulmonary Metastases. AATS 2018, 2018.
82. David B. Nelson MD, Quynh-Nhu Nguyen MD, Jeremy Erasmus, MD, Nabihah Tayob PhD, Kyle G. Mitchell, MD, Wayne L. Hofstetter, MD, Boris Sepesi, MD, Garrett L. Walsh, MD, Ara A. Vaporciyan, MD, Stephen G. Swisher, MD, Mara B. Antonoff, MD, Jack A. Roth, MD, David C. Rice, MD, Reza J. Mehran, MD. Local Failure after Stereotactic Body Radiation Therapy (SBRT) or Wedge Resection for Colorectal Pulmonary Metastases. AATS 2018, 2018.
83. Van Haren RM, Mehran R, Correa AM, Antonoff, MB, Baker CM, Hofstetter WL, Mena GE, Roth JA, Sepesi B, Swisher SG, Vaporciyan AA, Walsh GL, Rice DC. J. Maxwell Chamberlain Memorial Paper for General Thoracic Surgery Enhanced Recovery Protocol Decreases Pulmonary and Cardiac Complications Following Thoracotomy for Primary Lung Cancer. STS 54th Annual Meeting, 2018.
84. Atay SM, Van Haren RM, Niu J, Giordano SH, Antonoff MB, Hofstetter WL, Mehran R, Rice DC, Vaporciyan AA, Walsh GL, Roth JA, Swisher SG, Sepesi B,. Pathologic Treatment Response Is Associated With Increased Overall Survival in Patients Undergoing Neoadjuvant Chemotherapy Followed by Pneumonectomy. STS 54th Annual Meeting, 2018.
85. Mehran RJ, Walsh GL, Zalpour A, Cata JP, Correa AM, Antonoff MB, Rice DC. Intercostal Nerve Blocks With Liposomal Bupivacaine: Demonstration of Safety, and Potential Benefits. Seminars in Thoracic and Cardiovascular Surgery, 2017.
86. Nelson D, Godoy M, Benveniste M, Shewale J, Correa A, Spicer J, Hofstetter W, Mehran R, Rice D, Sepesi B, Walsh G, Vaporciyan A, Swisher S, Roth J, Antonoff M. Clinicoradiographic Predictors of Aggressive Behavior in Resected Malignant Ground glass Opacity Lesions. Western Thoracic Surgical Assoication 43rd Annual Meeting, 2017.
87. Rice D, Mehran R, Correa A, Antonoff M, Hofstetter W, Roth J, Sepesi B, Swisher S, Walsh G, Vaporciyan A. Is There Any Value To Robotic Assisted Lobectomy For Lung Cancer?. 2017 ISMICS Annual Scientific Meeting, 2017.
88. Sepesi B, Ye Y, Zhang L, Gu J, Ji L, Antonoff M, Hofstetter WL, Rice D, Mehran R, Walsh GL, Vaporciyan AA, Swisher SG, Roth JA, Wu X. Genetic Variants in Cytokine Signaling Pathways Are Associated With Survival in Surgically Resectable Non-Small Cell Lung Cancer. AATS Centennial 2017, 2017.
89. Lapid D, Nelson D, Correa A, Sepesi B, Hofstetter W, Rice D, Roth J, Swisher S, Walsh G, Mehran R, Vaporciyan A, Antonoff M.. Perioperative Outcomes Following Lobectomy for Stage I Non-Small Cell Lung Cancer; Differences Between Men and Women. AATS Centennial, 2017.
90. Nelson DB, Rice DC, Niu J, Atay SM, Vaporciyan AA, Antonoff MB, Hofstetter WL, Walsh GL, Swisher SG, Roth JA, Tsao AS, Gomez DR, Giordano SH, Mehran RJ, Sepesi B.. Predictors of Trimodality Therapy and Trends in Therapy for Malignant Pleural Mesothelioma. European Society of Thoracic Surgeons Annual Meeting 2017, 2017.
91. Antonoff MB, Ragalie W, Sepesi B, Roth J, Walsh GL, Hofstetter W, Swisher S, Rice DC, Vaporciyan A, Mehran R. Patient-Reported Symptoms: Differences Between Men and Women Following Pulmonary Resection. 2017 Multidisciplinary Thoracic Cancers Symposium:Poster Presentation, 2017.
92. Sepesi B, Cuentes EP, Canales J, Behrens C, Correa A, Antonoff M, Gibbons D, Heymach J, Hofstetter W, Mehran R, Rice D, Roth J, Vaporciyan A, Walsh G, Weissferdt A, Kalhor N, Moran C, Swisher S, Wistuba I. Tumor Infiltrating Lymphocytes and Overall Survival in Surgically Resected Stage II and III Non-Small Cell Lung Cancer. 2017 Multidisciplinary Thoracic Cancers Symposium(Oral Presentation), 2017.
93. Nelson DB, Correa A, Dhupar R, Goltsov A, Maru D, Sepesi B, Antonoff M, Mehran RJ, Rice DC, Walsh GL, Vaporciyan AA, Swisher SG , Roth JA, Davila R, Betancourt S, Skinner H, Blum M, Hofstetter WL. Endoscopic Mucosal Resection for Submucosal Esophageal Cancer. 2017 American Association for Thoracic Surgery:79, 2017.
94. Antonoff MB, Shewale J, Nelson DB, Rice D, Sepesi B, Hofstetter W, Mehran RJ, Vaporciyan AA, Walsh G, Swisher S, Roth J. Natural History of Ground Glass Lesions Among Patients With Previous Lung Cancer: Predictors of Progression. 2017 American Association for Thoracic Surgery:256, 2017.
95. Bassuner J, Rice DC, Antonoff MB, Correa A, Walsh GL, Vaporciyan AA, Garg N, Sepesi B, Swisher SG, Hofstetter WL, Roth JA, Mehran R. Polytetrafluoroethylene or collagen matrix for diaphragmatic reconstruction?. STS 53rd Annual Meeting, 2017.
96. Atay SM, Niu J, Giordano SH, Antonoff M, Heymach J, Hofstetter WL, Mehran R, Rice D, Roth JA, Vaporciyan A, Walsh G, William W, Swisher S, Sepesi B. Perioperative Outcomes and Downstaging Following Neoadjuvant Therapy For Lung Cancer - Analysis of the National Cancer Database. IASLC 2016, 2016.
97. Atay SM, Correa A, Hofstetter WL, Mehran RJ, Rice DC, Roth JA, Sepesi B, Swisher SG, Vaporciyan A, Walsh G, Antonoff M. Perioperative Outcomes of Patients Undergoing Pulmonary Lobectomy on Clopidogrel. STSA 2016, 2016.
98. Sceusi E, Atay S, Correa A, Swisher S, Vaporciyan A, Roth J, Walsh G, Hofstetter W, Mehran R, Rice D, Sepesi B, Antonoff M. Outcomes for Patients with Surgically Resected Thymic Neuroendocrine Tumors. NANETS symposium: Exploring Novel Mechanisms and Therapies for Neuroendocrine Cancers, 2016.
99. Sepesi B, Parra Cuentas E, Rodriguez Canales J, Behrens C, Correa A, Antonoff M, Gibbons M, Heymach J, Hofstetter W, Mehran R, Rice D, Roth J, Vaporciyan A, Walsh G, Weissferdt A, Kalhor N, Moran C, Swisher S, Wistuba W. The Expression of Programmed Death 1 Ligand (PD-L1) in the Tumor and Tumor Infiltrating Macrophages Predicts Overall and Disease Free Survival in Surgically Resected Pathologic Stage I Non-Small Cell Lung Cancer. WTSA 2016, 2016.
100. Shimodaira Y, Slack RS, Chen HC, Bhutani MS, Lee JH, Weston B, Elimova E, Lin Q, Harada K, Amlashi FG, Mizrak D, Blum MA, Roth JA, Swisher SG, Skinner HD, Hofstetter WL, Komaki R, Walsh G, Ajani JA. Influence of Induction chemotherapy (IC) in Trimodality-Eligible Esophageal Cancer Patients: Secondary Analysis of a Randomized trial. ASCO 2016, 2016.
101. Sceusi E, Leiva-Juarez M, Mehran R, Kalhor N, Shaw K, Futreal A, Correa A, Moran C, Wistuba II, Rao X, Swisher S, Vaporciyan A, Wang J, Antonoff, Hofstetter W, Rice D,Sepesi B, Walsh G, Roth J. Well Differentiated Neuroendocrine Carcinoma (Typical Carcinoid) with Mediastinal Lymph Node Metastases: Surgical Outcomes and Whole Exome Sequencing (WES). AATS 96th Annual Meeting, Baltimore, MD(Control # 575), 2016.
102. Antonoff MB, Correa A, Sepesi B, Nguyen Q, Walsh G, Swisher S, Vaporciyan A, Mehran R, Hofstetter W, Rice D. Salvage pulmonary resection following SBRT: A feasible and safe option for local failure. AATS 96th Annual Meeting(Control # 508), 2016.
103. Sanchez N, Shewale JB, Baker C, Wilks SA, Correa AM, Sepesi B, Mehran T, Rice DC, Roth JA, Walsh GL, Swisher SG, Vaporciyan A, Hofstetter W. Implications of Early Foley Removal in Thoracic Surgical Oncology Patients Utilizing Epidural Analgesia. STSA 2015- 62nd Annual Meeting, 2015.
104. Spicer JD, Shewale JB, Antonoff MB, Correa AM, Hofstetter W, Rice DC, Vaporciyan A, Mehran R, Walsh GL, Roth JA, Swisher S, Sepesi B. The Influence of Reconstructive Technique on Perioperative Outcomes Following Chest Wall Resection. STSA 2015 - 62nd Annual Meeting, 2015.
105. Walsh GL. Hybrid Approaches to T3/T4 lesions. AATS Focus on Thoracic Surgery: Technical Challenges and Complications, 2015.
106. Walsh GL. Post-pneumonectomy Syndrome (PPS). AATS Focus on Thoracic Surgery: Technical Challenges and Complications, 2015.
107. Spicer J, Rice R, Shewal J, Sepesi B, Antonoff M, Walsh G, Swisher S, Estrera T, Safi H, Khalil K. Comparative Outcomes Following Tracheal Resection for Benign Versus Malignant Conditions. Canadian Association of Thoracic Surgeons Annual Meeting 2015, 2015.
108. Spicer J, Shewale J, Sepesi B, Antonoff M, Correa A, Hofstetter W, Rice D, Vaporciyan A, Mehran R, Walsh G, Roth J, Swisher S. The Role of Pneumonectomy after Neoadjuvant Chemotherapy for N2 Non-Small Cell Lung Cancer. Canadian Association of Thoracic Surgeons Annual Meeting 2015, 2015.
109. Spicer JD, Shewale J, Correa AM, Heymach JV, Antonoff MB, Hofstetter W, Mehran R, Roth J, Rice D, Sepesi B, Vaporciyan AA, William W, Walsh G, Swisher S. Pre-Operative Chemotherapy Followed by Surgery for N2 Non-Small Cell Lung Cancer: A 15-Year Experience. IASLC 2015, 2015.
110. Antonoff MB, Simon GR, Gold KA, Patel S, Gomez D, Ferrarotto R, Allen J, Stevens R, Suarez Saiz FJ, Berger M, Walsh G, Mynhier M, High R, Futreal A, Hahn S, Swisher S, Heymach J, Chin L. MD Anderson Oncology Expert Advisor™: A Cognitive Clinical Decision Support Tool for Evidence-Based Multi-Disciplinary Lung Cancer Care. IASLC 2015, 2015.
111. Antonoff MB, Ragalie W, Correa AM, Spicer JD, Sepesi B, Roth JA, Walsh GL, Hofstetter WlL, Swisher SG, Rice DC, Vaporciyan AA, Mehran RJ. Indications For Counseling And Intervention After Pulmonary Resection: Results Of Post-discharge Nursing Telephone Assessments. Western Thoracic Surgical Association Annual Meeting 2015, 2015.
112. Walsh GL. Difficult Esophageal Reconstructions/Conduit Options When the Stomach is Not Suitable. 10th Current Trends in Aortic, Cardiac and General Thoracic Surgery, 2015.
113. Walsh GL. Resecting locally-invasive lung cancer- Pearls in Lung Cancer Resection. STS - 51st Annual Meeting, 2015.
114. Sepesi B, Schmidt HM, Lada M, Walsh GL, Mehran RJ, Rice DC, Roth JA, Vaporciyan AA, Ajani JA, Watson TJ, Swisher SG, Low DE, Hofstetter WL. Surgical Therapy is an Important Multimodality Component in Patients with Distal Esophageal Adenocarcinoma Independent of Regional Lymph Node Location. Southern Thoracic Surgical Association 61st Annual Meeting:4, 2014.
115. Alpers D, Walsh G, Dunnington J, Riley M, Evans T, Elsayegh S, Cook MC, Yniesta H. Celebrate Improvement @ MD Anderson. Patient Safety & Micro-needles in the Operating Room, 2014.
116. Sepesi B, Correa AM, Mehran RJ, Rice DC, Roth JA, Vaporciyan AA, Ajani JA, Walsh GL, Swisher SG, Hofstetter WL. Trends and Improving Outcomes of 882 Surgical Patients With Gastro-Esophageal Junction Adenocarcinoma – A Single Institution Experience. The International Society for Diseases of the Esophagus 2014, 2014.
117. Walsh GL. Lung Cancer Invading Spine-Resect En Bloc or 2 Stages?. AATS Annual Meeting 2014, 2014.
118. Walsh GL . Mesothelioma. General Thoracic Surgical Club Meeting 2014, 2014.
119. Sepesi B, Hofstetter WL, Rice DC, Mehran RJ, Vaporciyan AA, Walsh G, Roth JA, Swisher SG. Experience with Primary and Metastatic Adenoid Cystic Carcinoma. 2014 Society of Surgical Oncology Annual Cancer Symposium, 2014.
120. Francis AM, Correa AM, Betancourt-Cuellar SL, Kim, JY, Sepesi B, Ajani JA, Komaki R, Erasmus J, Maru DM, Mehran RJ, Rice DC, Roth JA, Vaporciyan AA, Walsh GL, Hofstetter WL, Swisher SG. Esophageal Tumor Thickness on Computed Tomography as a Predictor of Residual Tumor in Esophageal Adenocarcinoma Following Preoperative Chemoradiation. 9th Annual Academic Surgical Congress -San Diego, CA(ASC20140730), 2014.
121. Kim MP, Correa AM, Blackmon SH, Hofstetter W, Mehran R, Rice DC, Roth JA, Vaporciyan AA, Walsh GL, Swisher SG. Preoperative Flourodeoxyglucose-Positron Emission Tomography Scan with Positive N1 Disease Does Not Predict Worse Survival in Pathologic Stage II Patients. IASLC 2013(#P1.07-010), 2013.
122. Stephens A, Rice D, Swisher S, Vaporcyian A, Hofstetter W, Walsh G, Mehran R, Roth J. VATS lobectomy is Associated with Improved Short-Term and Long-Term Outcomes Compared to Open Lobectomy for C-Stage I NSCLC: A Propensity-Matched Analysis of 963 Cases. 21st European Conference on General Thoracic Surgery, 2013.
123. Francis AM, Sepesi B, Correa AM, Mehran RJ, Rice DC, Roth JA, Vaporciyan AA, Walsh GL, Swisher SG, Hofstetter WL. Long-Term Survival and Recurrence Rates Following Trimodality Therapy of Esophageal Adenocarcinoma – The Influence of Histologic Tumor Viability. ASA 2013 Meeting - Indianapolis, Indiana, 2013.
124. Sepesi B, Correa AM, Pataer A, Kalhor N, Bekele BN, Erasmus JJ, Hofstetter WL, Kim E, Komaki R, Mehran RJ, Moran CA, Papadimitrakopoulou, Rice DC, Roth JA, Vaporciyan AA, Walsh GL, William WN, Wistuba II, Swisher SG.. The Impact of Histopathologic Response on Pathologic TNM Lung Cancer Staging System (AJCC Seventh) Following Neoadjuvant Chemotherapy. STS 2013 Annual Meeting, 2013.
125. David EA, Wai C, Correa AM, Hofstetter WL, Rice DC, Roth JA, Swisher SG, Walsh GL, Vaporciyan AA, Thall PF, Mehran RJ. Visceral Pleural Invasion Is Not Predictive of Survival in NSCLC Patients with Small. Society of Thoracic Surgeons 49th Annual Meeeting 2013:290, 2013.
126. Ganeshan DM, Correa AM, Bhosale P, Vaporciyan AA, Rice DC, Mehran RJ, Walsh GL, Iyer R, Roth JA, Swisher SG, Hofstetter WL.. Diaphragmatic Hernia After Esophagectomy in 440 Patients with Long-term Follow-up. STSA 2012, 2012.
127. Cheedella NKS, Suzuki A, Correa AM, Hofstetter WL, Mehran RJ, Rice DC, Maru DM, Vaporciyan AA, Mariel Taketa T, Blum MA, Welsh J, Lin SH, Lee JH, Bhutani MS, Weston B, Walsh GL, Swisher SG, Ajani JA. Association of clinical complete response (cCR) after preoperative chemoradiation and pathological complete response (pathCR) in patients with gastroesophageal cancer (GEC) and indispensability of trimodality therapy (TMT. 2012 ASCO Meeting, 2012.
128. Sepesi B, Swisher SG, Walsh G, Correa A, Mehran R, Rice D, Roth J, Vaporciyan A, Hofstetter WL.. Omental Reinforcement of the Thoracic Esophagogastric Anastomosis – An Analysis of Leak and Reintervention Rates in Planned and Salvage Esophagectomy Patients. Proc Am Assoc Thorac Surg, 2012.
129. Owen CS, Frenzel JC, Walsh GL. Reducing variability in operating room utilization. 2012 ASCO's Quality Care Symposium, 2012.
130. Blackmon SH, Correa AM, Skoracki R, Chevray P, Kim M, Mehran R, Rice DC, Roth J, Swisher SG, Vaporciyan AA., Walsh GL, Hofstetter W.. Super-Charged Pedicled Jejunal Interposition for Esophageal Replacement: A 10 Year Experience. STS 48th Annual Meeting, Fort Lauderdale, FL, 2012.
131. Blackmon SH, Stephens E, Correa AM, Hofstetter W, Kim MP, Mehran R, Rice DC, Roth JA, Swisher SG, Walsh GL, Vaporciyan AA. Predictors of Recurrence in the Lung and Survival in Pulmonary Metastasectomy for Colorectal Carcinoma Patients. STS 48th Annual Meeting, 2012.
132. Marks JL, Hofstetter W, Correa A, Mehran RJ, Rice D, Roth J, Walsh G, Vaporciyan A, Erasmus J, Chang J, Maru D, Lee JH, Lee J, Ajani JA, Swisher SG.. Salvage Esophagectomy After Failed Definitive Chemoradiation For Esophageal Adenocarcinoma. Southern Thoracic Surgical Association STSA 58th Annual Meeting, 2011.
133. Harvin JA, Lahat G, Correa AM, Lee JJ, Maru D, Ajani A, Marom E, Welsh J, Walsh GL, Roth JA, Mehran RJ, Vaporciyan AA, Rice DC, Swisher SG and Hofstetter WJ. Neoadjuvant Chemoradiation Followed by Surgery for Esophageal Adenocarcinoma: Significance of Microscopically Positive Circumferential Margins. Proc Am Assoc Thorac Surg, 2011.
134. Kim JY, Correa AM, Swisher SG, Rice DC, Walsh GL, Vaporciyan AA, Mehran RJ, Roth JA, Bhutani M, Maru D, Welsh J, Ajani J, Rohren E, Hofstetter WL. Does the Timing of Esophagectomy after Neoadjuvant Chemoradiation Affect Outcome?. STS 47th Annual Meeting - Jan. 2011:17, 2011.
135. Hayashi Y, Correa AM, Hofstetter WL, Vaporciyan AA, Rice DC, Walsh GL, Mehran RJ, Suzuki A, Lee JH, Bhutani MS, Lin SH, Welsh J, Maru D, Swisher S, Ajani JA. The association between body mass index and baseline clinical stage of esophageal carcinoma. 2011 ASCO Annual Meeting, 2011.
136. Hayashi Y, Correa AM, Hofstetter WL, Vaporciyan AA, Rice DC, Walsh GL, Mehran RJ, Swisher SG, Ajani JA. The influence of pretreatment body mass index on long-term prognosis of patients with esophageal carcinoma after surgery. Gastrointest Cancer Res Supplement 2:S7, 2010.
137. Brouquet A, Vauthey JN, Contreras C, Walsh G, Vaporicyan AA, Swisher SG, Curley S, Mehran RJ, Abdalla E. Improved Survival After Resection of Liver and Lung Colorectal Metastases Compared to Resection of Liver-Only Metastases: A Study of 112 Patients with Limited Lung Metastatic Disease. Western Surgical Association Meeting, 2010.
138. Gaur P, Sepesi B, Hofstetter WL, Correa AM, Bhutani MS, Ajani JA, Erasmus J, Komaki R, Lee JHL, Maru D, Mehran R, Rice DC, Roth JA, Vaporciyan AA, Walsh GL, Peters JH, Watson TJ, Swisher SG. A Clinical Nomogram Predicting Pathologic Lymph Node Involvement in Esophageal Cancer Patients. American Surgical Association 130th Annual Meeting:77, 2010.
139. Kim MP, Hofstetter WL, Correa A, Rice DC, Roth JA, Walsh GL, Mehran RJ, Vaporciyan AA, Ajani JA, Maru DM, Chang JY, Marom EM, Macapinlac HA, Lee JH, Swisher SG. Pathologic T0N1 after neoadjuvant therapy and surgery for esophageal cancer: an orphan status. 46th Annual Meeting Program, The Society of Thoracic Surgeons:174-175, 2010.
140. Kim MP, Correa A, Moran C, Erasmus J, Hofstetter WL, Mehran RJ, Rice DC, Walsh GL, Vaporciyan AA, Swisher SG, Roth JA. Resection of lung cancer in lymphoma survivors. 46th Annual Meeting Program, The Society of Thoracic Surgeons- January 2010(Abstract #59):206, 2010.
141. Komaki R, Wei, X Allen P, Roth JR, Swisher S, Rice D, Walsh G, Fossella FV, Erasmus J, Cox JD. Treatment for superior sulcus tumors (SST): Surgery first followed by adjunct RT/ChT improved survival for patients with marginally resectable superior sulcus tumors. American Society of Clinical Oncology 2010 Annual Meeting(J Clin Oncol 28:15s, 2010 (suppl; abstr 7026)), 2010.
142. Hayash Yi, Correa AM, Hofstetter WL, Vaporciyan AA, Rice DC, Walsh GL, Mehran RJ, Swisher A, Ajani JA. The influence of pretreatment body mass index on long-term prognosis of patients with esophageal carcinoma after surgery. 2010 ASCO Annual Meeting, 2010.
143. Blackmon SH, Stephens EH, Correa AM, Roth JA, Hofstetter W, Benjamin R, Mehran R, Swisher SG, Walsh GL, Vaporciyan AA.. Progression following chemotherapy is a novel predictor of poor outcome following pulmonary metastasectomy in sarcoma patients. J Am Coll Surg Supp 211(3):S35, 2010.
144. Gopaldas RR, Bakaeen FG, Dao TK, Walsh GL, Swisher SG, Chu D. Outcomes of video-assisted thorascopic surgery (VATS) versus open thoracotomy pulmonary lobectomy in a cohort of 13,619 patients. Southern Thoracic Surgical Association 2009 56th Annual Meeting:70, 2009.
145. Swisher SG, Hofstetter W, Komaki R, Correa AM, Erasmus J, Liao Z, Lee JH, Maru D, Mehran R, Patel S, Phan A, Rice DC, Roth JA, Vaporciyan AA, Walsh GL, Ajani JA.. Improved Long-term Outcome with Chemoradiotherapy Strategies in Locoregionally Advanced Esophageal Cancer. Southern Thoracic Surgical Association 56th Annual Meeting(pg 198):198, 2009.
146. Gopaldas RR, Bakaeen FG, Dao TK, Walsh GL, Swisher SG, Chu D.. Video-assisted thorascopic surgery (VATS) versus open thoracotomy pulmonary lobectomy in a cohort of 13,619 patients. 56th Annual Meeting of the Southern Thoracic Surgical Association, 2009.
147. Correa AM, Hayashi Y, Hofstetter WL, Komaki R, Vaporciyan AA, Rice DC, Walsh GL, Lee JH, Bhutani MS, Ross WA, Liao Z, Swisher SG, Ajani JA. In Patients with Clinical T2N0M0 Esophageal Cancer, Surgery First or Preoperative Chemoradiotherapy?. 2009 Gastrointestinal Oncology Conference, 2009.
148. Walsh GL. Involvement of the T-spine, including Pancoast tumors. Journal of Thoracic Oncology 4(9):S131-133, 2009.
149. Walsh G. Current Approach to Treating Superior Sulcus Tumors. 7th Current Trends in Aortic and Cardiothoracic Surgery:88, 2009.
150. Walsh G. The Current Status of Tracheal Replacement. 7th Current Trends in Aortic and Cardiothoracic Surgery:92, 2009.
151. Gaur P, Correa AM, Huang JL, Hofstetter W, Maru D, Mehran R, Roth JA, Vaporciyan AC, Walsh GL, Swisher SG.. Correlation of endoscopic tumor length with lymph node involvement and poor long-term survival in esophageal cancer patients. 2009 Gastrointestinal Cancers Symposium, 2009.
152. Blackmon S, Shah N, Correa AM, Benjamin R, Hofstetter W, Lev D, Pollock R, Rice DC, Roth JA, Swisher SG, Vaporciyan AA, Walsh GL, Mehran R.. Complete resection of extra-pulmonary sarcomatous metastases in addition to pulmonary metastasectomy is associated with long-term survival. The Society of Thoracic Surgeons 45th Annual Meeting, 2009.
153. Rice DC, Lee JH, Eapen JG, Stewart J, Hofstetter WL, Mehran R, Vaporciyan AA, Walsh GL, Swisher SG. Mediastinal Staging for Mesothelioma: Endoscopic Ultrasound or Mediastinoscopy?. 45th Annual Meeting Society of Thoracic Surgeons:18, 2009.
154. Walsh, GL. Surgical Techniques for Pancoast Tumors. 88th Annual Meeting AATS/STS General Thoracic Surgery Symposium, San Diego, CA, 2008.
155. Bolton W, Rice D, Goodyear A, Correa A, Erasmus J, Hofstetter W, Komaki R, Mehran R, Pisters K, Roth J, Swisher S, Vaporciyan A, Walsh G, Weaver J, Rhines L.. Long-Term Survival with Surgical Management For Superior Sulcus Tumors with Vertebral Resection. 88th Annual Meeting of the American Association for Thoracic Surgery. San Diego, CA. 5/10-14/08:29, 2008.
156. Mehran R, Shah N, Correa A, Vaporciyan A, Rice D, Hofstetter W, Walsh G, Benjamin R, Swisher S, Pollock R, Roth J. Pulmonary Metastatectomy In Sarcoma Patients With Extra-Thoracic Metastases. 18th World Congress of the World Society of Cardio-Thoracic Surgeons, 2008.
157. Kassis ES, Vaporciyan AA, Swisher SG, Correa AM, Bekele N, Erasmus JJ, Hofstetter WL, Komaki R, Mehran RJ, Moran CA, Pisters KM, Rice DC, Walsh GL, Roth JA.. Application of the Revised Lung Cancer Staging System (IASLC Staging Project) to a Cancer Center Population. 88th Annual Meeting of the American Association for Thoracic Surgery, 2008.
158. Bolton WD, Hofstetter W, Francis A, Correa AM, Ajani JA, Bhutani B, Erasmus J, Komaki R, Maru D, Mehran R, Rice DC, Roth JA, Vaporciyan AA, Walsh GL, Swisher SG.. Impact of Tumor Length and Submucosal Involvement on the Long-Term Survival of pT1 Early Stage Esophageal Adenocarcinoma. 88th Annual Meeting of the American Association for Thoracic Surgery, 2008.
159. Javeri H, Arora R, Correa AM, Dixon D, Komaki R, Hofstetter W, Rice D, Walsh G, Vaporciyan A, Swisher S, Lee JH, Bhutani M, Ross W, Liao Z, Maru D, Dekovich A, Ajani JA. Comparison of the outcomes of patients with localized esophageal carcinoma receiving bimodal versus trimodal therapy. (Poster)- 4th Annual Meeting of the International Society of Gastrointestinal Oncology (ISGIO) - Philadelphia, PA, 2007.
160. Yendamuri S, Vaporciyan AA, Zaidi T, Fernandez R, Rice DC, Walsh GL, Swisher SG, Spitz M, Roth JA, Katz RL. Deletion of chromosome 10q detected by luorescent in situ hybridization (FISH) is a potential new tool for early detection of non small cell lung cancer (NSCLC). 12th World Conference on Lung Cancer 2(8):S357, 2007.
161. Walsh G. Induction Therapy Followed by Resection. The American Association of Thoracic Surgery 87th Annual Meeting, AATS/STS General Thoracic Symposium, Washington, DC:Abstract Pg. 40-42, 2007.
162. Blackmon SH, Rice DC, Correa AM, Hofstetter W, Swisher SG, Mehran R, Vaporciyan AA, Walsh GL, Roth JA. Does A Gastrostomy Tube Versus Jejunostomy Tube Prior To Esophagectomy For Primary Esophageal Cancer Patients Have Additional Risk?. The Society of Thoracic Surgeons 43rd Annual Meeting, San Diego, California, 2007.
163. Yendamuri S, Vaporciyan AA, Zaidi T, Fernandez R, Rice DC, Spitz M, Swisher S, Walsh GL, Roth JA, Katz RL. 3p and 10q deletions detected by fluorescence in situ hybridization (FISH): A potential new tool for early detection of non-small cell lung cancer (NSCLC). 2007 American Society of Clinical Oncology Annual Meeting, 2007.
164. Rice D, Correa A, Hofstetter W, Mehran R, Swisher S, Walsh G, Vaporciyan A, Roth j. Recent Survival Trends for Clinically Staged Stage I Lung Cancer. The Society of Thoracic Surgeons 43rd Annual Meeting, San Diego, CA, 2007.
165. Yendamuri S, Walsh G, Vaporciyan A, Hofstetter W, Rice DC, Mehran RJ, Roth JA.. Comparison of limited surgery and 3D conformal radiation in high risk patients with stage IA non small cell lung cancer: A propensity score matched analysis. J Thorac Oncol 2(8):S388, 2007.
166. Rice D, Stevens C, Forster K, Vaporciyan A, Walsh GL, Swisher S, Hofstetter W, Mehran R, Roth J, Liao Z, Smythe R. Survival and Recurrence Patterns Following Extrapleural Pneumonectomy And Intensity Modulated Radiation Therapy For Malignant Pleural Mesothelioma. Southern Thoracic Surgical Association's 53rd Annual Meeting, Tucson, Arizona, 2006.
167. Blackmon SH, Martin LW, Correa AM, Wynn Bob, Hofstetter W, Mehran RJ, Rice D, Swisher S, Walsh GL, Roth JA, Vaporciyan AA. Propensity Matched Analysis of Three Techniques for Intrathoracic Esophagogastric Anastomosis. Southern Thoracic Surgical Association's 53rd Annual Meeting, Tucson, Arizona, 2006.
168. Hofstetter W, Correa AM, Bekele N, Ajani JA, Phan A, Komaki RR, Liao Z, Maru D, Wu TT, Mehran RJ, Rice DC, Roth JA, Vaporciyan AA, Walsh GL, Francis A, Blackmon S, Swisher SG. Proposed Modification of Nodal Status In Ajcc Esophageal Cancer Staging System. Southern Thoracic Surgical Association 53rd Annual Meeting, 2006.
169. Rodney A, Siefker-Radtke A, Tannir NM, Swisher S, Walsh GL, Millikan RE, Pagliaro LC. Treatment outcomes of patients (Pts) with primary mediastinal germ cell tumors (PMGCT): The M.D. Anderson Cancer Center (MDACC) Experience. 42nd Annual Meeting of the American Society of Clinical Oncologists, Atlanta, GA, 2006.
170. Bakaeen F, Chu D, Correa AM, Rice D, McAllister R, Vaporciyan AA, Walsh G, Putnam JB, Swisher SG, Roth JA, Huh J, Smythe, WR. The Use of Aprotinin in Extrapleural Pneumonectomy: Effect on Hemostasis And Blood Product Utilization. Association of VA Surgeons Meeting, 2006.
171. Herrera LJ, Correa AM, Vaporciyan AA, Hofstetter WL, Rice DC, Swisher SG, Walsh GL, Roth JA, Mehran RJ. Increased Risk of Aspiration and Pulmonary Complications after Lung Resection in Head and Neck Cancer Patients. STS 42nd Annual Meeting:Pg. 214, 2006.
172. Brown K, Bisanz A, Walsh G, Vaporciyan A, Hofstetter W. A Proactive approach to preventing constipation in postoperative oncology pulmonary resection patients. Oncology Nursing Forum 33:414, 2006.
173. Jaroszewski DE, Rice DC, Vaporciyan AA, Walsh GL, Seabolt PB, Bakaeen FG, Reardon MJ. Multi-modality treatment of primary cardiac sarcomas. The European Society for Cardiovascular Surgery, 54th International Congress, Athens, Greece, May 19-22, 2005 , Interactive Cardiovascular and Thoracic Surgery 4, 2005.
174. Malaisrie SC, Correa AM, Ajani A, Komaki, Hofstetter W, Rice DC, Vaporciyan AA, Walsh GL, Lahoti S, Lee JH, Bresalier R, Roth JA, Swisher SG. EUS-identified celiac adenopathy remains a poor prognostic factor despite preoperative chemoradiotherapy in patients with adenocarcinoma of the distal esophagus. American Association for Thoracic Surgery, 85th Annual Meeting, San Francisco, California:Pg. 102, 2005.
175. Martin LW, Correa AM, Dolormente M, Francisco R, Martin F, Sarabia AJ, Hong WK, Smythe WR, Putnam JB Jr, Hofstetter W, Rice DC, Vaporciyan AA, Swisher SG, Walsh GL, Roth JA. Outcomes for resected stage IIIA non-small cell lung cancer over 15 years at a single institution. American Association for Thoracic Surgery, 85th Annual Meeting, San Francisco, California:Pg. 72, 2005.
176. Ascioti AJ, Hofstetter WL, Miller MJ, Rice DC, Swisher SG, Vaporciyan AA, Roth JA, Putnam JB, Smythe RJ, and Walsh GL. Long segment supercharged pedicled jejunal flap for total esophageal reconstruction. Proc Am Assoc Thorac Surg 98(5):1391-8, 2005. PMID: 16256794.
177. Malaisrie SC, Hofstetter WL, Correa AM, Ajani JA, Komaki RR, Liao Z, Phan A, Rice DC, Vaporciyan AA, Walsh GL, Lahoti S, Lee JH, Bresalier R, Roth JA, Swisher SG. Endoscopic ultrasonography-identified celiac adenopathy remains a poor prognostic factor despite preoperative chemoradiotherapy in esophageal adenocarcinoma. STS 2005, 2005.
178. Rice D, Vaporciyan A, Stevens C, Wu J, Walsh G, Swisher S, Hofstetter W, Erasmus J, Smythe WR. Extended surgical staging for potentially respectable malignant mesothelioma. Society of Thoracic Surgeons, 41st Annual Meeting, Tampa, Florida, 2005.
179. Martin LW, Swisher SG, Hofstetter W, Correa AM, Rice DC, Vaporciyan AA, Walsh GL, Roth JA.. Intrathoracic leaks following esophagectomy are no longer associated with increased mortality. American Surgical Assoc(64), 2005.
180. Rohatgi P, Swisher S, Correa A, Wu TT, Liao X, Komaki R, Walsh G, Vaporciyan A, Rice DC, Roth JA, Ajani JA. Degree of pathologic response after preoperative chemoradiotherapy correlates with failure patterns and outcome of patients with carcinoma of the esophagus. Proc. Am. Assoc. Cancer Res:46, 2005.
181. Malaisrie SC, Hofstetter WL, Correa AM, Ajani JA, Komaki RR, Rice DC, Vaporciyan AA, Walsh GL, Roth JA, Swisher SG. The Addition of Induction Chemotherapy to Preoperative Concurrent Chemoradiotherapy Improves Tumor Response in Patients with Esophageal Adenocarcinoma. Western Thoracic Surgical Association, 2005.
182. Walsh GL. Principles of surgical management of patients with lung cancer. Proceedings of the 1st Annual SINO-US Seminar on Clinical Oncology: Multidisciplinary Management of Lung Cancer, Shanghai, China:Pg. 40-41, 2004.
183. Swisher SG, Erasmus J, Maish M, Correa AM, Ajani J, Cox J, Komaki R, Lee HK, Macapinlac H, Putnam JB, Rice D, Smythe WR, Vaporciyan A, Walsh G, Hong D, Wu T-T, Pollock R, Roth J. PET predicts pathologic response and long-term survival following preoperative chemoradiation in esophageal cancer. Proc. Am. Soc. Clin. Oncol. -Gastrointestinal Cancers Symposium, New Orleans, Louisiana, 2004.
184. Komaki R, Putnam JB, Roth JR, Allen P, Swisher S, Walsh G, Kies M, Fossella FV, Hong WK, Herbst R, Oh YW, Liao Z, Vaporciyan R, Rice D, Smythe R, Munden R, Cox JD. Does surgery and preoperative treatments improve the outcome of patients with locally advanced superior sulcus tumor (SST)?. Proceedings of the 86th Annual Meeting of the American Radium Society, Napa Valley, CA, 2004.
185. McCann UGII, Correa AM, Walsh GL. Surgical management of locally advanced lung cancer: The M.D. Anderson experience. The Michael E. DeBakey International Surgical Society, XVth Congress, Houston, Texas, 2004.
186. Vaporciyan AA, Lee H, Cox J, Swisher SG, Komaki R, Smythe WR, Walsh GL, Rice DC, Roth JA, Putnam JB Jr. The impact of chemoradiotherapy on pulmonary morbidity after esophagectomy. The 84th Annual Meeting of the American Association for Thoracic Surgery, Toronto, Canada:Pg. 88, 2004.
187. Walsh GL. Combined modality therapy for thymoma. The 84th Annual Meeting of the American Association for Thoracic Surgery, General Thoracic Symposium, Toronto, Canada:Pg. 44, 2004.
188. Swisher SG, Ajani JA, Rice DC, Walsh GL, Hunt KK, Correa AM, Komaki R, Vaporciyan AA, Wu TT, Roth JA. Impact of pathologic response on pTNM esophageal cancer staging system following preoperative chemoradiation (CRT). Southern Surgical Association, 2004.
189. Rice DC, Swisher SG, Correa AM, Ajani JA, Putnam JB, Smythe WR, Walsh GL, Vaporciyan AA, Roth JA. Induction chemoradiotherapy prior to esophagectomy in elderly patients is not associated with increased morbidity. 40th Annual Meeting of the Society of Thoracic Surgeons, San Antonio, Texas, Proc. Soc. Thorac. Surg:Pg. 266-267, 2004.
190. Swisher SG, Maish M, Erasmus J, Correa AM, Rice D, Putnam JB, Smythe WR, Walsh G, Vaporciyan A, Roth J. Utility of PET, CT, and EUS to Identify Pathologic Responders In Esophageal Cancer. 40th Annual Meeting, The Society of Thoracic Surgeons, San Antonio, Texas, Proc. Soc. Thorac. Surg:Pg. 170-171, 2004.
191. Vaporciyan AA, Correa A, Rice D, Roth R, Smythe WR, Swisher SG, Walsh GL, Putnam JB Jr. Identification of risk factors associated with atrial fibrillation after thoracic surgery: prospective analysis of 2,335 patients. American Association for Thoracic Surgery 83rd Annual Meeting, Boston, Massachusetts, 2003.
192. Flamm AL, Smith ML,Walsh GL. Nine years and 500 consults later: a data summary of what we did, and what we learned. Clinical Ethics Consultation First International Assessment Summit, Cleveland, Ohio, 2003.
193. Swisher SG, Ajani JA, Komaki RR, Nesbitt JC, Cox J, Lahoti S, Martin F, Putnam JB Jr, Smythe WR, Vaporciyan AA, Walsh GL, Roth JA. Final results of phase II trial evaluating chemotherapy, concurrent chemoradiation and surgery in locoregionally advanced esophageal cancer. American College of Surgeons South Texas Chapter Annual Meeting, Houston, Texas, 2003.
194. Allen MS, Wood DE, Harpole DH, McKenna RJ, Walsh GL, Vallieres E. Prospective randomized study evaluating a biodegradable polymeric sealant for sealing intraoperative air leaks that occur during pulmonary resection. The Society of Thoracic Surgeons Thirty-ninth Annual Meeting, San Diego, California, 2003.
195. Putnam JB Jr, Correa A, Swisher SG, Smythe WR, Rice DC, Roth JA, Vaporciyan AA, Walsh GL. A model for prospective quality improvement in thoracic surgical oncology. Texas Surg. Soc, 2003.
196. Putnam JB Jr, Roberson SL, Lewin JS, Correa AM, Swisher SG, Walsh GL, Rice DC, Vaporciyan AA, Roth JA, Smythe WR. Risk analysis for pneumonia following esophagectomy. The Society of Thoracic Surgeons Thirty-ninth Annual Meeting, San Diego, California, 2003.
197. Rice DC, Kim HW, Smythe WR, Swisher SG, Vaporciyan AA, Putnam JB Jr, Walsh GL, Lippman SM, Roth JA, Sabichi A, Lee JL. The risk of second primary lung cancer after resection of stage I non-small cell lung cancer. The Society of Thoracic Surgeons Thirty-ninth Annual Meeting, San Diego, California:Pg. 108, 2003.
198. Swisher S, Ajani J, Komaki R, Putnam J, Walsh G, Liao Z, Yao J, Faust J, Wu T-T, Roth J, MDACC Esophageal Research Study Group. CPT-11-Taxotere-5-FU regimen for induction and concurrent chemoradiotherapy prior to surgery in patients with resectable esophageal or GEJ carcinoma. Proc. Am. Soc. Clin. Oncol 22:272, 2003.
199. Agarwal B, Swisher S, Kelly K, Ajani J, Komaki R, Molke K, Lehman J, Walsh G, Correa A, Ho LN, Liao ZX, Lynch P, Rice D, Smythe R, Steven C, Vaporciyan AA, Yao J, Roth J. Pre-operative chemoradiation downstages esophageal adenocarcinoma and abolishes differences in post-operative survival between T3N0 and T3N1 esophageal cancers. Gastroenterology 124:A652, 2003.
200. Agarwal B, Swisher S, Ajani J, Kelly K, Fanning C, Komaki RR, Putnam JB Jr, Abu-Hamada I, Molke KL, Walsh GL, Correa AM, Ho L, Liao Z, Lynch PM, Rice DC, Smythe WR, Stevens CW, Vaporciyan AA, Yao J, Roth JA. Persistent malignant lymphadenopathy after preoperative chemoradiation identifies patients with poor postoperative survival. 13th International Symposium on Endoscopic Ultrasonography, American Society for Gastrointestinal Endoscopy, New York, New York. Gastrointest. Endosc 56:S110, 2002.
201. Lee HK, Vaporciyan AA, Cox JD, Putnam JB Jr, Ajani JA, Liao Z, Swisher SG, Roth JA, Smythe RW, Walsh GL, Mohan R, Komaki R. Postoperative pulmonary complications following preoperative chemoradiation for esophageal carcinoma: correlation with pulmonary dose-volume histogram. Proc. of American Society for Therapeutic Radiology and Oncology Annual Meeting, October 06-09, 2002, New Orleans, Louisiana. Int'l J. Radiation Onc/Biol/Physics 54:132-133, 2002.
202. Walsh GL. Multi-team approaches to complex malignancies. Thirty-third World Congress of the International College of Surgeons, Taipei, Taiwan:Pg. 55, 2002.
203. Walsh GL. Surgical treatment of lung cancer. Thirty-third World Congress of the International College of Surgeons, Taipei, Taiwan:Pg. 50, 2002.
204. Agarwal B, Swisher S, Kelly K, Lynch P, Ajani J, Komaki RR, Putanm JB, Molke KL, Lehmann J, Bismar MM, Walsh GL, Correa AM, Ho L, Kelly J, Liao ZX, Rice DC, Smythe WR, Stevens CW, Vaporciyan AA, Yao J, Roth JA. Role of EUS lymph node assessment after preoperative chmoXRT in esophageal cancer patients. Gastrointestinal Endoscopy 55:AB229, 2002.
205. Swisher SG, Hofstetter WL, Correa AM, Putnam Jr J, Ajani JA, Dolormente M, Francisco R, Komaki RR, Lara A, Martin F, Rice D, Sarabia AJ, Smythe WR, Vaporciyan AA, Walsh GL, Roth JA. Evolving treatment outcomes of resected esophageal cancer over three decades for 951 patients at a single institution. American Surgical Association, 122nd Annual Meeting, Hot Springs, Virginia. Am. Surg. Assoc:Pg 100-101, 2002.
206. Taylor NA, Liao Z, Stevens C, Walsh G, Roth J, Putnam J Jr, Fossella F, Cox JD, Komaki R. Postoperative radiotherapy increases local regional control of patients with stage IIIA non-small cell lung cancer treated with induction chemotherapy followed by surgery. Proc.of the Eighty-fourth Annual Meeting of the American Radium Society, San Juan, Puerto Rico, 2002.
207. Agarwal B, Swisher S, Kelly K, Ajani J, Komaki RU, Putnam JB, Molke KL, Lehman J, Bismar MM, Walsh GL, Correa AM, Ho L, Liao Z, Lynch P, Rice DC, Smythe WR, Steven CW, Vaporciyan AA, Yao J, Roth JA. Determinants of response to chemoradiation in patients with esophageal cancer. Proc Am Gastroenterol Assoc 122:A-351, 2002.
208. Vaporciyan AA, Rice DC, Correa AM, Walsh GL, Putnam JB Jr, Swisher SG, Smythe WR, Roth JA. Resection of advanced thoracic malignancies requiring cardiopulmonary bypass. . Proc. of European Association for Cardio-Thoracic Surgery/European Society of Thoracic Surgeons Joint Meeting, Lisbon, Portugal, Eur. J. Cardiothorac. Surg 22:47-52, 2001.
209. Swisher SG, Ajani JA, Komaki RR, Walsh GL, Nesbitt JC, Martin FD, Lahoti S, Smythe WR, Vaporciyan AA, Putnam JB Jr, Roth JA. Improved long-term survival in esophageal cancer following the novel strategy of induction chemotherapy prior to concurrent chemoradiation and surgery. Twenty-seventh Annual Meeting of the Western Thoracic Surgical Association:Pg. 66, 2001.
210. Ajani J, Komaki R, Walsh G, Putnam J, Swisher S, Lahoti S, Ho J, Faust J, Ro W, Smythe W, Vaporciyan A, Pisters P, Kelly J, Stevens C, Roth J. CPT-11 plus cisplatin as induction chemotherapy followed by chemoradiotherapy in resectable carcinoma of the esophagus and GE junction (EC-GEJC). The Thirty-seventh Annual Meeting of the American Society of Clinical Oncology, San Francisco, California, 2001.
211. Kim E, Putnam J Jr, Komaki R, Walsh G, Ro J, Shin H, Moon H, Swisher S, Fossella F, Khuri F, Hong W, Shin D. A phase II study of a multidisciplinary approach with induction chemotherapy (IC), followed by surgical resection (SR), radiation therapy (RT) and consolidation chemotherapy (CC) for unresectable malignant thymomas: final report. The Thirty-seventh Annual Meeting of the American Society of Clinical Oncology, San Francisco, California, 2001.
212. Porter GA, Cantor S, Patel SR, Walsh GL, Rusch VW, Leung DH, DeJesus Y, Hunt KK, Feig BW, Pollock RE, Benjamin RS, Brennan MF, Pisters PW. Cost-effectiveness of pulmonary resection and systemic chemotherapy in the management of metastatic soft tissue sarcoma. The Thirty-seventh Annual Meeting of the American Society of Clinical Oncology, San Francisco, California, 2001.
213. Siefker-Radtke AO, Walsh GL, Swanson DA, Logothetis CJ, Millikan RE. Is there a role for surgery in the management of metastatic urothelial cancer? The M.D. Anderson Experience. . The Thirty-seventh Annual Meeting of the American Society of Clinical Oncology, San Francisco, California, 2001.
214. Swisher S, Roth J, Komaki R, Hicks M, Ro J, Hong WK, Ahrar K, Correa A, Dolormente M, Dreiling L, Fang B, Fossella F, Francisco R, Glisson B, Herbst R, Huaringa A, Gu J, Kelly J, Kemp B, Khuri F, Kurie J, Lee J, Lee JS, Liao Z, Merritt J, Morice R, Morello F, Mosheim M, Munden R, Papadimitrakopoulou V, Pisters K, Putnam J, Sarabia A, Shelton T, Stevens C, Shin D, Smythe W, Vaporciyan A, Walsh G, Yin M, Yver A. Induction of pro-apoptotic mediators and tumor regression following intratumoral delivery of adenoviral p53 (RPR/INGN 201) and radiation therapy in patients with non-small cell lung cancer (NSCLC). The Thirty-seventh Annual Meeting of the American Society of Clinical Oncology, San Francisco, California, 2001.
215. Swisher SG, Wynn P, Mosheim MB, Putnam JB Jr, Komaki RR, Ajani JA, Smythe WR, Vaporciyan AA, Roth JA, Walsh GL. Is surgical salvage indicated for recurrent esophageal tumors following definitive chemo-radiation?. Proc. of American Association of Thoracic Surgery's Eighty-first Annual Meeting, San Diego, California, 2001.
216. Xiong Q, Yao J, Phan A, Giacco G, Hess K, Roth J, Putnam J, Walsh G, Swisher S, Mansfield P, Pisters P, Feig B, Ajani J. Frequency of esophagogastric junction involvement among upper gastrointestinal cancers. The Thirty-seventh Annual Meeting of the American Society of Clinical Oncology, San Francisco, California, 2001.
217. McMullan DM, Dao TN, Walsh GL. Intraoperative autotransfusion in cancer patients. American College of Surgeons, South Texas Chapter, San Antonio, Texas, 2001.
218. Huh J, LeMaire SA, Walsh GL. Surgical management of recurrent rhabdomyosarcoma of the diaphragm. Michael E. DeBakey International Surgical Society XIIIth Congress, Houston, Texas, 2000.
219. Vaporciyan AA, Merriman KW, Ece F, Roth JA, Smythe WR, Swisher SG, Walsh GL, Putnam JB Jr. Incidence of major pulmonary morbidity after pneumonectomy: association with timing of smoking cessation. Forty-seventh Annual Meeting of the Southern Thoracic Surgical Association, Marco Island, Florida, 2000.
220. Shaikh ZHA, Walsh GL, Champlin RE, Rolston KVI, Kontoyiannis DP. The diagnostic yield of open lung biopsy (OLB) in bone marrow transplant (BMT) recipients. Thirty-eighth Annual Meeting of the Infectious Diseases Society of America, New Orleans, Louisiana, 2000.
221. Swisher SG, Roth JA, Komaki R, Hicks M, Ro J, Dreiling L, Yver AB, Stevens C, Putnam JB Jr, Smythe WR, Vaporciyan AA, Walsh GL. A phase II trial of adenoviral mediated p53 gene transfer (RPR/INGIN 201) in conjunction with radiation therapy in patients with localized non-small cell lung cancer. Thirty-sixth Annual Meeting, American Society of Clinical Oncology, New Orleans, Louisiana, 2000.
222. Putnam JB Jr, Benjamin RS, Rha SJ, Walsh GL, Swisher SG, Vaporciyan AA, Smythe WR, Roth JA. Early results of isolated single lung perfusion for treatment of unresectable sarcomatous metastases. Eightieth Annual Meeting, American Association for Thoracic Surgery, Toronto, Ontario, Canada, 2000.
223. Walsh GL, Davis BM, Swisher SG, Vaporciyan A, Smythe WR, Merriman K, Roth JA, Putnam JB Jr. A single-institution, multidisciplinary approach to primary sarcomas involving the chest wall requiring full thickness resections. Eightieth Annual Meeting, American Association for Thoracic Surgery, Toronto, Ontario, Canada, 2000.
224. Wang W, Lin S, Kemp B, Walsh G, Hong W, Mao L. C-cam, a candidate tumor suppressor gene, is abnormally expressed in primary lung cancers. Proc. of Amer. Assoc Can Res 41:500-500, 2000.
225. Sueoka N, Lee HY, Walsh GL, Fang B, Ji L, Roth JA, LaPushin R, Hong W, Kurie J. Role of insulin-like growth factor binding protein-6 in the proliferation of human bronchial epithelial cells and non-small cell lung cancer cell lines. Proc. of Amer Assoc Can Res 41:500, 2000.
226. Komaki R, Roth JA, Walsh GL, Putnam JB Jr, Swisher S, Vaporciyan A, Lee JS, Fossella F, Chasen M, Cox JD. Multidisciplinary approach for 143 patients with superior sulcus tumors treated at The University of Texas M. D. Anderson Cancer Center. J JASTRO 12:110-110, 2000.
227. Shin DM, Walsh GL, Smythe WR, Ro JY, Shin HJ, Swisher SG, Lu C, Fossella FV, Khuri FR, Yalamanchilli A, Hong WK, Khokhar A, Perez-Soler R. Pathologic response of liposomal-entrapped cisplatin analog (L-NDDP) administered in patients (PTS) with malignant pleural mesothelioma (MPM): phase II clinical study. J Intl Assoc Study of Lung Cancer 29:19-19, 2000.
228. Siegenthaler MP, Pisters KM, Merriman KW, Swisher SG, Roth JA, Walsh GL, Vaporciyan AA, Smythe WR, Putnam JB Jr. Preoperative chemotherapy for lung cancer does not increase surgical morbidity. Thirty-sixth Annual Meeting, The Society of Thoracic Surgeons, Fort Lauderdale, Florida:Pg. 182, 2000.
229. Eton O, East M, Ross MI, Savary CA, Cohen L, Lee JE, Mansfield PF, Walsh GL, Roth JA, Callender DL, Eicher SA, Curley SA, Myers J, Ellerhorst JA, Papdopoulos NE, Plager C, Bedikian AY, Tomasovic SP, Reitsma D, Srivastava PK. Preliminary clinical results of an active specific immunotherapy induction trial of autologous tumor-derived heat-shock protein peptide complex-96 in patients with metastatic melanoma. Cancer Research Institute, Cancer Immunosurveillance 1999, New York City, New York:Pg. 01-11, 1999.
230. Fairweather J, Ajani JA, Komaki R, Janjan NA, Pisters PW, Mansfield PF, Walsh GL, Delclos ME, Lynch PM, Raijman I, Feig BW, Hargraves K. Phase I study of CPT-11 plus radiotherapy in patients with locally advanced upper GI carcinomas. Thirty-fifth Annual Meeting, American Society of Clinical Oncology, Thirty-fifth Annual Meeting, Atlanta, Georgia, 1999.
231. Kurie JM, Lee JS, Khuri FR, Morice RC, Walsh GL, Broxson A, Ro JY, Kemp BL, Lee J-K, Lotan R, Xu X, Lu D, Hong WK. 4-hydroxyphenylretinamide (4-HPR) in the reversal of bronchial metaplasia and dysplasia in smokers. Thirty-fifth Annual Meeting, American Society of Clinical Oncology, Atlanta, Georgia, 1999.
232. Perez-Soler R, Walsh GL, Swisher SG, Shin HJC, Kemp BL, Terry K, Khuri FR, Fossella FV, Hong WK, Lopez-Berestein G, Khokhar AR, Shin DM. Phase II study of a liposome-entrapped cisplatin analog (L-NDDP) administered intrapleurally in patients with malignant pleural mesothelioma. Thirty-fifth Annual Meeting, American Society of Clinical Oncology, Atlanta, Georgia, 1999.
233. Khuri FR, Lotan R, Kemp B, Wu H, Feng L, Lee JJ, Parr B, Lee JS, Walsh G, Hong WK, Xu XC. Prognostic significance of RAR in stage I non-small cell lung cancer. Ninetieth Annual Meeting, American Association for Cancer Research, Philadelphia, Pennsylvania, 1999.
234. Swisher SG, Roth JA, Nemunaitis J, Lawrence DD, Kemp BL, el Naggar AK, Hong WK, Mack M, Weill D, Merritt JA, Putnam JB Jr, Walsh GL. Outcome of intralesional adenoviral p53 gene replacement with or without cisplatin in patients with advanced non-small cell lung cancer. Seventy-ninth Annual Meeting of the American Association for Thoracic Surgery, New Orleans, Louisiana, 1999.
235. York J, Walsh GL, Gokaslan ZL. Combined chest wall resection with vertebrectomy and spinal reconstruction for the treatment of pancoast tumors. . The American Association of Neurological Surgeons and Congress of Neurological Surgeons, Fifteenth Annual Meeting, Section on Disorders of the Spine and Peripheral Nerves, Lake Buena Vista, Florida, 1999.
236. Gandhi S, Walsh GL, Komaki R, Gokaslan Z, Putnam JB Jr, Roth JA, Merriman K, Vaporciyan A, Swisher SG. An aggressive multidisciplinary surgical approach to superior sulcus tumors with vertebral invasion can lead to long-term survival. The Society of Thoracic Surgeons Thirty-fifth Annual Meeting, San Antonio, Texas:90, 1999.
237. Martin CA, Walsh GL, Moreland K. Relationship of weight loss and postoperative nutritional complications in esophagogastrectomy patients. American Society of Parenteral and Enteral Nutrition Twenty-third Clinical Congress, San Diego, California 23(1), 1999.
238. Walsh GL, Taylor G, Nesbitt JC, Amato RJ. Improved survival following intensive chemotherapy and radical resections in patients with primary nonseminomatous germ cell tumors of the mediastinum. The Society of Thoracic Surgeons Thirty-fifth Annual Meeting, San Antonio, Texas:190, 1999.
239. Swisher SG, Deford L, Merriman K, Hunt KK, Walsh G, Vaporciyan A, Smythe WR, Morris M, Roth J, Putnam JB, Jr. Impact of operative volume on morbidity, mortality and hospital usage following esophagectomy for esophageal cancer. Proc West Thorac Surg Assoc, 1999.
240. Nesbitt J, Ajani JA, Komaki R, Walsh GL, Putnam JB Jr, Swisher SG, Pisters P, Lynch P, Raijman I, Pazdur R, Delclos M, Martin F, Roth JA. Preoperative taxol-based chemotherapy followed by chemoradiation therapy in patients with potentially resectable esophageal carcinoma. American Society of Clinical Oncology Thirty-fourth Annual Meeting, Los Angeles, California, 1998.
241. Swisher SG, Roth JA, Neumanitis J, Lawrence DD, Kemp BL, Carrasco CH, Connors C, El-Nagger AK, Fossela FV, Glisson BS, Hong WK, Khuri FR, Kurie JM, Lee JJ, Lee JS, Merritt JA, Nesbitt JC, Nguyen D, Pisters KMW, Putnam JB Jr, Schrump DS, Shin DM, Perez-Soler R, Walsh GL. Adenoviral mediated p53 gene transfer in patients with advanced non-small cell lung cancer (NSCLC). Proc Am Soc Clin Oncol 17:431a, 1998.
242. Komaki R, Delclos ME, Walsh GL, Morice RC. Indications and results of endobronchial brachytherapy. Forty-first Annual Clinical Conference, New Frontiers in Research and Treatment of Aerodigestive Tract Cancers, Houston, Texas 41:46-48, 1998.
243. Shin DM, Walsh GL, Putnam JB Jr, Komaki R, Cox JD, Roth JA, Hong WK. Recent advances in the management of malignant thymoma. Forty-first Annual Clinical Conference, New Frontiers in Research and Treatment of Aerodigestive Tract Cancers, Houston, Texas 41:53-54, 1998.
244. Walsh GL, Taubert J, DeJesus Y. Clinical care pathways in thoracic surgery. Forty-first Annual Clinical Conference, New Frontiers in Research and Treatment of Aerodigestive Tract Cancers, Houston, Texas 41:121-122, 1998.
245. York JE, Gokaslan ZL, Walsh GL. Combined chest wall resection with vertebrectomy and spinal reconstruction for the treatment of pancoast tumors. Proc. North American Spine Society, Charleston, South Carolina, 1998.
246. Hittelman WN, Lee JJ, Lee JS, Yu R, Kurie J, Mao L, Morice RC, Walsh GL, Ro JY, Hong WK. Persistent genetic instability despite decreased proliferation in human lung tissue following smoking cessation. Proceedings American Association for Cancer Research Annual Meeting, New Orleans, Louisiana 39:336, 1998.
247. Lee HY, Walsh GL, Marcia D, Hong WK, Kurie J. All-trans retinoic acid inhibits Jun N-terminal kinase-dependent signaling pathways. American Association for Cancer Research Annual Meeting, New Orleans, Louisiana 39:275, 1998.
248. Sueoka N, Lee HY, Rajah R, Walsh GL, Hong WK, Cohen P, Kurie J. The role of insulin-like growth factor binding proteins in retinoids signaling. American Association for Cancer Research Annual Meeting, New Orleans, Louisiana 39:111, 1998.
249. Swisher SG, Hu M, Holmes EC, Hunt K, Ajani J, McFadden D, Nelson S, Nesbitt J, Putnam JB Jr, Vaporciyan A, Walsh GL, Zinner M, Roth JA. Impact of number of involved lymph nodes on long-term survival in esophageal cancer. Fifty-first Annual Cancer Symposium, Society of Surgical Oncology, San Diego, California, 1998.
250. Wu W, Fan YH, Kemp BL, Walsh GL, Mao L. Frequent overexpression of cdc25A and cdc25B in non-small cell lung cancer is not associated with c-myc overexpression. American Association for Cancer Research Annual Meeting, New Orleans, Louisiana 39:544, 1998.
251. Shin DM, Walsh GL, Swisher SG, Khokhar AR, Wimberly A, Shin HJ, Ro JY, Kong WK, Perez-Soler R. Antitumor activity of a liposome entrapped cisplatin analog (L-NDDP) administered intrapleurally in patients with malignant pleural mesothelioma. Tenth NCI-EORTC Symp. On New Drugs in Can. Therapy 52:19, 1998.
252. Ajani JA, Nesbitt J, Komaki R, Walsh GL, Putnam JB, Jr, Swisher SG, Pisters P, Lynch P, Pazdur RR, Delclos M, Martin F, Roth JA. Three-step paclitaxel-based therapy in patients with resectable esophageal carcinoma. Proc Invest Taxol Workshop, 1998.
253. Nesbitt JC, Ferson DZ, Walsh GL, Schrump DS, Swisher SG, Nesbitt KK, Putnam JB Jr. The laryngeal mask airway: a valuable adjunct for laser bronchoscopy of obstructive tumors. American College of Chest Physicians Clinical Congress on Diseases of the Chest, New Orleans, Louisiana, 1997.
254. Nesbitt JC, Whitehead WE, Darwish AA, Walsh GL, Schrump DS, Swisher SG, Willis KD, Roth JA, Putnam JB Jr. Survival and operative risk following pneumonectomy. American College of Chest Physicians Clinical Congress on Diseases of the Chest, New Orleans, Louisiana, Chest 112:8S-9S, 1997.
255. Varon J, Walsh G. Feasibility of non-invasive mechanical ventilation in the treatment of acute respiratory failure in cancer. The American Society of Anesthesiologists Annual Meeting, San Diego, California 87, 1997.
256. Roth JA, Swisher SG, Lawrence DD, Kemp BL, Carrasco CH, El-Naggar AK, Fossella FV, Glisson BS, Hong WK, Khuri FR, Kurie JM, Nesbitt JC, Pisters K, Putnam JB Jr, Schrump DS, Shin DM, Walsh GL. Gene replacement for lung cancer. J Intl Assoc Study of Lung Cancer 18:76, 1997.
257. Shin DM, Komaki R, Putnam JB Jr, Walsh GL, Nesbitt J, Ro JY, Schea RA, Pisters KMW, Schrump D, Gregurich MA, Cox JD, Roth J, Hong WK. Multidisciplinary approach of therapy for advanced stages of unresectable invasive thymoma. First International Meeting on Advances in the Knowledge of Cancer Management, UICC, Vienna, Austria, 1997.
258. Kurie JM, Lee JS, Morice R, Walsh GL, Khuri FR, Broxson A, Ro J, Lippman SM, Hong WK. Auto-fluorescence bronchoscopy in the detection of bronchial metaplasia and dysplasia in chronic smokers. American Society of Clinical Oncology Annual Meeting, Denver, Colorado 16, 1997.
259. Shin D, Komaki R, Putnam JB Jr, Walsh GL, Nesbitt JC, Ro Y, Schea R, Schrump D, Cox J, Roth JA, Hong WK. Induction chemotherapy followed by surgical resection, radiotherapy, and consolidative chemotherapy may cure the advanced stages of unresectable thymoma. American Society of Clinical Oncology Annual Meeting, Denver, Colorado 16, 1997.
260. Swisher SG, Roth JA, Lawrence DD, Kemp BL, Carrasco CH, Fossella FV, Glisson BS, Hong WK, Khuri FR, Kurie JM, Nesbitt JC, Putnam JB Jr, Schrump DS, Shin DM, Walsh GL. Adenoviral-mediated p53 gene transfer in patients with advanced non-small cell lung cancer (NSCLC). American Society of Clinical Oncology Annual Meeting, Denver, Colorado 16, 1997.
261. Gokaslan ZL, McCutcheon IE, Walsh GL, Putnam JB Jr, Nesbitt JC. Transthoracic vertebrectomy in cancer patients. Annual Meeting of the American Association of Neurological Surgeons, Denver, Colorado, 1997.
262. Han GR, Dohi D, Lee HY, Walsh GL, Nesbitt J, Hong W, Cohen P, Kurie J. Retinoic acid increases insulin-like growth factor binding protein-3 expression through a retinoic acid receptor-alpha-dependent, transforming growth factor-beta-independent signaling pathway. American Association for Cancer Research, San Diego, California 38, 1997.
263. Hittelman WN, Yu R, Kurie J, Lee JS, Morice RC, Walsh GL, Ro JY, Hong WK, Lee JJ. Evidence for genomic instability and clonal outgrowth in the bronchial epithelium of smokers. American Association for Cancer Research, San Diego, California 38, 1997.
264. Swisher SG, Roth JA, Lawrence D, Kemp B, Carrasco C, Fossella F, Glisson B, Hong WK, Khuri F, Kurie J, Nesbitt J, Pisters K, Putnam JB Jr, Schrump D, Shin D, Walsh GL. Persistent transgene expression following repeated injection of a recombinant adenovirus containing the p53 wildtype gene in patients with non-small cell lung cancer. American Association for Cancer Research, San Diego, California 38, 1997.
265. Keenan C, Fromm R, Kish S, Walsh GL, Varon J. ICU charges and DNR orders in critically ill cancer patients. Twenty-sixth Educational & Scientific Symposium, Society of Critical Care Medicine, San Diego, California:Pg. 4, 1997.
266. Walsh GL, Gokaslan ZL, McCutcheon IE, Yasko AW, Mineo MT, Swisher SG, Schrump DS, Nesbitt JC, Putnam JB Jr, Roth JA. Anterior approaches to the thoracic spine in patients with cancer: indications and results. Thirty-third Annual Meeting of the Society of Thoracic Surgeons, San Diego, California:Pg. 240-241, 1997.
267. Roth JA, Swisher SG, Lawrence DD, Kemp BL, Carrasco CH, El-Naggar AK, Fossella FV, Glisson BS, Hong WK, Khuri FR, Kurie JM, Nesbitt JC, Pisters K, Putnam JB Jr, Schrump DS, Shin DM, Walsh GL. Gene therapy strategies for lung cancer. J Intl Assoc Study of Lung Cancer 18:141, 1997.
268. Ferson DZ, Nesbitt JC, Kenfield-Nesbitt K, Walsh GL, Putnam JB Jr, Johansen MJ, Jones RL, Roth JA. The laryngeal mask airway: a new standard for airway evaluation in thoracic surgery. Forty-third Annual Meeting of the Southern Thoracic Surgical Association, Cancun, Mexico, 1996.
269. Soltero E, Nesbitt JC, Dinney C, Walsh GL, Schrump DS, Willis KD, Putnam JB Jr. Surgical management of renal cell carcinoma with inferior vena cava tumor thrombus. Forty-third Annual Meeting of the Southern Thoracic Surgical Association, Cancun, Mexico, 1996.
270. Morice RC, Walsh GL, Ali MK, Roth JA. Redefining the lowest exercise peak oxygen consumption acceptable for lung resection of high-risk patients. The Sixty-second Annual International Scientific Assembly, American College of Chest Physicians, San Francisco, California, Chest 110:161S, 1996.
271. Keenan CH, Varon J, Walsh GL, Kish S, Fromm RE. Charges pre and post do-not-resuscitate orders and outcome in critically ill cancer patients. . The Sixty-second Annual International Scientific Assembly, American College of Chest Physicians, San Francisco, California, Chest 110:147S, 1996.
272. Walsh GL, Soysal O, Putnam JB Jr, Nesbitt JC, Willis KM, Roth JA. Should pulmonary metastasectomies be performed in patients over 70 years of age?. Sixty-fifth Annual Meeting of the Royal College of Physicians and Surgeons of Canada, Halifax, Nova Scotia, Canada 39(4), 1996.
273. Hittelman W, Yu R, Boiko I, Kurie J, Lee JS, Morice RC, Walsh GL, Ro JY, Hong WK, Lee JJ. Detection of preneoplasia and early carcinoma. Fifth Annual Meeting of the I.A.S.C.L. Lung Tumor Biology Workshop, Ermatingen, Switzerland, 1996.
274. Dohi DF, Kim YH, Walsh GL, Nesbitt JC, Shin DM, Consoli U, Andreef M, Hong WK, Kurie JM. Retinoic acid-induced growth inhibition of normal bronchial epithelial cells is abrogated by immortalization with a hybrid adenovirus 12/simian virus 40. Eighty-seventh Annual Meeting of the American Association for Cancer Research, Washington, DC 37, 1996.
275. Lee H-Y, Heyman RA, Walsh GL, Nesbitt JC, Hong WK, Kurie JM. A synthetic retinoid, TTNPB, that preferentially binds RAR nuclear retinoid receptors inhibits squamous differentiation of normal human bronchial epithelial cells. Eighty-seventh Annual Meeting of the American Association for Cancer Research, Washington, DC 37, 1996.
276. Lee JS, Komaki R, Morice RC, Fox NT, Ro JY, Murphy WK, Shin DM, Walsh GL, Hittelman WN, Hong WK. A phase I biomarker correlation study of Taxol and endobronchial brachytherapy for non-small cell lung cancer. Eighty-seventh Annual Meeting of the American Association for Cancer Research, Washington, DC 37, 1996.
277. Wheeler R, Shahanian H, Montgomery J, Walsh GL, Lu Z, Yan J-M, Diasio R. Pharmacokinetic study of radiolabeled BCX-34: A T-cell-specific agent. Eighty-seventh Annual Meeting of the American Association for Cancer Research, Washington, DC 37, 1996.
278. Varon J, Fromm RE, Keenan CH, Walsh GL. Should a cancer patient be resuscitated following an in-hospital cardiac arrest?. Twenty-fifth Annual Meeting of the Society of Critical Care Medicine, New Orleans, Louisiana, 1996.
279. Gokaslan ZL, McCutcheon I, Walsh GL, Sawaya R. Anterior thoracic/lumbar reconstruction and instrumentation using Synthes® thoracolumbar locking plate/screws in cancer patients. Annual Meeting of the Congress of Neurological Surgeons, San Francisco, California, 1995.
280. Putnam JB Jr, Soysal O, Roth JA, Walsh GL, Nesbitt JC, Schrump DS. Results of esophagectomy for severe dysplasia in Barrett's esophagus. Annual Meeting of the Sixth World Congress of the International Society for Diseases of the Esophagus, Milan, Italy:Pg. 168, 1995.
281. Putnam JB Jr, Walsh GL, Nesbitt JC, McMurtrey MJ, Roth JA, Suell DA, Schrump DS, Ohnmacht GA, Willis KM. The technique of esophagectomy does not influence survival after resection of esophageal carcinoma. Annual Meeting of the Sixth World Congress of the International Society for Diseases of The Esophagus, Milan, Italy:Pg. 22, 1995.
282. Dohi D, Kim YH, Walsh GL, Nesbitt JC, Andreef M, Hong WK, Kurie JM. SV40/Adenovirus antagonizes retinoid-induced growth inhibition in human bronchial epithelial cells. Eighty-sixth Annual Meeting of American Association for Cancer Research, Toronto, Ontario, Canada:Pg. 508, 1995.
283. Kim YH, Dohi D, Walsh GL, Nesbitt JC, Xu XC, Zou CP, Hong WK, Lotan R, Kurie JM. Lung carcinogenesis is associated with altered RA nuclear receptor (RAR)- expression. Proc Third Joint Conference of the American Association for Cancer Research and the Japanese Cancer Association: Molecular biology of Cancer: Implications for Prevention and Therapy, Maui, Hawaii, 1995.
284. Kim YH, Dohi D, Walsh GL, Nesbitt JC, Xu X, Zou CP, Hong WK, Lotan R, Kurie JM. Lung carcinogenesis is associated with altered RA nuclear receptor (RAR)-beta expression. Proc Mechanism of Action of Retinoids, Vitamin D, and Steroid Hormones: American Association for Cancer Research, Whistler, British Columbia, Canada, 1995.
285. Putnam JB Jr, Suell DA, Roth JA, McMurtrey MJ, Ryan MB, Walsh GL, Nesbitt JC, Schrump DS. A comparison of three techniques of esophagectomy for carcinoma of the intrathoracic esophagus. Second International Conference on Biology, Prevention and Treatment of Gastrointestinal Malignancies, Koln, Germany, 1995.
286. Walsh GL, O'Connor M, Wong R, Milas M, Willis K, Nesbitt JC, Putnam JB Jr, Roth JA. Is follow-up of lung cancer patients following resection medically indicated and cost effective?. Annual Meeting of The Society of Thoracic Surgeons, Palm Springs, California:Pg. 134, 1995.
287. Walsh GL, Morice RC, Putnam JB Jr, Nesbitt JC, McMurtrey MJ, Ryan MB, Roth JA. Resection of lung cancer is justified in high-risk patients selected by exercise oxygen consumption. . Lung Cancer 12:301, 1995.
288. Soysal O, Walsh GL, Nesbitt JC, McMurtrey MJ, Roth JA. Resection of sternal tumors: extent, reconstruction, and survival. Forty-first Annual Meeting of the Southern Thoracic Surgical Association, Marco Island, Florida:Pg. 42, 1994.
289. Walsh GL, Shin D, Komaki R, McMurtrey M, Hong W, Roth JA. An aggressive multimodality protocol does not improve survival in patients with malignant pleural mesothelioma (MPM). Annual Meeting of The Society of Surgical Oncology, Inc., Houston, Texas, 1994.
290. Carrasco CH, Nesbitt JC, Charnsangavej C, Ryan MB, Walsh GL, Lawrence DD, Wallace S. Management of tracheal and bronchial stenoses with Gianturco stents. Thirtieth Annual Meeting of The Society of Thoracic Surgeons, New Orleans, Louisiana:Pg. 120, 1994.
291. Walsh GL, Morice R, Putnam JB Jr, Nesbitt JC, McMurtrey MJ, Ryan MB, Reising J, Natarajan G, Roth JA. An aggressive surgical approach is justified in high-risk patients with lung cancer identified by exercise oxygen consumption testing. Thirtieth Annual Meeting of The Society of Thoracic Surgeons, New Orleans, Louisiana:Pg. 126, 1994.
292. Putnam JB Jr, Suell DM Jr, McMurtrey MJ, Ryan B, Walsh GL, Roth JA. Esophagectomy: comparison of three techniques from one institution with a residency training program. Twenty-ninth Annual Meeting of The Society of Thoracic Surgeons, San Antonio, Texas:Pg. 104, 1993.
293. Ajani J, Roth JA, Putnam JB, Jr Rodman H, Ryan B, Walsh GL, Lynch P, Gould P. Feasibility of five preoperative chemotherapy courses for resectable adenocarcinoma of the esophagus and GE junction. Proc. Am. Assoc. Cancer Res 33:218, 1992.
294. Macris MP, Walsh GL, Nesbitt JC, Roth JA, Putnam JB Jr. Video-assisted thoracoscopy in thoracic surgical oncology. Society of Thoracic Surgeons Eighth International Symposium, Puerto Rico, 1992.
295. Walsh G, Dewar M, Chiu RC-J. Skeletal muscle cardiac assist with an extra-aortic balloon for counterpulsation. Heart Transplantation 7:318, 1988.
296. Ianuzzo CD, O'Brien P, Kochamba G, Walsh G, Dewar M, Chiu RC-J. Biochemical changes in transformed fatigue resistant skeletal muscle. Devices and Technology Branch Contractors Meeting 1987. National Institutes of Health, Bethesda, Maryland:Pg. 117, 1987.
297. O'Brien P, Kochamba G, Walsh G, Dewar M, Chiu RC-J, Ianuzzo CD. Biochemical transformation of electrically stimulated skeletal muscle for use in cardiac assist. Presented at the Thirty-eighth Annual Fall Meeting of the American Physiological Society, San Diego, California, The Physiologist 30:200, 1987.
298. Chiu RC-J, Walsh GL, Dewar ML, DeSimon JH, Khalafalla AS, Ianuzzo D. Implantable extra-aortic balloon assist powered by transformed fatigue-resistant skeletal muscle. Am. Assoc. Surg., Chicago, Illinois, 1987.
299. Walsh G, Dewar M, Neilson I, DeSimon JH, Lough J, Khalafalla A, Chiu RC-J. Stimulation parameters of skeletal muscle for cardiac assist. Proc. of the Eighth Annual Conference of the IEEE Engineering in Medicine and Biology Society, Fort Worth, Texas 1:62-64, 1986.
300. Dewar M, Walsh G, Abraham R, DeSimon J, Foot E, Stewart JA, Chiu RC-J. Cardiomyoplasty: technical considerations for a new procedure. Proc. Annual Meeting Canadian Cardiovascular Society, Ottawa, Ontario. Clin. Invest. Med 8:B35, 1986.
301. Walsh GL, Dewar ML, DeSimon J-H, Khalafalla AS, Neilson IR, DeSimon JH, Chiu RC-J. Characteristics of transformed fatigue-resistant skeletal muscle for long-term cardiac assistance by extra-aortic balloon counterpulsation. Proc. American College of Surgeons 1986 Clinical Congress, New Orleans, Louisiana, Surg. Forum 37:205-207, 1986.
302. Walsh GL, Dewar M, Neilson IR, DeSimon J-H, Lough J, Khalafalla A, Chiu RC-J. Counterpulsation with fatigue-resistant skeletal muscle. Proc. Annual Meeting Canadian Cardiovascular Society, Ottawa, Ontario, Clin. Invest. Med 8:B79, 1986.
303. Dewar ML, Walsh GL, Stewart JA, Chiu RC-J, Abraham RG. Myocardioplasty and thrombus formation. Proc. of 10th World Congress of Cardiology, Washington DC, 1986.
304. Walsh G, Dewar M, Khalafalla A, Neilson I, Chiu RC-J. Stimulation parameters for preconditioned skeletal muscle. Proc. Annual Meeting North American Society of Pacing & Electrophysiology, Wellesley, Massachusetts, Clin. Prog. Electrophysiol & Pacing 4, 1986.

Book Chapters

1. Gokaslan ZL, Bagley CA, Walsh GL. Trapdoor Exposure of the Cervicothoracic Junction. In: Neurosurgical Operative Atlas: Spine and Peripheral Nerves, 3rd Edition. Third. Thieme Medical Publishers: New York, NY, 136-138, 2017.
2. Walsh GL. Lung Cancer: Surgical Strategies for Tumors Invading the Chest Wall. In: Sabastian and Spencer Surgery of the Chest, 9th Edition. 9th. Elsevier, 336-354, 2016.
3. Tatsui CE, Rhines LD, Walsh GL. Thoracic En Bloc spondylectomy. In: Master Techniques in Surgery:Thoracic Surgery / Lung Resections, Bronchoplasty. Lippincott Williams & Wilkins: Philadelphia, PA, 329-336, 2015.
4. Yu P, Walsh GL. Microvascular Reconstruction of Tracheal Defects. In: Master Techniques in Surgery: Thoracic Surgery: Transplantation, Tracheal Resections, Mediastinal Tumors, Extended Thoracic Resections. Wolters Kluwer: Philadelphia, PA, 403-412, 2015.
5. David EA, Walsh GL. Carinal Resection. In: Mastery of Cardiothoracic Surgery, 3e. 3. Wolters Kluwer, 2013.
6. David EA, Gomez DR, Komaki R, Walsh GL. Staging and prognosis. In: Personalized Management of Lung Cancer. Future Medicine Ltd: London, UK, 42-60, 2013.
7. Kim JY, Walsh GL. Surgical Management of IVC Tumors. In: Cardiothoracic Surgery Review, First Edition. 1. Lippincott Williams & Wilkins, 2011.
8. Kim JY, Walsh GL. Germ cell tumors of the mediastinum. In: Cardiothoracic Surgery Review, First Edition. 1. Lippincott Williams & Wilkins, 2011.
9. Martin LW, Walsh GL. Vertebral Body Resection. In: Principles & Practice of Lung Cancer ; The Official Reference Text of the IASLC. Fourth. Lippincott Williams & Wilkins, 491-498, 2010.
10. Steliga MA, Straznicka M, Walsh GL. Lung Cancer: Surgical Strategies for Tumors Invading the Chest Wall. In: Sabiston and Spencer Surgery of the Chest 8e. 8. Elsevier, 295-311, 2010.
11. Walsh GL. Staging of Thoracic Malignancies: A Surgeon's Perspective. In: Tumors and Tumor Like Conditions of the Lung and Pleura. Elsevier, 41-49, 2010.
12. Herrera L, Walsh GL. Management of residual disease after therapy for mediastinal germ cell tumor and normal serum markers. In: Difficult Decisions in Thoracic Surgery An Evidence-Based Approach. Springer London, 474-481, 2007.
13. Gokaslan ZL, Bagley CA, Walsh GL. "Trap Door" Exposure of the Cervicothoracic Junction. In: Neurosurgical Operative Atlas: Spine & Peripheral Nerves. Second. American Association od Neurological Surgeons, 117-123, 2007.
14. Reul R, Walsh GL. Tissue adhesives in thoracic surgery. In: Advanced Therapy in Thoracic Surgery. B.C. Decker, Chapter 3, pp. 47-60, 2005.
15. McMullan DM, Walsh GL . Pleural effusions. In: Current Therapy in Thoracic and Cardiovascular Surgery. Mosby, pp 297-303, 2004.
16. Straznicka M, Walsh GL. Lung Cancer: Surgical Strategies for Tumors Invading the Chest Wall. In: Sabiston & Spencer Surgery of the Chest. Elsevier: Saunders,, pp 295-311, 2004.
17. Martin LW, Walsh GL. Vertebral body resection. In: Aggressive Surgery for Lung Cancer. Elsevier, Inc: Philadelphia, 2004.
18. Swisher SG, Putnam JB Jr, Feig BW, Miller MJ, Walsh GL. Staging and surgery of esophageal carcinoma. In: Atlas of Cancer. Lippincott, Williams & Wilkins, pp 178-187, 2003.
19. Walsh GL. Invited Commentary, Exposure for spine tumors. In: Thoracic Surgical Oncology: Exposures and Techniques. Lippincott, Williams & Wilkins, pp 279-280, 2003.
20. Walsh GL. Invited Commentary, Superior sulcus tumor resection: anterior approach. In: Thoracic Surgical Oncology: Exposures and Techniques. Lippincott, Williams & Wilkins, pp 191-193, 2003.
21. Walsh GL. Invited Commentary, Superior sulcus tumor resection: posterior approach. In: Thoracic Surgical Oncology: Exposures and Techniques. Lippincott, Williams & Wilkins, pp 179-181, 2003.
22. Walsh GL. Posterolateral approaches to the superior sulcus. In: Operative Techniques in Thoracic and Cardiovascular Surgery: A Comparative Atlas,. W.B. Saunders, pp 94-103, 2003.
23. DeJesus AY, Walsh GL. Role of clinical practice guidelines and clinical pathways in the treatment of patients with lung cancer. In: Lung Cancer, 2002.
24. Ferguson E, Walsh GL. Sarcomas of the heart and great vessels, Soft Tissue Sarcomas, Chapter 10. In: ACS Atlas of Clinical Oncology. B.C. Decker, Inc, 2001.
25. Walsh GL, Gandhi S, Komaki R. Management of superior sulcus tumors. In: Controversies in Lung Cancer. Marcel Dekker, 225-255, 2001.
26. Gokaslan ZL, Walsh GL. "Trap door" exposure of the cervicothoracic junction. In: Neurosurgical Operative Atlas. The American Association of Neurological Surgeons, pp 253-260, 1999.
27. Walsh GL. The bank robber with a short sprint but a long race. In: Near Misses in Pulmonary and Cardiothoracic Critical Care. Butterworth-Heinemann, 01-04, 1999.
28. Walsh GL. A Canadian corpse who wiggled her toes. In: Near Misses in Pulmonary and Cardiothoracic Critical Care. Butterworth-Heinemann, 81-84, 1999.
29. Walsh GL. The cancer patient with a large left-sided pleural effusion and the intensive care unit resident with stubby fingers. In: Near Misses in Pulmonary and Cardiothoracic Critical Care. Butterworth-Heinemann, 31-33, 1999.
30. Walsh GL. Chest pain in a college party animal. In: Near Misses in Pulmonary and Cardiothoracic Critical Care. Butterworth-Heinemann, 11-13, 1999.
31. Walsh GL. The college freshman with warm hands but cold feet. In: Near Misses in Pulmonary and Cardiothoracic Critical Care. Butterworth-Heinemann, pp 97-100, 1999.
32. Walsh GL. The long-forgotten ride in a small car with a large friend. In: Near Misses in Pulmonary and Cardiothoracic Critical Care. Butterworth-Heinemann, 21-24, 1999.
33. Walsh GL. Loss of vision in a man carrying groceries on ice. In: Near Misses in Pulmonary and Cardiothoracic Critical. Butterworth-Heinemann,, 15-16, 1999.
34. Walsh GL. A nursing student gives her first sponge bath. In: Near Misses in Pulmonary and Cardiothoracic Critical Care. Butterworth-Heinemann, 59-61, 1999.
35. Walsh GL. The opera singer with a hoarse voice. In: Near Misses in Pulmonary and Cardiothoracic Critical Care. Butterworth-Heinemann, pp 101-103, 1999.
36. Walsh GL. Respiratory arrest in an old man with bad breath. In: Near Misses in Pulmonary and Cardiothoracic Critical Care. Butterworth-Heinemann, 17-19, 1999.
37. Walsh GL. A third-year anesthesia resident armed with a double-lumen tube. In: Near Misses in Pulmonary and Cardiothoracic Critical Care. Butterworth-Heinemann, pp. 105-108, 1999.
38. Walsh GL. Who turned the mediastinoscope light off?. In: Near Misses in Pulmonary and Cardiothoracic Critical Care. Butterworth-Heinemann, 1999.
39. Walsh GL. A young head and neck resident and her clean white coat. In: Near Misses in Pulmonary and Cardiothoracic Critical Care. Butterworth-Heinemann, 63-64, 1999.
40. Brewer RJ, Walsh GL. Anesthesia for thoracic surgery in the oncology patient. In: Anesthesiology Clinics of North America. W.B. Saunders Co.,, 605-628, 1998.
41. Komaki R, Morice RC, Walsh GL. High dose-rate remote afterloading endobronchial brachytherapy. In: Lung Cancer. Blackwell Science, Inc, 163-179, 1998.
42. Nesbitt JC, Walsh GL. Surgical management of esophageal perforation. In: Advanced Therapy in Thoracic Surgery. B.C. Decker Inc.,, 500-511, 1998.
43. Nesbitt JC, Walsh GL. Tracheobronchial stents. In: Advanced Therapy in Thoracic Surgery. B.C. Decker Inc.,, 270-280, 1998.
44. Walsh GL, Nesbitt JC. Recent advances in diagnostic and therapeutic bronchoscopy. In: Advanced Therapy in Thoracic Surgery. B.C. Decker Inc, 36-53, 1998.
45. Walsh GL, Morice RC, Putnam JB, Jr, Nesbitt JC, McMurtrey MJ, Ryan MB, Reising J, Willis KM, Morton JD, Roth JA. Resection of lung cancer is justified in high-risk patients selected by exercise oxygen consumption. . In: R.J. Ginsberg, A.S. Wechsler, and W.G. Williams (eds.), The Yearbook of Thoracic and Cardiovascular Surgery, Chicago, IL., Mosby-Yearbook, Inc, pp 5-7, 1996.
46. Komaki R, Morice RC, Walsh GL, Garden AS, Davis M. High dose-rate remote afterloading endobronchial brachytherapy. In: Comprehensive Textbook of Thoracic Oncology. Williams & Wilkins, 940-946, 1996.
47. Walsh GL, Morris P. Thoracoscopic pericardiectomy. In: Operative Laparoscopy and Thoracoscopy. Lippincott-Raven Press, Lippincott-Raven Press, 1996.
48. Nesbitt JC, Putnam JB, Jr, Walsh GL, Roth JA. Malignant diseases of the lung. In: Current Practice of Surgery. Churchill Livingstone, Inc, 01-54, 1995.
49. Walsh GL. General principles and surgical considerations in the management of mediastinal masses. In: Thoracic Oncology. W. B. Saunders, 445-467, 1995.
50. Komaki R, Garden AS, Cundiff H, Walsh GL. Endobronchial radiotherapy. In: Lung Cancer. Blackwell Scientific Publications, 187-196, 1993.
51. Desrosiers C, Neilson I, Walsh G, Kochamba G, Li C, Hill A, Chiu RC-J. Skeletal muscle powered counter pulsator. In: Transformed Muscle for Cardiac Assist and Repair. Futura Publishing Co, Inc, 321-327, 1990.
52. Dionisopoulos T, Brady P, Walsh G, Dewar M, Desrosiers C, Chiu RC-J. Cardiomyoplasty: The interface problem and growth potential. In: Transformed Muscle for Cardiac Assist and Repair. Futura Publishing Co, Inc, 241-246, 1990.
53. Walsh G, Chiu, RC-J. Skeletal muscle for cardiac repair and assist: A historical overview. In: Biomechanical Cardiomyoplasty and Muscle-Powered Devices. Futura Publishing Co.,, 01-18, 1986.